US20240150747A1 - Encystment and stabiilisation of ciliate protozoa cells - Google Patents
Encystment and stabiilisation of ciliate protozoa cells Download PDFInfo
- Publication number
- US20240150747A1 US20240150747A1 US18/281,486 US202118281486A US2024150747A1 US 20240150747 A1 US20240150747 A1 US 20240150747A1 US 202118281486 A US202118281486 A US 202118281486A US 2024150747 A1 US2024150747 A1 US 2024150747A1
- Authority
- US
- United States
- Prior art keywords
- aqueous solution
- cells
- ciliate
- composition
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000223782 Ciliophora Species 0.000 title claims abstract description 401
- 229920000642 polymer Polymers 0.000 claims abstract description 230
- 239000000203 mixture Substances 0.000 claims abstract description 149
- 238000000034 method Methods 0.000 claims abstract description 137
- 239000000416 hydrocolloid Substances 0.000 claims abstract description 49
- 230000001939 inductive effect Effects 0.000 claims abstract description 18
- 241000237852 Mollusca Species 0.000 claims abstract description 13
- 230000003019 stabilising effect Effects 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims description 303
- 229920001282 polysaccharide Polymers 0.000 claims description 152
- 239000005017 polysaccharide Substances 0.000 claims description 151
- 150000004804 polysaccharides Chemical class 0.000 claims description 149
- 229920001525 carrageenan Polymers 0.000 claims description 142
- 239000000679 carrageenan Substances 0.000 claims description 142
- 229940113118 carrageenan Drugs 0.000 claims description 142
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 137
- 235000010418 carrageenan Nutrition 0.000 claims description 133
- 241000607479 Yersinia pestis Species 0.000 claims description 93
- 239000007853 buffer solution Substances 0.000 claims description 77
- 229920002148 Gellan gum Polymers 0.000 claims description 69
- 241000248417 Tetrahymena rostrata Species 0.000 claims description 68
- 239000000216 gellan gum Substances 0.000 claims description 60
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 57
- 235000010492 gellan gum Nutrition 0.000 claims description 56
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 45
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 45
- 229920001285 xanthan gum Polymers 0.000 claims description 41
- 238000011534 incubation Methods 0.000 claims description 39
- 235000010493 xanthan gum Nutrition 0.000 claims description 39
- 239000000230 xanthan gum Substances 0.000 claims description 39
- 229940082509 xanthan gum Drugs 0.000 claims description 39
- 241000237858 Gastropoda Species 0.000 claims description 38
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 29
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 28
- 230000001580 bacterial effect Effects 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 20
- 241000196324 Embryophyta Species 0.000 claims description 20
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 17
- 239000007995 HEPES buffer Substances 0.000 claims description 15
- 241000195493 Cryptophyta Species 0.000 claims description 14
- 239000013028 medium composition Substances 0.000 claims description 14
- 235000010443 alginic acid Nutrition 0.000 claims description 13
- 229920000615 alginic acid Polymers 0.000 claims description 13
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 12
- 229940072056 alginate Drugs 0.000 claims description 12
- 239000006172 buffering agent Substances 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 11
- 239000000969 carrier Substances 0.000 claims description 11
- 241000233866 Fungi Species 0.000 claims description 10
- 229920001817 Agar Polymers 0.000 claims description 9
- 229920000936 Agarose Polymers 0.000 claims description 9
- 239000008272 agar Substances 0.000 claims description 9
- 235000010419 agar Nutrition 0.000 claims description 9
- 229920001586 anionic polysaccharide Polymers 0.000 claims description 9
- 150000004836 anionic polysaccharides Chemical class 0.000 claims description 9
- 229920006037 cross link polymer Polymers 0.000 claims description 6
- 241000243200 Oligohymenophorea Species 0.000 claims description 5
- 241001467592 Spirotrichea Species 0.000 claims description 5
- 241000223892 Tetrahymena Species 0.000 claims description 5
- 230000002147 killing effect Effects 0.000 claims description 5
- 241000263762 Armophorea Species 0.000 claims description 4
- 241000248331 Colpodea Species 0.000 claims description 4
- 241001456120 Heterotrichea Species 0.000 claims description 4
- 241001467590 Karyorelictea Species 0.000 claims description 4
- 241000248342 Litostomatea Species 0.000 claims description 4
- 241000243338 Nassophorea Species 0.000 claims description 4
- 241001501891 Ophryoglenina Species 0.000 claims description 4
- 241000243198 Peritrichia Species 0.000 claims description 4
- 241001503943 Phyllopharyngea Species 0.000 claims description 4
- 241000828008 Plagiopylea Species 0.000 claims description 4
- 241000243335 Prostomatea Species 0.000 claims description 4
- 241001490743 Scuticociliatia Species 0.000 claims description 4
- 241000248385 Tetrahymena corlissi Species 0.000 claims description 4
- 241000167876 Tetrahymena empidokyrea Species 0.000 claims description 4
- 241000248392 Tetrahymena hegewischi Species 0.000 claims description 4
- 241000223891 Tetrahymena hyperangularis Species 0.000 claims description 4
- 241000248387 Tetrahymena limacis Species 0.000 claims description 4
- 241000248419 Tetrahymena malaccensis Species 0.000 claims description 4
- 241000248424 Tetrahymena pigmentosa Species 0.000 claims description 4
- 241000248418 Tetrahymena pyriformis Species 0.000 claims description 4
- 241000248384 Tetrahymena thermophila Species 0.000 claims description 4
- 241000248381 Tetrahymena vorax Species 0.000 claims description 4
- 241001123204 Tetrahymenidae Species 0.000 claims description 4
- 229940023476 agar Drugs 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 241000248425 Tetrahymena patula Species 0.000 claims 2
- 210000004027 cell Anatomy 0.000 description 489
- 239000002245 particle Substances 0.000 description 65
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 48
- 235000010204 pine bark Nutrition 0.000 description 43
- 239000000243 solution Substances 0.000 description 39
- 208000031513 cyst Diseases 0.000 description 37
- 238000003860 storage Methods 0.000 description 29
- 125000000129 anionic group Chemical group 0.000 description 27
- 239000000654 additive Substances 0.000 description 22
- 239000000872 buffer Substances 0.000 description 21
- 238000001802 infusion Methods 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000000725 suspension Substances 0.000 description 15
- 238000004132 cross linking Methods 0.000 description 13
- 239000000017 hydrogel Substances 0.000 description 13
- 239000002689 soil Substances 0.000 description 13
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 13
- 230000035899 viability Effects 0.000 description 13
- -1 CMC) Chemical class 0.000 description 11
- 206010011732 Cyst Diseases 0.000 description 11
- 239000002361 compost Substances 0.000 description 11
- 230000018044 dehydration Effects 0.000 description 11
- 238000006297 dehydration reaction Methods 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 11
- 230000003993 interaction Effects 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 241001300076 Deroceras reticulatum Species 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000001524 infective effect Effects 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 230000006641 stabilisation Effects 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 229910021642 ultra pure water Inorganic materials 0.000 description 7
- 239000012498 ultrapure water Substances 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000002538 fungal effect Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 241001474374 Blennius Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000005667 attractant Substances 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 229920001477 hydrophilic polymer Polymers 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- 238000004382 potting Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 210000004215 spore Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 4
- 241000609240 Ambelania acida Species 0.000 description 4
- 241001298365 Arion ater Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- 101000641031 Homo sapiens Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 4
- 235000011613 Pinus brutia Nutrition 0.000 description 4
- 241000018646 Pinus brutia Species 0.000 description 4
- 240000000111 Saccharum officinarum Species 0.000 description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 description 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 239000010905 bagasse Substances 0.000 description 4
- 235000013877 carbamide Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 230000031902 chemoattractant activity Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108010009004 proteose-peptone Proteins 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical group CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 3
- 241000589636 Xanthomonas campestris Species 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229920006318 anionic polymer Polymers 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000012062 aqueous buffer Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 229940105329 carboxymethylcellulose Drugs 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000003071 parasitic effect Effects 0.000 description 3
- 238000009304 pastoral farming Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000003415 peat Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000037351 starvation Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 241000022344 Intramacronucleata Species 0.000 description 2
- 241000893572 Lambornella Species 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 235000008577 Pinus radiata Nutrition 0.000 description 2
- 241000218621 Pinus radiata Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000005285 Tagetes patula Species 0.000 description 2
- 241001501881 Tetrahymenina Species 0.000 description 2
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000010165 autogamy Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 210000004081 cilia Anatomy 0.000 description 2
- 210000000254 ciliated cell Anatomy 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 150000002016 disaccharides Chemical group 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000010459 dolomite Substances 0.000 description 2
- 229910000514 dolomite Inorganic materials 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 2
- 229910000155 iron(II) phosphate Inorganic materials 0.000 description 2
- 229910000399 iron(III) phosphate Inorganic materials 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 210000002231 macronucleus Anatomy 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000003750 molluscacide Substances 0.000 description 2
- 230000002013 molluscicidal effect Effects 0.000 description 2
- 150000002772 monosaccharides Chemical group 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 239000003016 pheromone Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000137586 Ambigolimax valentianus Species 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- 102100027199 Cell death-inducing p53-target protein 1 Human genes 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 241000773831 Deroceras invadens Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 101000914537 Homo sapiens Cell death-inducing p53-target protein 1 Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 240000004752 Laburnum anagyroides Species 0.000 description 1
- 241000893574 Lambornella clarki Species 0.000 description 1
- 241001505912 Limax flavus Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 239000005956 Metaldehyde Substances 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229910006069 SO3H Inorganic materials 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- IXWIAFSBWGYQOE-UHFFFAOYSA-M aluminum;magnesium;oxygen(2-);silicon(4+);hydroxide;tetrahydrate Chemical compound O.O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Mg+2].[Al+3].[Si+4].[Si+4].[Si+4].[Si+4] IXWIAFSBWGYQOE-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 125000000188 beta-D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 239000012681 biocontrol agent Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 238000009264 composting Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000011894 couscous Nutrition 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 230000037416 cystogenesis Effects 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- SDEKDNPYZOERBP-UHFFFAOYSA-H iron(ii) phosphate Chemical compound [Fe+2].[Fe+2].[Fe+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O SDEKDNPYZOERBP-UHFFFAOYSA-H 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- GKKDCARASOJPNG-UHFFFAOYSA-N metaldehyde Chemical compound CC1OC(C)OC(C)OC(C)O1 GKKDCARASOJPNG-UHFFFAOYSA-N 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000007727 pp-medium Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 238000005029 sieve analysis Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 150000004044 tetrasaccharides Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 150000004043 trisaccharides Chemical group 0.000 description 1
- 210000003812 trophozoite Anatomy 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P9/00—Molluscicides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
- C08L1/28—Alkyl ethers
- C08L1/286—Alkyl ethers substituted with acid radicals, e.g. carboxymethyl cellulose [CMC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/10—Protozoa; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/90—Protozoa ; Processes using protozoa
Definitions
- the present disclosure relates to compositions and methods for inducing encystment of and/or stabilising ciliate cells.
- the present disclosure relates to polymers and polymeric solutions which may be used to induce encystment of trophont ciliate cells to form encysted ciliate cells and/or stabilise encysted cells.
- the present disclosure also relates to methods of infecting and/or colonising molluscs with the compositions and ciliates described herein.
- Pests for example slugs and snails, are a problem in agriculture and horticulture because they damage plants and affect the productivity and quality of crops and plant products.
- Various strategies have been used to control pest molluscs which include the use of chemical molluscicides (e.g. methiocarb and metaldehyde) which are usually distributed in baits. These chemicals are not just specific for molluscs, and target other animals raising concerns about their toxic effect and environmental contamination.
- Biological agents such as biological pesticides, have been proposed as an alternative to chemical molluscicides.
- One example is the slug parasitic ciliate Tetrahymena rostrata.
- T. rostrata ciliates transition from being feeding ciliated cells (called “trophont” cells) to reproductive or resting cyst cells (called “cyst” or “encysted” cells) via a process called “encystment”.
- the encysted cells then undergo “excystment” to form juvenile cells (called “theront” cells).
- the present inventors have identified processes for growing and formulating ciliate cells at various developmental stages for production, storage and delivery as a biological pesticide for the control of pests, such as molluscs.
- various polymers improve the storage, stability and viability of ciliate cells.
- the polymers described herein can induce the encystment of trophont ciliate cells to form one or more encysted ciliate cells.
- the polymers can be provided as an aqueous polymer solution, which may be used to encyst or stabilise ciliate cells suspended therein or can be a dried polymer (e.g. via dehydration) wherein one or more encysted ciliate cells are interspersed therein.
- the polymers may be non-ionically crosslinked.
- the encysted ciliate cells remain viable during storage either suspended in the polymeric solution or interspersed within the polymer following dehydration.
- the polymers described herein can be used to stabilise and store preformed encysted cells.
- the encysted ciliate cells can be subsequently released from the polymer and undergo excystment into theront ciliate cells, which the inventors have also identified can be highly infective to pests such as molluscs.
- the present invention therefore provides compositions which can be used to store, stabilise and transport viable encysted ciliate cells, allowing for their use as an effective pest control agent, such as being applied to areas affected or likely to be affected by a pest species.
- composition comprising encysted ciliate cells that are interspersed within a polymer.
- the polymer may be a non-ionically crosslinked polymer.
- the polymer comprises a polysaccharide.
- the polysaccharide is an anionic polysaccharide.
- the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria.
- the polysaccharide is derived from algae or bacteria.
- the polysaccharide is an algal polysaccharide or a bacterial polysaccharide.
- the polysaccharide is an algal polysaccharide.
- the polysaccharide is a bacterial polysaccharide.
- the polysaccharide is selected from the group consisting of carrageenan, agarose, agar, alginate, xanthan gum and gellan gum or a mixture thereof. In one embodiment, the polysaccharide is carrageenan, xanthan gum or gellan gum, or a mixture thereof. In one embodiment, the polysaccharide is carrageenan. In another embodiment, the polysaccharide is xanthan gum. In another embodiment, the polysaccharide is gellan gum.
- the polymer is dispersed in an aqueous solution, and the encysted ciliate cells are suspended in the aqueous solution comprising the polymer.
- the polymer is a dried polymer.
- the aqueous solution comprising the polymer forms a hydrocolloid.
- the aqueous solution comprising the polymer forms an anionic hydrocolloid.
- the ciliate cells may be suspended within the hydrocolloid.
- the aqueous solution comprises between about 0.01% w/v to about 5% w/v polymer based on the total volume of the aqueous solution.
- the aqueous solution comprises between about 0.01% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
- the aqueous solution is a buffer solution.
- the buffer solution comprises a HEPES buffering agent.
- the concentration of the HEPES buffering agent in the buffer solution is between about 1 mM to about 25 mM.
- the buffer solution has a pH of between about 6.0 to about 9.0.
- the encysted ciliate cells interspersed within the polymer remain viable for at least about four weeks.
- the ciliate cells are a member of the Ciliophora phylum. In one embodiment, the ciliate cells are a member of the Heterotrichea, Karyorelictea, Armophorea, Litostomatea, Colpodea, Nassophorea, Phyllopharyngea, Prostomatea, Plagiopylea, Oligohymenophorea, Protocruziea, Spirotrichea, or Cariotrichea class. In one embodiment, the ciliate cells are a member of the Apostomatia, Astomatia, Hymenostomatia, Peniculia, Peritrichia, or Scuticociliatia order.
- the ciliate cells are a member of the Tetrahymenidae, Ophryoglenina, or Peniculina family. In one embodiment, the ciliate cells are a member of the Tetrahymena genus. In one embodiment, the ciliate cells are of the T. rostrata, T. hegewischi, T. hyperangularis, T. malaccensis, T. patula, T. pigmentosa, T. exertsneri, T. deweyae T. pyriformis, T. thermophila, T. vorax, T. geleii, T. corlissi, T. empidokyrea or T. limacis species. In one embodiment, the ciliate cells are of the T. rostrata species.
- a method of inducing the encystment of ciliate cells comprising incubating a population of trophont ciliate cells in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- a method of stabilising encysted ciliate cells comprising suspending a population of encysted ciliate cells in an aqueous solution comprising a polymer.
- the embodiments described above for the polymer, aqueous solution and ciliate cells in relation to the composition comprising ciliate cells equally apply to the methods of encystment and stabilising of ciliate cells described herein.
- the aqueous solution comprising the polymer forms a hydrocolloid. In some embodiments, the aqueous solution comprising the polymer forms an anionic hydrocolloid. In one embodiment, the polymer is not ionically crosslinked during encystment.
- the trophont ciliate cells are incubated in the aqueous solution at a temperature of between about 10° C. to about 30° C. In one embodiment, the trophont ciliate cells are incubated in the aqueous solution for period of time of between about 12 to about 72 hours. In one embodiment, the encysted ciliate cells are stored in the aqueous solution at a temperature of between about 10° C. to about 30° C.
- the method further comprises the step of adding magnesium ions to the aqueous solution prior to or during incubation in an amount effective to stimulate encystment of one or more trophont ciliate cells.
- the method may further comprise the step of adding magnesium ions to the aqueous solution following incubation in an amount effective to stabilise the one or more encysted ciliate cells.
- the magnesium ions may be provided by a suitable magnesium salt, for example magnesium sulfate.
- the method further comprises dehydrating the aqueous solution to obtain a dried polymer wherein the one or more encysted ciliate cells are interspersed within the polymer.
- an encystment media composition comprising an aqueous solution and a non-ionically crosslinked polymer.
- the embodiments described above for the polymer and aqueous solution in relation to the compositions comprising ciliate cells and methods of encystment and stabilising of ciliate cells methods equally apply to the encystment media composition described herein.
- an agricultural or horticultural composition comprising the composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above, in combination with one or more agriculturally or horticulturally acceptable carriers.
- a method of infecting or colonising a pest species with a ciliate comprising applying to an area affected or likely to be affected by a pest species a composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above.
- a method of infecting or colonising a pest species with a ciliate comprising applying a composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above to the pest species.
- a method for reducing agricultural crop damage comprising applying to an agricultural crop area affected or likely to be affected by a pest species a pest species a composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above.
- the method results in the ciliate killing or affecting the fitness of the pest species.
- the pest species is an invertebrate.
- the pest species is a mollusc.
- the mollusc is a Gastropod.
- the Gastropod is a snail or slug.
- any embodiment herein shall be taken to apply mutatis mutandis to any other embodiment unless specifically stated otherwise.
- the skilled person would understand that examples and embodiments of polymers, aqueous solutions, additives and ciliate cells described herein in relation to the composition comprising encysted ciliate cells equally apply to the method of inducing encystment and method of stabilising ciliate cells, encystment media compositions, agricultural or horticultural compositions, methods of infecting a pest species and/or methods for reducing agricultural crop damage.
- composition of matter, group of steps or group of compositions of matter shall be taken to encompass one and a plurality (i.e. one or more) of those steps, compositions of matter, groups of steps or group of compositions of matter.
- FIG. 1 Cosmetic cell developmental stages: Schematic diagram of the main developmental stages of the ciliate T. rostrata depicting 1) trophont ciliate cells, 2) encysted ciliate cells and 3) theront ciliate cells.
- Trophont ciliate cells undergo “encystment” to form encysted ciliate cells (or “cysts”).
- Encysted ciliate cells undergo “excystment” to form theront ciliate cells.
- Theront ciliate cells undergo “maturation” to form trophont ciliate cells.
- FIG. 2 Carrageenan induces encystment of T. rostrata at 26° C.: Percentage of encysted cells (% round) following incubation of trophonts in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) at 26° C. The corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days incubation.
- FIG. 3 Carrageenan induces encystment of T. rostrata at 20° C.: Percentage of encysted cells (% round) following incubation of trophonts in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) at 20° C. The corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days incubation.
- FIG. 4 Encysted ciliate cells suspended in carrageenan remain stable after 4 weeks storage: Encysted ciliate cells in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) were transferred and stored to 20° C.
- the corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days storage at 20° C.
- FIG. 5 Magnetic sulfate stabilises encysted ciliate cells in carrageenan: Survival of encysted ciliate cells in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) exposed to 50 mM magnesium sulfate after 24 hours incubation at 26° C. prior to transfer to 20° C. The corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days storage at 20° C.
- FIG. 6 Micrograph of encysted ciliate cells formed in carrageenan having the distinctive capsules characteristic of typical T. rostrata cysts.
- FIG. 7 Encysted ciliate cells in carrageenan tolerate dehydration: Micrograph of encysted ciliate cells in carrageenan following dehydration.
- FIG. 8 Composted pine bark particles induce encystment of T. rostrata : Extracts of composted pine bark (CI, DCIP and DUP4) were added at various concentration to T. rostrata at 1-3 ⁇ 104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours the percent of cells that had encysted was determined.
- FIG. 9 Carrageenan and gellan gum induce encystment of T. rostrata : Solutions of carrageenan buffered before and after (#) autoclaving and gellan gum (HA and LA) were added at various concentration to T. rostrata at 1-3 ⁇ 104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours the percent of cells that had encysted was determined.
- FIG. 10 Morphology of encysted ciliate cells in compost infusion, MgSO4 and carrageenan: Giemsa stained theronts produced in buffered CI, MgSO4, 0.025% w/v carrageenan (CGN) and 0.125% w/v carrageenan (CGN) at 26° C./20° C. at a low cell density of 1-3 ⁇ 104 cells per ml.
- FIG. 11 Carrageenan produces infections theronts: Trophonts cultures were encysted in encystment buffer with CI (circles), 62.5 uM MgSO4 (squares), 0.025% w/v carrageenan (CGN) (diamonds) and 0.125% w/v carrageenan (CGN) (triangles) at 26° C. resulting in cyst suspensions on days 1-3. The cysts were transferred to 20° C. and excystment of theronts was completed by day 7-8 and were then maintained under starvation conditions in the respective encystment buffer at 20° C. The average viable counts per ml are shown with maximum and minimal values of three separate culture. A summary timeline for encystment, excystment and theront persistence is given.
- FIG. 12 Sudvival of slugs exposed to theronts produced in carrageenan: Survival of D. reticulatum slugs when challenge with theronts made in carrageenan, UP6 (extract of composted pine bark) and 62.5 uM MgSO4 buffer solutions
- FIG. 13 Carrageenan and xanthan gum induce encystment of T. rostrata : Extracts of composted pine bark, carrageenan and xanthan gum were added at various concentration to T. rostrata at 1-3 ⁇ 104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours the percent of cells that had encysted was determined.
- FIG. 14 High acyl gellan gum induce encystment of T. rostrata : Solutions of HA gellan gum, made with a heat (90-100° C. or 50-60° C.)—cooling (to 17-20° C.) step or without (17-20° C.), were added at various concentration to T. rostrata at 1-3 ⁇ 104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours, the percent of cells that had encysted was determined.
- the term “or” is intended to mean an inclusive “or” rather than an exclusive “or”. That is, unless specified otherwise, or clear from context, “X employs A or B” is intended to mean any of the natural inclusive permutations. That is, if X employs A; X employs B; or X employs both A and B, then “X employs A or B” is satisfied under any of the foregoing instances. Further, at least one of A and B and/or the like generally means A or B or both A and B.
- the articles “a” and “an” as used in this application and the appended claims may generally be construed to mean “one or more” unless specified otherwise or clear from context to be directed to a singular form.
- ciliate cells being suspended in an aqueous solution comprising a polymer, refers to a polymer solution that can flow but is sufficient to hold the ciliate cells in suspension. The ciliate cells can migrate throughout the polymer solution while remaining suspended.
- intersperse refers to ciliate cells being at least in part distributed and scattered within the polymer.
- incubate refers to maintaining ciliate cells under controlled conditions favourable for inducing encystment and/or maintaining viability of the ciliate cells.
- biological pesticide refers to a pest management agent that is based on organisms or natural products that provide pest intervention through a predatory, parasitic or chemical relationship, often having a short term effect on the environment.
- the methods and compositions of the present invention comprise the incubation/suspension/interspersion of ciliate cells within a polymer, for example an aqueous solution comprising the polymer or a dried polymer.
- ciliates refers to a group of protozoans characterized by the presence of hair-like organelles called cilia. It is the presence of cilia which distinguishes ciliate cells from other protist cells.
- the developmental stage cycle of ciliate cells can be separated into three main stages, namely the formation of 1) “trophont” ciliate cells (also known as trophozoites), 2) “encysted” or “cyst” ciliate cells and 3) “theront” ciliate cells. Cells go through several stages of development during autogamy and cyst maturation.
- the ciliate cells may be ciliate protozoa cells.
- the trophont cells are at the growing and feeding stage, encysted cells are the reproductive or resting stage, and theront cells are excysted cells.
- a simple summary of the life cycle of ciliate cells is provided in FIG. 1 , where trophont cells undergo a process called “encystment” to form encysted cells. The encysted cells can then undergo a process called “excystment” to form theront cells. The developmental cycle closes where the theront cells mature (i.e. “maturation”) to form trophont cells.
- the encystment of trophont ciliate cells can be induced by various external stimuli such as starvation and cell aggregation.
- trophonts respond to encystment stimuli by transforming into small, rapid swimming pre-cystic cells and then round up and secrete large amounts of mucin which condenses and gradually forms a laminar cyst wall which develops into the thick wall of encysted ciliate cells.
- polymers such as polysaccharides
- the present inventors have identified that, in some embodiments, polymers, such as polysaccharides, can induce encystment of trophont ciliate cells into encysted ciliate cells.
- the encysted ciliate cells incubated/suspended in the aqueous solution remain stable and viable and do not excyst into theront ciliate cells, even after dehydration to form a dried polymer wherein the encysted ciliate cells are interspersed within the polymer.
- theront ciliate cells may be incubated/suspended/interspersed within the aqueous solution. Accordingly, it will be appreciated that a ciliate cell from any developmental stage may be used in the methods and compositions of the present invention.
- the ciliate cells may be encysted ciliate cells or trophont ciliate cells. In one preferred embodiment, the ciliate cells are trophont ciliate cells. In an alternative embodiment, the ciliate cells are encysted ciliate cells. In some embodiments, the ciliate cells are excysted ciliate cells. In one embodiment, the ciliate cells are theront cells. In some embodiments, the ciliate cells may be a mixture of trophont ciliate cells or encysted ciliate cells. In one embodiment, the trophont ciliate cell may undergo encystment within the aqueous solution to form an encysted ciliate cell. The present inventors have found that, in some embodiments, ciliate cells remained stable and viable for a longer period of time in the presence of polymers described herein.
- the ciliate cells may be any member of the Ciliophora phylum. In one preferred embodiment, the ciliate cells are cells that are capable of encystment.
- the specific type of ciliate cell that is used may also depend on a number of variables, including but not limited to, the type of polymer and/or aqueous solution, the area to be treated with polymer, the soil type the polymer is being dispersed in, and/or the pest species being targeted for pest control (e.g. the type of pest, such as a Gastropod).
- the ciliate cell is a member of the Intramacronucleata, Ventrata, Spirotrichia, or Rhabdophora subphylum. In one preferred embodiment, the ciliate cell is a member of the Intramacronucleata subphylum.
- the ciliate cell is a member of Heterotrichea, Karyorelictea, Armophorea, Litostomatea, Colpodea, Nassophorea, Phyllopharyngea, Prostomatea, Plagiopylea, Oligohymenophorea, Protocruziea, Spirotrichea, or Cariotrichea class.
- the ciliate cells are a member of the Oligohymenophorea class.
- the ciliate cells are a member of the Apostomatia, Astomatia, Hymenostomatia, Peniculia, Peritrichia, or Scuticociliatia order. In a preferred embodiment, the ciliate cells are a member of the Hymenostomatia order.
- the ciliate cells are a member of the Tetrahymenina, or Ophryoglenia sub order. In one embodiment, the ciliate cells are a member of the Tetrahymenina sub order. In another embodiment, the ciliate cells are a member of the Ophryoglenia sub order.
- the ciliate cells are a member of the Tetrahymenidae, Ophryoglenina, or Peniculina family.
- the ciliate cells are a member of the Tetrahymena or Lambornella genus. In one embodiment, the ciliate cells are a member of the Lambornella genus. In a preferred embodiment, the ciliate cells are a member of the Tetrahymena genus.
- the ciliate cells are of the T. rostrata, T. hegewischi, T. hyperangularis, T. malaccensis, T. patula, T. pigmentosa, T. exertsneri, T. deweyae, T. pyriformis, T. thermophila, T. vorax, T. geleii, T. corlissi, T. empidokyrea or T. limacis .
- the ciliate cells is of the T. rostrata species.
- the ciliate cells are of the Lambornella clarki species.
- the ciliate cells are cultured from an isolated strain of T. rostrata TRAUS (deposited under PTA-126056 on 13 Aug. 2019 at the American Type Culture Collection).
- compositions Comprising Encysted Ciliate Cells
- the present inventors have identified a composition comprising encysted ciliate cells that are interspersed within a polymer can improve the storage, stability and viability of ciliate cells.
- the polymer of the composition may be provided as an aqueous polymer solution or as a dried polymer.
- the polymer may be a hydrocolloid as described herein.
- the polymer and aqueous solution comprising a polymer are described herein.
- the polymer is not lethal to ciliate cells, and allows sufficient diffusion of oxygen to the ciliate cells incubated/suspended therein to maintain cell viability.
- the polymer is a hydrophilic polymer.
- the polymer may be selected hydrophilic acrylics, peptides, dendrimers, star-polymers, aliphatic polymers, natural polymers, polysaccharides, synthetic polymers, anionic polymers, cationic polymers, neutral polymers, and synthetic polymers, and mixtures or co-polymers thereof.
- the polymer is an anionic polymer.
- the polymer may have a high molecular weight (Mw).
- the polymer has an average molecular weight (MW) in the range of between about 100 to about 1,000 kDa.
- the polymer has an average molecular weight (MW) of at least about 100, 200, 300, 400, 500, 600, 700, 800 900 or 1,000 kDa.
- the polymer has an average molecular weight (MW) of less than about 1,000, 900, 800, 700, 600, 500, 400, 300, 200 or 100 kDa. Combinations of these molecular weights to form various ranges are also possible, for example the polymer has an average molecular weight (MW) of between about 200 kDa to about 800 kDa.
- the molecular weight of the polymer may vary depending on the type used to prepare the aqueous solution (e.g. hydrocolloid). For example, different grades of carrageenan can be used.
- the polymer comprises a polysaccharide (i.e. a carbohydrate polymer).
- a polysaccharide is a polymeric carbohydrate comprising two or more monosaccharide units bound together by glycosidic linkages. Polysaccharides are widespread in nature and can be found in animals, plants, and bacteria, and can also be synthetically manufactured.
- the polysaccharide may be a naturally occurring polysaccharide (e.g. derived from bacteria or algae such as xanthan gum, gellan gum or carrageenan) or a synthetic polysaccharide (e.g. CMC), or a mixture thereof.
- polysaccharides can induce encystment of trophont ciliate cells to form encysted ciliate cells, which remain encysted and viable during storage.
- hydroxyl (—OH) groups along with the presence of various hydrophilic groups (e.g.
- polysaccharides such as sulphate groups on carrageenan and carboxyl groups on the gellan gum and xanthan gum, can increase the affinity for binding to water molecules of the aqueous solution and capture of water to form a hydrocolloid, and in turn effectively dehydrates the trophont cells suspended within the polysaccharide solution, thus inducing encystment.
- the complex structure and hydrocolloid formation of various polysaccharides when dissolved in water may cause mechanical stress inducing encystment due to crowding the ciliate cells.
- the internal structure of the hydrocolloid may vary from randomly arranged polysaccharide subunits such as linear or coiled domains to a more ordered structure such as double helices or matrices. These double helices or matrices may further aggregate into a more complex hydrocolloid structure.
- encystment efficiency may be improved.
- the hydrocolloid molecules may interact with one or more ligands on the surface of the ciliate cells to stimulate an encystment response, including for example interaction with one or more surface-exposed glycoproteins.
- the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria. In one embodiment, the polysaccharide is an algal polysaccharide or a bacterial polysaccharide.
- the plant polysaccharide (e.g. derived from plants) is selected from the group consisting of cellulose, starch, guar gum, pectin, locust bean gum, gum arabic, tragacanth and karaya, or a mixture thereof.
- the algal polysaccharide (e.g. derived from algae) is selected from the group consisting of carrageenan, agarose, agar and alginate, or a mixture thereof. In one embodiment, the polysaccharide is carrageenan.
- the animal derived polysaccharide is chitosan (e.g. from crustacean shells), chitin or gelatin, or a mixture thereof.
- the fungal polysaccharide is galactomannan.
- the bacterial polysaccharide may be an extracellular polysaccharide.
- the extracellular polysaccharide may be selected from the group consisting of xanthan gum, gellan gum (including derivatives such as sphingans, welan, rhamsan and diutan), bacterial alginate, glucans (including alpha-glucans such as dextran, mutan, alternan and reuteran, and beta-glucans, such as cellulose and curdlan), hyaluronan, succinoglycan, levan, GalactoPol and FucoPol.
- polysaccharides may be obtained by any suitable method.
- Some non-limiting examples include polysaccharides obtained from a commercial supplier, or polysaccharides extracted from soil particles (including for example composted or non-composted particles, such as pine bark, peat or sugarcane bagasse and other composted or non-composted plant substrates).
- bacterial polysaccharides as described herein may be derived from composted pine bark particles.
- bacterial polysaccharides derived from the composted pine bark particles may be harvested from the composted pine bark (e.g. isolated from the composted pine bark), and subcultured separately and added to the aqueous solution.
- the composted pine bark particles may be included as an additive which is suspended in the aqueous solution, wherein the bacterial polysaccharide (or other metabolite) is derived therefrom.
- the aqueous solution described herein may further comprise composted pine bark particles.
- the composted pine bark particles are described herein, including under the heading “Additives”.
- composted pine bark particles may be obtained by adding urea (and optionally some trace elements) to saturated pine bark particles. It will be appreciated that the pine bark is the major carbon source and urea is the source of nitrogen, which together triggers the bacterial decomposition of the pine bark particles to obtain the “composted” pine bark particles. Alternatively, the “composted” pine bark particles may be obtained from a suitable potting mix.
- potting mix refers to a growing mix often used in gardens and nurseries, which comprise composted pine bark particles and other ingredients such as sand, added nutrients and other additives such as vermiculite.
- An example of a potting mix is Australian Growing Solutions.
- the potting mix may be filtered to obtain the composted pine bark particles.
- the pine bark particles may comprise Pinus radiata pine particles.
- adding composted pine bark particles to the aqueous solution introduces the bacterial polysaccharides into the aqueous solution.
- the bacterial polysaccharides as described herein may be derived from non-composted particles.
- non-composted particles such as pine bark particles or sugarcane bagasse particles
- non-composted particles may be subjected to conditions effective to encourage microbial growth on the particles, e.g. the particles undergo a microbial fermentation or culturing under conditions effective to encourage microbial growth on the particle surface (e.g. maceration).
- non-composted particles may be fermented with a defined culture of one or more bacteria to provide a non-composted particle preparation that provides on or more bacterial polysaccharides that can induce encystment.
- bacterial polysaccharides on a plant material requires a nitrogen source (e.g. urea) and optionally a buffer such as a phosphate buffer, followed by removal the larger particles to obtain the bacterial polysaccharide.
- a nitrogen source e.g. urea
- a buffer such as a phosphate buffer
- xanthan gum may be produced by culturing Xanthomonas campestris on non-composted particles such as sugarcane bagasse, followed by removal of the large particles to obtain xanthan gum, which can be precipitated to obtain small particles comprising the xanthan gum, which can be dried and then rehydrated for later use in encystment.
- the bacterial polysaccharide is isolated from composted pine bark or fermented sugarcane bagasse.
- the polysaccharide may be a synthetic polysaccharide, including synthetic versions of one or more of the polysaccharides described herein. Examples of suitable synthetic polysaccharides include carboxymethyl cellulose (CMC).
- CMC carboxymethyl cellulose
- the polysaccharide is an anionic polysaccharide.
- anionic in the context of a polysaccharide refers to a polysaccharide comprising one or more anionic groups (e.g. sulfate; SO32- or carboxylate; COO—).
- anionic nature of the polysaccharide may be controlled by the environment, for example by controlling the pH of the aqueous solution described herein (e.g.
- anionic polysaccharides can induce encystment of trophont ciliate cells to form encysted ciliate cells which remain encysted and viable during storage.
- the polysaccharides anionic groups may interact with one or more ligands on the surface of T. rostrata trophont ciliate cells, including for example interaction with one or more surface-exposed glycoproteins, which may help stimulate encystment, for example either by aggregating the cells and/or stimulating capsule formation.
- the sulfate (SO32-) groups on carrageenan, and carboxylate (COO—) groups on gellan gum have a strong negative charge and affinity to polycation macromolecule and/or amphoteric proteins on the surface of ciliate cells. The resulting interaction may be sensed by the cell and trigger encystment.
- the polysaccharide may be selected from the group consisting of carrageenan, agarose, agar, alginate, alginic acid, carboxymethylcellulose, pectin, pectic acid, hyaluronic acid, polyglucuronic acid, cellulose, gellan gum, xanthan gum, starch, chitosan, and chitin, or mixtures or co-polymers thereof.
- the polymer comprises a polysaccharide selected from the group consisting of carrageenan, agarose, gellan gum, xanthan gum and agar, or a mixture thereof.
- the polymer comprises a polysaccharide selected from the group consisting of carrageenan, gellan gum and xanthan gum, or a mixture thereof.
- the polymer may comprise any one or more of the above mentioned polymers (e.g. polysaccharides), including synthetic versions, mixtures or copolymers thereof.
- the polymer is carrageenan.
- Carrageenan is a sulfated polysaccharide, namely a sulfated galactan that is extracted from seaweed.
- Carrageenan comprises an anionic linear polymers comprising 1,3 ⁇ -1,4 ⁇ -galactans having one ( ⁇ -) two ( ⁇ -) or three ( ⁇ -) sulfates per disaccharide unit.
- carrageenan can induce encystment of trophont ciliate cells to form encysted ciliate cells which remain encysted and viable during storage.
- carrageenan can be used to suspend and store preformed encysted ciliate cells.
- the encysted ciliate cells can excyst to form theront cells once released from the carrageenan and can infect pests such as molluscs.
- the carrageenan comprises a mixture of ⁇ -carrageenan, ⁇ -carrageenan, and ⁇ -carrageenan.
- the carrageenan may comprise predominantly of ⁇ -carrageenan (e.g. one sulfate per disaccharide unit).
- the polymer is carrageenan purchased from Sigma Aldrich, catalogue number C1013 (CAS Number 9000-07-1).
- the carrageenan may comprise a small amount of potassium cations, for example less than about 15%, 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001%, or 0.0001% w/w potassium cations.
- the aqueous solution comprising carrageenan can form a hydrocolloid.
- solubilised carrageenan chains change conformation to from being random coils to a more ordered helical structure, which can then aggregate via weak intermolecular interactions, namely hydrogen bonding, between the carrageenan helices to form the hydrocolloid.
- the carrageenan may also comprise a small fraction of potassium (K+) cations, the presence of which can stabilize the junction zones between two carrageenan helices by binding to the negatively charged sulfate groups without hindering the hydrogen bonding of the two helices.
- K+ potassium
- the stabilisation of junction zones between carrageenan helices by monovalent potassium cations does not result in ionic crosslinking thus retaining the hydrocolloids water-soluble properties.
- carrageenan has a sulfate content (SO3-).
- the polymer has a sulfate content of between about 1% to about 50% w/w sulfate based on the total mass of the polymer.
- the polymer has a sulfate content of at least about 1, 2, 5, 10, 15, 20, 25, 30, 40 or 50% w/w sulfate based on the total weight of the polymer.
- the polymer has a sulfate content of less than about 50, 40, 30, 25, 20, 15, 10, 5, 2 or 1% w/w sulfate based on the total weight of the polymer. Combinations of any two of these upper or lower values to form a range is also possible, for example between about 5% to about 40% w/w, or between about 10% to about 30% w/w sulfate based on the total weight of the polymer.
- the polysaccharide is gellan gum.
- Gellan gum is a bacterial polysaccharide and, like carrageenan, is a linear polymer which can act as a hydrocolloid.
- Gellan gum comprises tetrasaccharide repeats, 1,4- ⁇ -L-rhamnose, 1,3- ⁇ -D-glucose, 1,4- ⁇ -D-glucose, 1,4- ⁇ -D-glucuronic acid.
- Gellan gum comprises two acyl substituents, acetate and glycerate, which occur on the same glucose subunit. Depending on the number of acyl substituents, gellan gum can exist in either high acyl (HA), native, or low acyl (LA) forms.
- HA high acyl
- LA low acyl
- the polysaccharide is a high acyl (HA) gellan gum (Kelcogel® LT100 HA gellan gum).
- the gellan gum has an acyl content (e.g. the number of acyl groups attached to the polysaccharide) of at least 25%, 30%, 35%, 40%, 45% or 50% w/w based on the total weight of the gellan gum.
- a gellan gum hydrocolloid stimulates encystment of T. rostrata , with HA gellan gum capable of producing durable cysts.
- gellan gum that has not been heat-treated may induce encystment with high efficiency.
- gellan gum polymers within the hydrocolloid interact in an irregular matrix structure resulting in a higher viscosity compared to gellan gum which has been heat treated and cooled which results in a softer, lower viscosity hydrocolloid. Nonetheless, both heat-treated and non-heat treated gellan gum was found to induce encystment.
- the polysaccharide is xanthan gum.
- Xanthan gum is a hetero-polysaccharide produced by the fermentation of the bacterial microbe Xanthomonas campestris . Its main chain is made up of glucose units. The beta-D-glucoses are linked (1->4) to form the backbone similar to cellulose. At every second glucose residue is an added trisaccharide side chain consisting of alpha-D-mannose, beta-D-glucuronic acid, and a beta-D-mannose terminal unit. Thus, the overall repeating structure is a pentasaccharide.
- the overall repeating structure is a pentasaccharide.
- the glucuronic and pyruvic acid groups give xanthan gum a highly negative charge.
- the polymer is not ionically crosslinked.
- crosslink refers to the formation of interactions within or between polymers which result in the formation of a three-dimensional matrix.
- An ionically cross linked polymer is linked together by ionic interactions (i.e. an electrostatic attraction between oppositely charged ions).
- ionic-cross linking may be a charge interaction between the polymer and an oppositely charged molecule as the linker, such as may be a cation or anion, as described in Parhi et al. (2017).
- hydrogel refers to a substance formed when a hydrogel-forming polymer (e.g. natural or synthetic polymer) is cross-linked (e.g. via ionic crosslinking) to create a three-dimensional “solid” matrix structure which entraps water molecules to form a gel. Consequently, where the polymer is part of an aqueous solution (e.g.
- the composition is not a hydrogel. In one embodiment, the composition is not an alginate hydrogel.
- ionic crosslinking does not preclude the presence of weaker interactions between the polymer and water molecules, for example other types of physical cross-linking such as hydrogen bonding which, according to some embodiments or examples described, can facilitate the formation of a hydrocolloid.
- non-ionic physical cross-linking includes molecular entanglement of the polymer, hydrogen bonding and hydrophobic interaction.
- the composition does not comprise an effective amount of an ionic cross-linker, for example a multivalent metal cation or multivalent anion, in an amount effective to ionically crosslink the polymer to form a hydrogel (e.g. capable of crosslinking the polymer to form a hydrogel as defined above).
- an ionic cross-linker for example a multivalent metal cation or multivalent anion
- the polymer may be dispersed in an aqueous solution.
- the encysted ciliate cells may be interspersed/suspended in the aqueous solution comprising the polymer.
- the polymer may be dispersed in an aqueous solution.
- the aqueous solution comprising the polymer may also be called an aqueous polymer solution.
- the aqueous solution comprising the polymer forms a hydrocolloid.
- the ciliate cells may be suspended within the hydrocolloid.
- the hydrocolloid may be an anionic hydrocolloid (e.g. derived from an anionic polymer).
- a “hydrocolloid” can be defined as a water-soluble hydrophilic polymeric that interacts with an aqueous medium (e.g. water) to form a colloid system either as a gel or a sol of solubilised hydrophilic polymer particles.
- the colloid particles are hydrophilic polymers (e.g.
- polysaccharides dispersed in water resulting in a dispersion, and in some cases a viscous dispersion and/or gel.
- the presence of hydroxyl (—OH) groups can increase the affinity for binding to water molecules of the aqueous solution and/or to each other, for example via weak non-ionic interactions (e.g. hydrogen bonding), resulting in a dispersion (i.e. an intermediate between a true solution and a suspension) and thus exhibits the properties of a colloid.
- a hydrogel is three-dimensional “solid” matrix structure formed by a cross-linked hydrophilic polymer, the result of which is insoluble in water.
- the insoluble cross-linked hydrophilic polymer entraps water molecules (as opposed to being solubilised therein) within the cross-linked matrix structure to form a continuous gel network and is distinct from a hydrocolloid.
- the composition is not a hydrogel.
- the aqueous solution does not comprise a hydrogel.
- the aqueous solution does not comprise an alginate hydrogel.
- the aqueous solution may be water or may be a buffered solution.
- buffer solution refers to an aqueous solution consisting of a mixture of a weak acid and its conjugate base, or vice versa.
- the pH of the buffer solution changes very little when a small amount of strong acid or base is added to it. Buffer solutions are used as a means of keeping pH at a nearly constant value.
- the buffer solution may also be referred to as an aqueous buffer solution.
- the buffer solution may be a HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), a phosphate buffer solution, or a Tris (tris(hydroxymethyl)aminomethane) buffer solution.
- the buffer solution is a HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer solution.
- the concentration of HEPES in the HEPES buffer solution is at least about 1, 2, 5, 7, 10, 12, 15, 20 or 25 mM. In some embodiments, the concentration of HEPES in the HEPES buffer solution is less than about 25, 20, 15, 12, 10, 7, 5, 2 or 1 mM. Combinations of these concentrations are also possible, for example between about 1 mM to about 25 mM, between about 5 mM to about 25 mM, between about 8 mM to 15 mM, for example about 10 mM.
- the buffer solution has a pH of at least about 6, 6.2, 6.4, 6.6, 6.8, 7, 7.2, 7.4, 7.6, 7.8, 8, 8.2, 8.4, 8.6, 8.8 or 9. In some embodiments, the buffer solution has a pH of less than about 9, 8.8, 8.6, 8.4, 8.2, 8, 7.8, 7.6, 7.4, 7.2, 7, 6.8, 6.4, 6.2, or 6. Combinations of these pH values are also possible, for example between about 6.8 to about 8.2. In one embodiment, the buffer solution has a pH of about 7. The pH of the buffer solution may be adjusted using sodium hydroxide.
- the concentration of the polymer in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of the polymer in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%. 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 10%, 15%, or 20% w/v based on the total volume of the aqueous solution.
- the concentration of the polymer in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%. 3.5%, 3%, 2.5%, 2%, 1.5%, 1.4%, 1.3%, 1.2%, 1.1%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution.
- the concentration of the polymer in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, between about 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- the concentration of the polymer in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution.
- the concentration of polymer in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5.
- the concentration of polymer in the aqueous solution may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the polymer in the aqueous solution is between about 0.002 mg/mL to about 2.5 mg/mL.
- the concentration of the polymer in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of the polymer in the aqueous solution is less than about 5%, 1%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution.
- the concentration of the polymer in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.01% w/v to about 0.3% w/v based on the total volume of the aqueous solution.
- the concentration of the polymer in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution. It will be appreciated that the above % w/v concentrations apply to any polymer described herein, including those listed above under the heading “Polymer”.
- the polymer is a polysaccharide.
- the concentration of polysaccharide in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of polysaccharide in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%.
- the concentration of polysaccharide in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%.
- the concentration of polysaccharide in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- the concentration of polysaccharide in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution.
- the concentration of polysaccharide in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of polysaccharide in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.01% w/v to about 0.3% w/v based on the total volume of the aqueous solution.
- the concentration of polysaccharide in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution.
- the concentration of polysaccharide in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution.
- the concentration of polysaccharide in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5.
- the concentration of polysaccharide in the aqueous solution may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the polysaccharide in the aqueous solution is between about 0.002 mg/mL to about 2.5 mg/mL.
- the polymer is carrageenan.
- the concentration of carrageenan in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of carrageenan in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.5%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%.
- the concentration of carrageenan in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%.
- the concentration of carrageenan in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- the concentration of carrageenan in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution.
- the concentration of carrageenan in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution.
- the concentration of carrageenan in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.025% w/v to about 0.25% w/v, or between about 0.1% w/v to about 0.3% w/v based on the total volume of the aqueous solution.
- the concentration of carrageenan in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution.
- an aqueous solution/hydrocolloid comprising between about 0.025% w/v to about 0.25% w/v carrageenan stimulates efficient encystment of T. rostrata , and theronts can be effectively excysted therefrom and infect slugs resulting in decreased grazing and significant mortality.
- the concentration of carrageenan in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution.
- the concentration of carrageenan in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5.
- the concentration of carrageenan in the aqueous solution may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the carrageenan in the aqueous solution is between about 0.002 mg/mL to about 2.5 mg/mL.
- the polymer is gellan gum.
- the concentration of gellan gum in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of gellan gum in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.5%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%.
- the concentration of gellan gum in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%.
- the concentration of gellan gum in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- the concentration of gellan gum in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of gellan gum in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution.
- the concentration of gellan gum in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.025% w/v to about 0.25% w/v, or between about 0.1% w/v to about 0.3% w/v based on the total volume of the aqueous solution.
- the concentration of gellan gum in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution.
- the concentration of gellan gum in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution.
- the concentration of gellan gum in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5.
- the concentration of gellan gum in the aqueous solution may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of gellan gum in the aqueous solution is between about 0.1 mg/mL to about 2.5 mg/mL.
- the polymer is xanthan gum.
- the concentration of xanthan gum in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of xanthan gum in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.5%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%.
- the concentration of xanthan gum in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%.
- the concentration of xanthan gum in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, between about 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- the concentration of xanthan gum in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution.
- the concentration of xanthan gum in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution.
- the concentration of xanthan gum in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.025% w/v to about 0.25% w/v, or between about 0.1% w/v to about 0.3% w/v based on the total volume of the aqueous solution.
- the concentration of xanthan gum in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution.
- the concentration of xanthan gum in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution.
- the concentration of xanthan gum in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5.
- the concentration of xanthan gum in the aqueous solution may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of xanthan gum in the aqueous solution is between about 0.1 mg/mL to about 2.5 mg/mL.
- the aqueous solution comprising the polymer may have a viscosity.
- the viscosity of the aqueous solution when the polymer is dispersed therein may be higher (e.g. “thicker”) than the native aqueous solution (e.g. no polymer dispersed therein).
- the viscosity of the aqueous solution comprising the polymer may be between about 5 to about 1,000 mPa ⁇ s when measured using a rotating cylinder method.
- the density of the ciliate cells in the aqueous solution is between about 1 ⁇ 102 cells/mL to about 1 ⁇ 1010 cells/mL.
- the density of the ciliate cells in the aqueous solution may be at least about 1 ⁇ 102 cells/mL, 1 ⁇ 103 cells/mL, 1 ⁇ 104 cells/mL, 1 ⁇ 105 cells/mL, 1 ⁇ 106 cells/mL, 1 ⁇ 107 cells/mL, 1 ⁇ 108 cells/mL, 1 ⁇ 109 cells/mL, or 1 ⁇ 1010 cells/mL.
- the density of the ciliate cells in the aqueous solution may be less than about 1 ⁇ 1010 cells/mL, 1 ⁇ 109 cells/mL, 1 ⁇ 108 cells/mL, 1 ⁇ 107 cells/mL, 1 ⁇ 106 cells/mL, 1 ⁇ 105 cells/mL, 1 ⁇ 104 cells/mL, 1 ⁇ 103 cells/mL, or 1 ⁇ 102 cells/mL. Combinations of any two of these upper or lower values to form a range are also possible, for example between about 1 ⁇ 103 cells/mL to about 1 ⁇ 106 cells/mL, between about 1 ⁇ 103 cells/mL to about 1 ⁇ 105 cells/mL, or between about 1 ⁇ 104 cells/mL to about 1 ⁇ 105 cells/mL.
- the aqueous solution comprises at least about 0.5, 1, 2, 5, 10, 15, 20, 25, 30, 35 or 40% w/v ciliate cells. In some embodiments, the aqueous solution comprises less than about 40, 35, 30, 25, 20, 15, 10, 5, 2, 1 or 0.5% w/v ciliate cells. Combinations of these % w/v values are also possible, for example the aqueous solution comprises between about 0.5% w/v to about 40% w/v ciliate cells.
- the vol:vol ratio of the ciliate cells to the aqueous solution is between about 1:10 to about 10:1. In some embodiments, the vol:vol ratio of the ciliate cells to the aqueous solution is at least about 1:10, 1:8, 1:4, 1:2, 1:1, 2:1, 4:1, 6:1, 8:1, or 10:1. In some embodiments, the vol:vol ratio of the ciliate cells to the aqueous solution is less than about 10:1, 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:6, 1:8, or 1:10. Combinations of any two of these upper or lower values to form a range are also possible.
- composition may further comprise additional additives, including those described under the heading “Additives” in relation to the method of inducing encystment of ciliate cells.
- additives include preservatives such as parabens, benzoates, sorbic acid, citrates or parabens, humectants such as glycerol or propylene glycol, antioxidants such as butylhydroxytoluene or butylhydroxyanisole, tocopherol, ascorbic acid, flavourings or other formulation auxiliaries. These may be dissolved/suspended in the aqueous solution with the polymer and ciliate cells, or mixed as separate components with the polymer encapsulating the ciliate cells.
- the composition further comprises an attractant or feeding stimulant.
- an attractant refers to an agent which assists in attracting one or more pest species to consume the polymer.
- feeding stimulant refers to an agent that encourages one or more pest species to remain consuming the polymer for a period of time to allow for the release of ciliate cells suspended or interspersed therein and the pest species to be exposed to the ciliate cells.
- the attractant may include a pheromone or a nutrient source.
- the composition further comprises a nutrient source.
- the nutrient source may be a molasses or a sugar.
- the nutrient source may be selected from the group consisting of starch, sugar, semolina, couscous or combination thereof.
- the nutrient source may also be a carbohydrate or a plant product.
- the composition further comprises a feeding stimulant.
- the feeding stimulant may be selected from one or more of a starch, carbohydrate, protein, amino acid, plant extracts (e.g. any one of essential oils, saps, resins, chlorophyll and other crude extracts of a plant that a pest species (e.g. slug or snail) may detect as a food source).
- the composition may comprise a single species of ciliate, multiple species of ciliate, or one or more species of ciliates with other organisms, such as pathogenic bacteria, fungal spores, or pathogenic nematodes. Accordingly, in some embodiments, the composition may further comprise one or more other additional components such as one or more of a bait, pesticide, biocontrol agent, or other organisms such as pathogenic bacteria, fungal spores or pathogenic nematodes. In another embodiment, the composition may further comprise one or more metallic salts, for example metallic phosphates and metallic sulfates. In some embodiments, the composition may further comprise iron(III) phosphate (FePO4), iron (II) phosphate (Fe3(PO4)2) and copper (II) sulfate (CuSO4).
- FePO4 iron(III) phosphate
- Fe3(PO4)2 iron (II) phosphate
- CuSO4 copper
- the composition further comprises pathogenic bacteria or fungal spores.
- the pathogenic bacteria or fungal spores may be suspended within the polymer with the ciliate cells, or may be inside the ciliate cells prior to suspension/interspersion within the polymer.
- pest species such as slugs and snails
- the presence of both ciliate cells and bacteria or fungal spores may result in a higher killing effect.
- ciliate cells that have ingested bacteria and/or fungi may be released from the polymer and subsequently enter or be ingested by a pest species (e.g. a slug). Once inside the pest species, the ciliate cells may release the bacteria and/or fungi which also has an adverse effect on the pest species, thus resulting in a higher killing effect.
- the present inventors have also identified an encystment media composition which can be used to induce encystment of trophont ciliate cells.
- the encystment media composition comprises an aqueous solution and a polymer as described herein.
- the encystment media composition comprises an aqueous solution and a non-ionically crosslinked polymer as described herein.
- the aqueous solution comprising the polymer forms a hydrocolloid. In one embodiment, the aqueous solution comprising the polymer forms an anionic hydrocolloid. In one embodiment, the polymer comprises a polysaccharide. In one embodiment, the polysaccharide is an anionic polysaccharide. In one embodiment, the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria. In one embodiment, the polysaccharide is derived from algae. In one embodiment, the algal polysaccharide is selected from the group consisting of carrageenan, agarose, agar and alginate, or a mixture thereof. In one embodiment, the polysaccharide is carrageenan.
- aqueous solution comprises between about 0.1% w/v to about 5% w/v polymer based on the total volume of the aqueous solution. In one embodiment, the aqueous solution comprises between about 0.1% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
- the aqueous solution is a buffer solution.
- the buffer solution comprises a HEPES buffering agent.
- the concentration of the HEPES buffering agent in the buffer solution is between about 1 mM to about 25 mM, or between about 5 mM to about 25 mM.
- the buffer solution has a pH of between about 6.0 to about 9.0.
- the concentration of the magnesium ions in the aqueous solution is at least about 15, 20, 30, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500 or 1000 ⁇ M. In other embodiments, the concentration of the magnesium ions in the aqueous solution is less than about 1000, 500, 450, 400, 350, 300, 250, 200, 100, 50, 30, 20, or 15 ⁇ M. Combinations of these concentration values to form various ranges are also possible, for example the concentration of the magnesium ions in the aqueous solution is between about 15 ⁇ M to about 1000 ⁇ M, between about 20 ⁇ M to about 300 ⁇ M, between about 30 ⁇ M to about 200 ⁇ M, or between about 50 ⁇ M to about 150 ⁇ M.
- the concentration of magnesium ions in the aqueous solution is between about 60 ⁇ M to about 65 ⁇ M, for example about 62.5 ⁇ M.
- the aqueous solution comprises magnesium sulfate (MgSO4) or magnesium carbonate (MgCO3).
- the aqueous solution comprises magnesium sulfate (MgSO4). It will be appreciated that when the magnesium sulfate or magnesium carbonate is dissolved in the aqueous solution, magnesium ions (Mg2+) are present.
- an encystment media composition as described herein for inducing encystment of ciliate cells.
- a method of inducing encystment of ciliate cells comprising incubating a population of trophont ciliate cells in an encystment media composition as described herein at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- the present inventors have identified a method of inducing encystment of trophont ciliate cells into encysted ciliate cells using an aqueous solution comprising a polymer, which may be buffered (e.g. with HEPES) to form a buffered aqueous polymer solution.
- the aqueous solution comprises a polymer as described herein.
- the aqueous solution comprising the polymer may also be called an aqueous polymer solution.
- a method of inducing the encystment of ciliate cells comprising incubating a population of trophont ciliate cells in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- the aqueous solution may be an encystment media composition as described herein.
- the aqueous solution comprising the polymer forms a hydrocolloid as described herein.
- the polymer is not ionically crosslinked as described herein.
- the polymer is not ionically crosslinked during encystment of the trophont ciliate cells.
- the polymer comprises a polysaccharide.
- the polysaccharide is an anionic polysaccharide.
- the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria.
- the polysaccharide is derived from algae or bacteria.
- the polysaccharide is selected from the group consisting of carrageenan, xanthan gum, gellan gum, agarose, agar and alginate, or a mixture thereof.
- the polysaccharide is carrageenan, xanthan gum or gellan gum.
- aqueous solution comprises between about 0.1% w/v to about 5% w/v polymer based on the total volume of the aqueous solution. In one embodiment, the aqueous solution comprises between about 0.1% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
- the aqueous solution is a buffer solution.
- the buffer solution comprises a HEPES buffering agent.
- the concentration of the HEPES buffering agent in the buffer solution is between about 5 mM to about 25 mM.
- the buffer solution has a pH of between about 6.0 to about 9.0.
- the method does not comprise adding an effective amount of an ionic cross-linker to the aqueous solution, for example a multivalent metal cation or multivalent anion, in an amount effective to ionically crosslink the polymer to form a hydrogel (e.g. capable of crosslinking the polymer to form a hydrogel as defined above).
- an ionic cross-linker for example a multivalent metal cation or multivalent anion
- the aqueous solution comprising the polymer is heat-treated prior to incubation with the trophont ciliate cells.
- the aqueous solution is heated to a temperature (in ° C.) of at least about 30, 40, 50, 60, 60, 70, 80, 90, 100, 110, 120 or 130 prior to incubation with the trophont ciliate cells.
- the aqueous solution is heated to a temperature (in ° C.) of less than about 130, 120, 110, 100, 90, 80, 70, 60, 50, 40 or 30 prior to incubation with the trophont ciliate cells.
- the heating temperature may be in a range provided by any two of these upper and/or lower values, for example between about 90° C. to about 130° C.
- the heat treatment may be performed by any suitable method, for example heating the aqueous solution on a hotplate or in an autoclave.
- the aqueous solution is heat-treated for a period of time (in minutes) or at least 1, 2, 5, 10, 15, 20, 25, 30 or 60 prior to incubation with the trophont ciliate cells.
- the heat treatment period may be a range provided by any two of these upper and/or lower values, for example between about 5 minutes to about 20 minutes.
- the aqueous solution may be cooled to room temperature prior to incubation with the trophont ciliate cells.
- the aqueous solution comprising the polymer is not heat-treated prior to incubation with the trophont ciliate cells.
- the presence or absence of a heat treatment step prior to incubation may improve encystment efficiency due to altering the internal hydrocolloid structure.
- the compositions of the present invention induced encystment of trophont ciliate cells irrespective of whether the aqueous solution was heat treated prior to incubation, highlighting the versatility of the encystment composition described herein.
- the method comprises including
- the trophont ciliate cells are young trophont ciliate cultures, for example have undergone less than 10, 9, 8, 7, 6, 5, 4, 3, 2 or 1 subcultures.
- the number of subcultures give an indication of the number of cell generations that have occurred since cells last went through autogamy. Trophont ciliate cultures that have undergone less than 10 subcultures are considered to contain “young” trophont cells.
- the vol:vol ratio of the population of ciliate cells to the aqueous solution is between about 1:10 to about 10:1. In some embodiments, the vol:vol ratio of the population of ciliate cells to the aqueous solution is at least about 1:10, 1:8, 1:4, 1:2, 1:1, 2:1, 4:1, 6:1, 8:1, or 10:1. In some embodiments, the vol:vol ratio of the population of ciliate cells to the aqueous solution is less than about 10:1, 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:6, 1:8, or 1:10. Combinations of any two of these upper or lower values to form a range are also possible.
- the population of trophont ciliate cells are incubated in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- the trophont ciliate cells may be incubated in the aqueous solution at a temperature effective to induce encystment to form encysted ciliate cells.
- the temperature may be between 10° C. to about 40° C.
- the temperature may be at least about 10, 15, 20, 25, 30, 35 or 40° C.
- the temperature may be less than about 40, 35, 30, 25, 20, 15 or 10° C. Combinations of any two of these upper or lower values to form a range is possible, for example between about 20° C. to about 30° C.
- the trophont ciliate cells may be incubated in the aqueous solution at a temperature of at least about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C.
- the temperature may be less than about 30, 29, 28, 27, 26, 25, 24, 23, 22, 21 or 20° C. Combinations of any two of these upper or lower values to form a range is possible, for example between about 20° C. to about 28° C.
- the trophont ciliate cells may be incubated in the aqueous solution at a temperature of about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C.
- the trophont ciliate cells may be incubated in the aqueous solution for a period of time effective to induce encystment to form encysted ciliate cells.
- the period of time may be between about 0.5 hours to about 96 hours.
- the period of time may be at least about 12, 24, 36, 48, 60, 72, 84, or 96 hours.
- the period of time may be less than about 96, 84, 72, 60, 48, 36, 24 or 12 hours. Combinations of any two of these upper or lower values to form a range is possible, for example between about 12 hours to about 72 hours.
- the trophont ciliate cells may be incubated in the aqueous solution at a temperature and for a period of time effective to induce encystment to form encysted ciliate cells (i.e. an encystment temperature) and then subsequently incubated at a temperature effective to store the encysted ciliate cells (i.e. a storage temperature).
- a temperature effective to store the encysted ciliate cells i.e. a storage temperature
- the encystment and storage temperature may be the same.
- the ciliate cells may be incubated at i) a first temperature to induce encystment to form encysted ciliate cells and then ii) transferred to a second temperature to store the encysted ciliate cells.
- the encystment temperature i) may be at least about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C.
- the encystment temperature may be less than about 30, 29, 28, 27, 26, 25, 24, 23, 22, 21 or 20° C. Combinations of any two of these upper or lower values to form a range is possible, for example between about 10° C. to about 30° C., e.g. about 26° C.
- the storage temperature ii) may be at least about 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C.
- the storage temperature may be less than about 30, 29, 28, 27, 26, 25, 24, 23, 22, 21, 20, 19, 18, 17, 16, or 15° C.
- Combinations of any two of these upper or lower values to form a range is possible, for example between about 10° C. to about 30° C., or between about 15° C. to about 25° C., e.g. about 20° C.
- the encystment temperature i) may be maintained for a period of time of between about 0.5 hours to about 96 hours.
- the encystment temperature may be maintained for at least about 12, 24, 36, 48, 60, 72, 84, or 96 hours.
- the encystment temperature may be maintained for less than about 96, 84, 72, 60, 48, 36, 24 or 12 hours. Combinations of any two of these upper or lower values to form a range is possible, for example between about 12 hours to about 72 hours.
- the storage temperature ii) may be maintained for a period of time of at least 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 12 weeks, 15 weeks, or 20 weeks.
- the method may further comprise the step of dehydrating the aqueous solution to obtain a dried polymer wherein the one or more encysted ciliate cells are interspersed within the polymer.
- the dehydration step essentially evaporates the aqueous solution leaving a dried polymer.
- a suitable aqueous environment such as water (e.g. rain or a sprinkler following application to an environment) or an aqueous solution as described herein.
- the aqueous solution may be dried using any conventional means, such as room temperature airflow, mild heat and/or vacuum.
- the ciliate cells interspersed within the dried polymer remain viable even after dehydration. Encystment of trophonts to ciliate cells may occur during dehydration.
- the aqueous solution may be dehydrated from a humidity under ambient conditions (e.g. an ambient humidity at 20° C. and atmospheric pressure) to a reduced humidity. For example, dehydrating the aqueous solution will result in a relative humidity of less than 100%.
- the aqueous soil solution comprising the incubated trophont ciliate cells and suspended soil particles is dehydrated to a relative humidity of less than about 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, or 40%, for example less than about 80%, 75%, or 70%. Combinations of these relative humidities are also possible, for example about 40% to about 75% relative to the ambient humidity.
- the dehydrated environment may be obtained by any suitable means, including for example using humidity chambers.
- the humidity levels may be measured by any routine means including a humidity monitor or hygrometer, such as a gravimetric hygrometer.
- the aqueous solution is dehydrated for at least about 0.5, 1, 2, 3, 4, 5, 8, 10, 12, 15, 18, 20, 24 or 30 days.
- the aqueous solution is dehydrated at a temperature of between about 20° C. to about 30° C., for example about 20° C.
- the hydrocolloid comprising the ciliate cells may be dried (e.g. dehydrated) to form a dried polymer/hydrocolloid comprising the ciliate cells.
- the trophont cells prior to incubating in the aqueous polymer solutions, were obtained via culturing T. rostrata in PPYE media (0.5% (w/v) proteose peptone (Oxoid LP0085), 0.5% (w/v) yeast extract (Oxoid LP0021), and 0.125% (w/v) glucose) or PP media (1% w/v Proteose Peptone (Oxoid LP0085) and 0.125% w/v glucose).
- the trophont cells are then subcultured in PP media. Using trophont cells cultured in PPYE and sub cultured in PP media may provide further advantages such as increased cyst resilience following encystment.
- the encysted ciliate cells are subsequently transferred to fresh nutrient medium where they undergo excystment to form theront ciliate cells.
- the encysted ciliate cells may be stabilised and stored at a suitable temperature and for a period of time as described herein, for example at 20° C. or by dehydration.
- One or more additives may be added to the aqueous solution either prior to or during incubation (e.g. prior to or during) encystment or after incubation (e.g. after encystment) of the ciliate cells.
- magnesium ions may be added to the aqueous solution prior to or during incubation in an amount effective to stimulate encystment of one or more trophont ciliate cells.
- concentration of the magnesium ions added to the aqueous solution prior to or during incubation is in a non-crosslinking amount, i.e. the magnesium ions are not present in an amount effective to ionically cross-link the polymer (e.g. carrageenan, xanthan gum and/or gellan gum) in which the trophont ciliate cells are interspersed therein.
- the concentration of the magnesium ions in the aqueous solution prior to or during incubation is provided in an amount effective to stimulate encystment of the one or more trophont ciliate cells, for example between is about 15 ⁇ M to about 500 ⁇ M.
- the concentration of the magnesium ions in the aqueous solution prior to or during incubation is at least about 15, 20, 30, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500 or 1000 ⁇ M.
- the concentration of the magnesium ions in the aqueous solution prior to or during incubation is less than about 1000, 500, 450, 400, 350, 300, 250, 200, 100, 50, 30, 20, or 15 ⁇ M.
- the concentration of the magnesium ions in the aqueous solution prior to or during incubation is between about 15 ⁇ M to about 1000 ⁇ M, between about 20 ⁇ M to about 300 ⁇ M, between about 30 ⁇ M to about 200 ⁇ M, or between about 50 ⁇ M to about 150 ⁇ M.
- the concentration of magnesium ions in the aqueous solution prior to or during incubation is between about 60 ⁇ M to about 65 ⁇ M, for example about 62.5 ⁇ M.
- the magnesium ions (e.g. provided by magnesium sulfate) may be added to the aqueous solution at any point prior to or during incubation to stimulate encystment of one or more trophont ciliate cells.
- the method may further comprise the step of adding magnesium ions to the aqueous solution following incubation (e.g. following encystment) in an amount effective to stabilise the one or more encysted ciliate cells.
- incubation e.g. following encystment
- the present inventors have found that adding magnesium ions to the buffer solutions comprising encysted ciliate cells prior to storing stabilised the one or more encysted cells for a prolonged period of time.
- the concentration of magnesium ions added to the aqueous solution following incubation is in an amount effective to stabilise encysted ciliate cells, for example between about 25 mM to about 100 mM. In some embodiments, the concentration of magnesium ions added to the aqueous solution following incubation is at least about 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 90 or 100 mM. In other embodiments, the concentration of magnesium ions added to the aqueous solution following incubation is less than about 100, 90, 80, 75, 70, 65, 60, 55, 50, 40, 35, 30 or 25 mM.
- the concentration of magnesium ions added to the aqueous solution following incubation is between about 25 mM to about 75 mM, for example about 50 mM.
- the ciliate cells are incubated with the aqueous solution for at least about 6, 12, 18 or 24 hours prior to the addition of magnesium ions.
- the method further comprises the step of adding magnesium ions to the aqueous solution following encystment to stabilise the one or more encysted ciliate cells.
- the magnesium ions are added to the aqueous solution after incubation but prior to storing the encysted ciliate cells.
- the magnesium ions are added to the aqueous solution after incubation but prior to transferring the aqueous solution from the encystment temperature to the storage temperature.
- the addition of magnesium ions may stabilise encysted cells at lower polymer concentrations.
- the magnesium ions described herein may be provided by a suitable magnesium salt, for example magnesium sulfate (MgSO4) or magnesium carbonate (MgCO3).
- the magnesium ions are provided by magnesium sulfate. It will be appreciated that when the magnesium sulfate or magnesium carbonate is dissolved in the aqueous solution, magnesium ions (Mg2+) are present.
- one or more bacterial metabolites may be added to the aqueous solution.
- the bacterial metabolites may be derived from composted pine bark particles.
- the composted pine bark particles may have an average particle size of between about 1 ⁇ m to about 200 ⁇ m.
- the composted pine bark particles may have an average particle size of at least about 1, 5, 10, 15, 20, 25, 30, 40, 50, 60, 80, 100, or 120 ⁇ m.
- the composted pine bark particles may have an average particle size of less than about 120, 100, 80, 60, 50, 40, 30, 25, 20, 15, 10, 5 or 1 ⁇ m. Combinations of average particle sizes are also possible, for example the composted pine bark particles may have an average particles size of between about 5 ⁇ m to about 100 ⁇ m, or between about 5 ⁇ m to about 60 ⁇ m.
- the composted pine bark particles may have an average particle size of less than about 60 ⁇ m. In one embodiment, the composted pine bark particles may have an average particle size of less than about 30 ⁇ m.
- the term “average particle size” refers to a mean average particle size as determined by sieve analysis.
- the aqueous solution comprises between about 0.01% w/v to about 10% w/v composted pine bark particles based on the total volume of the aqueous solution. In some embodiments, the aqueous solution comprises at least about 0.001, 0.01, 0.02, 0.05, 0.08, 0.1, 0.2, 0.5, 1, 2, 5, or 10% w/v composted pine bark particles based on the total volume of the aqueous solution. In some embodiments, the aqueous solution comprises less than 10, 5, 2, 1, 0.5, 0.2, 0.1, 0.08, 0.05, 0.02, 0.01 or 0.001% w/v composted pine bark particles based on the total volume of the aqueous solution. Combinations of these ranges are also possible.
- the aqueous solution may comprise other particles, such as algal cells, starch (e.g. corn starch), grains (e.g. rice), activated charcoal, magnesium silicate, polystyrene and dextrans (e.g. sulphopropyl and quaternary ammonia ethyl substituted dextrans) or bacterial cells, including in the % w/v amounts recited above for the composted pine bark particles.
- starch e.g. corn starch
- grains e.g. rice
- activated charcoal e.g. sulphopropyl and quaternary ammonia ethyl substituted dextrans
- bacterial cells including in the % w/v amounts recited above for the composted pine bark particles.
- aqueous solution and compositions described herein may comprise any one or more additives as described above and herein in relation to the method of encysting ciliate cells.
- the polymer solutions described herein can also stabilised ciliate cells.
- a method of stabilising encysted ciliate cells comprising suspending a population of encysted ciliate cells in an aqueous solution comprising a polymer as described herein.
- the encysted ciliate cells may be obtained by methods described herein, or one or more alternative encystment methods.
- the encysted ciliate cells may be obtained by incubating a population of trophont ciliate cells in a buffer solution comprising magnesium ions, or by incubating a population of trophont ciliate cells in an aqueous solution comprising suspended soil particles (i.e. an aqueous soil solution), wherein the trophont ciliate cells undergo encystment to form one or more encysted ciliate cells.
- the encysted ciliate cells are obtained by incubating a population of trophont ciliate cells in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells, as described herein.
- a method of stabilising excysted ciliate cells comprising suspending a population of excysted ciliate cells in an aqueous solution comprising a polymer as described herein.
- the polymers, aqueous solutions and/or hydrocolloids comprising the ciliate cells are stable and the ciliate cells remained viable during storage.
- the ciliate cells within the polymer (either as an aqueous solution, hydrocolloid or dried polymer) remained as encysted ciliate cells during storage.
- the present inventors discovered that, in some embodiments, trophont ciliate cells that were incubated within an aqueous polymer solution underwent encystment to form encysted ciliate cells, and remained as encysted ciliate cells during storage.
- pre-formed encysted cells were suspended or interspersed within the polymer as described herein, they also remained as encysted ciliate cells during storage. This demonstrates that ciliate cells can be stored and remain stable when suspended in polymers of the present disclosure.
- nearly all of the encysted ciliate cells within the polymer remained as encysted ciliate cells and viable for at least about 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 12 weeks, 15 weeks, 20 weeks, 6 months, 12 months, 18 months or 24 months, highlighting the effect suspension/interspersion within the polymer (e.g. carrageenan) has on ciliate cell stability.
- the polymer comprising encysted ciliate cells is stored in a sealed container.
- the ciliate cells suspended or interspersed within the polymer can be stored under ambient conditions (e.g. in the dark, room temperature).
- the storage temperature may be between about 1° C. to about 30° C.
- the storage temperature may be at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, or 30° C.
- the storage temperature may be less than about 30, 28, 26, 24, 22, 20, 18, 16, 14, 12, 10, 9, 8, 7, 6, 5, 4, 3, or 2° C. Combinations of these storage temperatures to form various ranges are also possible, for example, between about 3° C. to about 25° C., or between about 4° C. to about 28° C.
- the present inventors have identified that, in some embodiments, the encysted ciliate cells remained encysted and viable after 8 weeks storage at 20° C. These encysted cells remained viable and following release from the polymer, the encysted cells were able to excyst into theront cells and establish new populations in culture, highlighting the improved storage properties of the polymers of the present invention.
- the ciliate cells suspended or interspersed within the polymer can be stored in the dark. In some embodiments, the ciliate cells suspended or interspersed within the polymer can be stored with minimal to no additional moisture.
- the suspended or interspersed ciliate cells can subsequently be released from the polymer into the external environment.
- the polymer can be suspended/soaked in water which softening the polymer structure allowing for the encysted or encapsulated cells to be released to the external environment.
- the encysted cells within the polymer are able to undergo excystment to form theront ciliate cells upon release from the polymer.
- fresh media e.g. sodium citrate buffer or PPYE medium
- the encysted ciliate cells are gradually released which then undergo excystment to form theront ciliate cells.
- the theront ciliate cells can then mature into a healthy new trophont cell cultures.
- Theront cells are the infective form of T. rostrata which were more effective at killing or reducing the fitness of slugs faster than trophont ciliate cells.
- the compositions of the present invention can be used to transport and deliver viable and stable encysted ciliate cells to a pest species and/or to an area affected or likely to be affected by a pest species (e.g. slugs or snails), where once the cells are released from within the polymer, they can undergo excystment to form the infective theront ciliate cells which are released into the environment and infect the pest species.
- a pest species e.g. slugs or snails
- the compositions of present invention can be used to transport and deliver viable and stable excysted ciliate cells (e.g. theronts) to a pest species and/or to an area affected or likely to be affected by a pest species (e.g. slugs or snails).
- viable and stable excysted ciliate cells e.g. theronts
- a pest species e.g. slugs or snails.
- the compositions described herein can also stabilise theronts which remain viable and infective for a sufficient period of time, which can then be directly applied to pest species as described herein.
- compositions and ciliate cells as described herein can be dispersed in the environment for infection or colonisation of pests.
- the aqueous polymer solutions or polymers suspending ciliate cells as described herein can be dispersed in the environment for infection or colonisation of pests.
- a method of infecting or colonising a pest species with a ciliate comprising applying to an area affected or likely to be affected by a pest species a composition described herein or an encysted ciliate cell prepared or stabilised by the methods described herein, or a composition as described herein.
- a method of infecting or colonising a pest species with a ciliate comprising applying a composition as described herein or an encysted ciliate cell prepared or stabilised by the method as herein to the pest species.
- colonisation refers to the entry of the protist to an external facing tissue or orifice of the pest such as the sub-mantle tissue lining or gut tissue following ingestion of the polymer or ciliate cells released therefrom.
- the pest species may consume the polymer and release the encapsulated or suspended ciliate cells.
- compositions or ciliate cells can be applied to the pest species (e.g. applied directly to the pest species). Such direct application may include spraying the composition or ciliate cells onto the pest species.
- the compositions or ciliate cells can be applied to an agricultural, water (i.e. aquaculture) environment and/or horticultural environment.
- the compositions or ciliate cells may be applied to an area of soil affected by a pest (such as a slug or a snail).
- a pest such as a slug or a snail.
- the aqueous polymer solution or polymer comprising the ciliate cells may dissolve/disintegrate in the moist soil environment and release the ciliate cells into the soil.
- the encysted ciliate cells released may subsequently undergo excystment within the soil into theront ciliate cells which are infective and can infect various pest species living in, on or around the soil area.
- the trophont ciliate cells may encyst in the soil environment to form encysted ciliate cells, which can then subsequently excyst to form the infective theront ciliate cells, as per the life cycle in FIG. 1 or can invade the pest animal tissue directly.
- the released ciliate cells may also be ingested by the pest, and undergo transformation within the pest to form theront ciliate cells.
- the released ciliate cells are theront ciliate cells, these may go on to infect the pest species.
- the compositions or ciliate cells could be applied to an area and subsequently wetted (e.g. by the rain, sprinkler, inundation, or drip irrigation etc.) wherein the water environment promotes the release of the ciliate cells.
- a dried polymer e.g. carrageenan
- the compositions or ciliate cells are applied directly to the pest species (e.g. by spraying onto the pest species). It will be appreciated that such direct application may occur simultaneously with the application of the composition or ciliate cells to an area affected or likely to be affected by a pest species as described herein.
- the infected pest species may then spread the theronts to niches where other pests take refuge thus promoting colonising and infection.
- compositions and ciliate cells of the present invention can be applied to include farms, gardens, crops, nurseries, pastures, fields, greenhouses, shadehouses, hydroponic nurseries.
- the area or environment the compositions or ciliate cells are applied to is an agricultural crop.
- a method for reducing agricultural crop damage comprising applying to an agricultural crop area affected or likely to be affected by a pest species a pest species a composition described herein or an encysted ciliate cell prepared or stabilised by the methods described herein, or a composition as described herein.
- an agricultural or horticultural composition comprising the composition described herein or an encysted ciliate cell prepared or stabilised by the methods described herein, in combination with one or more agriculturally or horticulturally acceptable carriers.
- the compositions or ciliate cells may be added to a container with holes to allow access for pest species, for example commercial traps (refuges) currently on the market for pest control, such as slug and snail traps.
- pest species for example commercial traps (refuges) currently on the market for pest control, such as slug and snail traps.
- placing the compositions or ciliate cells in such traps may expose the pests long enough for them to get infected with the ciliate cells which then kills them, or even if the pests manage to leave the trap, the infected pest would disperse the ciliates as they migrate around the adjacent area, thus spreading the ciliate infection to other pests in the area.
- the trap can then be refilled with more of the compositions or ciliate cells as the pest species consumes them.
- the compositions or ciliate cells may comprise or be further mixed with one or more acceptable carriers.
- the acceptable carrier may be an agriculturally or horticulturally acceptable carrier.
- an “acceptable carrier” and/or an “agriculturally acceptable carrier” and/or a “horticulturally acceptable carrier” is any carrier on which can facilitate the transport of the compositions or ciliate cells to an area affected or likely to be affected by a pest species (such as an invertebrate), and which is otherwise suitable for agricultural or horticultural use. Any such suitable acceptable carrier can be used, including but not limited to seeds, seed coats, granular carriers, liquid slurry carriers, and liquid suspension carriers.
- Suitable agriculturally or horticulturally acceptable carriers include fillers, solvents, excipients, surfactants, suspending agents, spreaders/stickers (adhesives), antifoaming agents, dispersants, wetting agents, drift reducing agents, auxiliaries, adjuvants or a mixture thereof.
- the agriculturally or horticulturally acceptable carrier may be selected from the group consisting of a filler stimulant, an anti-caking agent, a wetting agent, an emulsifier, and an antioxidant, for example said composition comprises at least one of each of a filler stimulant, an anti-caking agent, a wetting agent, an emulsifier, and an antioxidant.
- solid carriers include but are not limited to mineral earths such as silicic acids, silica gels, silicates, talc, kaolin, attapulgus clay, limestone, lime, chalk, bole, loess, clay, bentonite, dolomite, diatomaceous earth, aluminas calcium sulfate, magnesium sulfate, magnesium oxide, peat, humates, ground plastics, fertilizers such as ammonium sulfate, ammonium phosphate, ammonium nitrate, and ureas, and vegetable products such as grain meals, bark meal, wood meal, and nutshell meal, cellulosic powders, seaweed powders, peat, talc, carbohydrates such as mono-saccharides and di-saccharides, starch extracted from corn or potato or tapioca, chemically or physically altered corn starch and the like.
- mineral earths such as silicic acids, silica gels, silicates, talc, kaolin,
- solid carriers for the compositions, cells and strains of the present invention are suitable as carriers: crushed or fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite; synthetic granules of inorganic or organic meals; granules of organic material such as sawdust, coconut shells, corn cobs, corn husks or tobacco stalks; kieselguhr, tricalcium phosphate, powdered cork, or absorbent carbon black; water soluble polymers, resins, waxes; or solid fertilizers.
- Such solid compositions may, if desired, contain one or more compatible wetting, dispersing, emulsifying or colouring agents which, when solid, may also serve as a diluent.
- the acceptable carrier preferably has a sufficient shelf life, and preferably assists in the dispersion of the compositions, ciliate cells and/or isolated strains to an area affected or likely to be affected by a pest species (such as an invertebrate).
- the pest species can be an invertebrate or a vertebrate.
- the vertebrate is a lower vertebrate.
- the pest species is an invertebrate.
- the invertebrate may be a mollusc or arthropod, such as a dipteran (e.g. a mosquito).
- the pest species is a vertebrate, for example a fish species.
- the invertebrate is a mollusc, for example a Gastropod.
- the Gastropod may be a snail or a slug.
- the slugs and snails to be controlled in include all land-dwelling slugs and snails, for example those which occur as polyphagus pests in agricultural and horticultural crops.
- Agriculturally and horticulturally problematic slug and snail types are, for example, slugs such as the invasive Anion ater group such as A ater, A rufus , and A vulgaris ).
- Other non-limiting examples of slugs to be controlled include Ambigolimax valentianus, Deroceras invadens, Limacus flavus, Deroceras reticulatum (i.e. grey field slugs).
- PPYE media consisted of 0.5% (w/v) proteose peptone (Oxoid LP0085), 0.5% (w/v) yeast extract (Oxoid LP0021), and 0.125% (w/v) glucose.
- PP medium was PPYE without yeast extract (0.5% w/v Proteose Peptone (Oxoid LP0085) and 0.125% w/v glucose).
- Strain TRAUS was isolated from an egg laid by a F1 laboratory-reared D. reticulatum whose parents were collected from Melbourne, Australia. The egg was surface sterilised in 0.01% v/v hypochlorite for 5 min then washed several times in sterile distilled water to remove the hypochlorite. The egg was aseptically opened using a needle to release the ciliates into water and then immediately transferred to 10 ml of SPP media in a 25 cm2 tissue culture flask with a vented lid (IWAKI).
- carrageenan (Sigma C1013, CAS Number: 9000-07-1) was mixed with 600 mL of water either at 17-20° C. or 90-100° C. for 15 minutes, or autoclaved at 121° C. for 10 minutes, and then allowed to cooled before addition of 10 mM HEPES pH 7 NaOH buffer.
- a composted pine bark infusion buffer (CI—H) was prepared, according to a modified protocol by Segade et al. (2016) by mixing 50 g of medium grade composted pine bark ( Pinus radiata ; Australian Growing Solutions, Tyabb, Victoria, Australia) in Milli Q ultrapure water. The suspension was maintained in agitation for 15 min at room temperature (20° C.) and then large particles were removed by sieving and/or centrifugation. The decanted suspension was sterilised by autoclaving and HEPES buffer pH 7 was added to a final concentration of 10 mM.
- UP6 and UP4 filtered composted pine bark infusion buffers were prepared by washing the fine surface layer particles out from approximately 500 g of the medium grade composted pine bark, in two batches in a 400 micron sieve (hop spider), with reverse osmosis water. The flow through was then passed through a 50 micron Nitex mesh netting cloth (Australian Entomological Supplies) and the collected filtrate was sterilised by autoclaving, then stored at room temperature.
- Particles from the infusions were harvested by centrifugation at 800 g for 10 min. The particles were then air dried, and then rehydrated to the desired concentration.
- Magnesium sulfate (MgSO4) was dissolved in ultrapure water at a concentration of 62.5 ⁇ M and subsequently autoclaved at 121° C. for 20 minutes.
- T. rostrata trophonts were obtained using an isolated strain of T. rostrata TRAUS (deposited under PTA-126056 on 13 Aug. 2019 at the American Type Culture Collection) and were cultivated at 20° C. in PPYE and subcultured in PP. The density of the culture was assessed by a direct cell counting using a haemocytometer indicating the culture was 4.6 ⁇ 104 cell/ml.
- Trophonts grown in PP media were harvested (800 ⁇ g 10 min), washed in 2 volumes of 10 mM HEPES pH 7 NaOH (HEPES) and resuspended to a volume equivalent to 5 ⁇ 104 original trophonts per ml in either 1) 0.25% carrageenan-H; 2) 0.125% carrageenan-H; or 3) CI—H, and subsequently transferred to tissue culture plates and incubated under various conditions to evaluate the response of trophonts to incubation in the solutions at different temperatures.
- HEPES pH 7 NaOH HEPES pH 7 NaOH
- Trophonts are tear-drop shaped (rostrate) whereas they change to a rounded form during encystment into encysted ciliate cells.
- the rounding of the trophonts was the indication that the conditions may stimulate cyst formation.
- Rounded cells were examined microscopically for characteristic cyst capsules.
- MPN Most Probable Number Method
- For the viability counts trophonts were determined as viable through their movement and were directly counted. All other viability counts on the cultures were done by determining MPN on 3 individual cultures and the 95% confidence limits are shown. The percent round cells counts on the incubated cultures were determined from their individual cultures with the maximum and minimum values.
- Example 2 Carrageenan Buffer Solution Induces Encystment of T. rostrata at 26° C.
- the response of the trophonts incubated in the autoclaved carrageenan buffer solutions at 26° C. is shown in FIG. 2 .
- the efficiency of encystment in 0.125% carrageenan-H and 0.25% carrageenan-H was equivalent to the CI—H encystment.
- the cysts formed in carrageenan have distinctive capsules which are characteristic of typical T. rostrata cysts (see FIG. 6 ).
- Example 3 Carrageenan Buffer Solution Induces Encystment of T. rostrata at 20° C.
- FIG. 3 The response of the trophonts incubated in the autoclaved carrageenan buffer solutions at 20° C. is shown in FIG. 3 . Encystment was tested carried out at 20° C. In CI—H there is a flux between encysted-excysted-re-encysted cells resulting in low overall cyst yield and a diversity in the cell population. This is seen in wide margins of error in cell counts. The number of cells that encysted in 0.25% carrageenan-H was greater than in 0.125% carrageenan-H or for the CI—H.
- Example 4 Encysted Cells in Carrageenan Buffer Solution Remain Viable and Encysted Following Transfer to 20° C.
- the effect of adding magnesium ions to the buffer solutions comprising encysted ciliate cells was evaluated and shown in FIG. 5 .
- This treatment was tested by adding MgSO4 after 24 hours incubation at 26° C. but prior to transfer to 20° C.
- the MgSO4 prevented excystment of cells in CI—H and both carrageenan-H solutions, and did not affect viability of any of the cells in any treatment.
- the Addition of metal can be used to produce stable cysts with different concentrations of polymer.
- Example 6 Dehydrated Encysted Ciliate Cells in Carrageenan Remain Viable and Stable
- the trophonts were suspended in 0.25% or 0.125% carrageenan-H and CI—H and were placed in humidity chambers at 20° C. suspended in humidity chambers above different saturated salts, sodium chloride or sodium bromide, which would equalise at relative humidity 75.7% or 59.1%, respectively. They were allowed to dehydrate at 20° C.
- the cell morphology in the dried carrageenan was assessed microscopically after 18 days and 31 days. All cells were round and cyst-like and were trapped in the dried film ( FIG. 7 ).
- T. rostrata TRAUS is capable of converting from trophonts to cysts in carrageenan solutions. Stable encystment in carrageenan is very efficient at both 20° C. and 26° C. and the cysts remained viable and stable.
- Carrageenan (Sigma C1013), LA-gellan gum (Kelcogel® F LA-gellan gum) and HA-gellan gum (Kelcogel® LT100 HA-gellan) were each dissolved separately in ultrapure water at room temperature to form a hydrocolloid suspension/solution.
- the carrageenan (CGN) was autoclaved at 121° C. for 20 minutes, and then cooled to room temperature. The gellan were not heat treated.
- the suspensions/solutions were then added at various concentrations to T. rostrata cells at 1-3 ⁇ 104 cell per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 26° C.
- the encystment in carrageenan and gellan gum buffer solutions were compared to three control infusion buffer solutions prepared using compost pine bark (CI) and collected, dried and resuspended composted pine park particles (CDIP and DUP4) buffered with HEPES buffer pH 7 to a final concentration of 10 mM, and were then added at various concentrations to T. rostrata cells at 1-3 ⁇ 104 cell per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 26° C.
- HEPES pH 7 NaOH
- Table 1 shows the proportion of T. rostrata cells that encysted using either the control pine bark infusion buffer solutions or the carrageenan/gellan gum buffer solution.
- T. rostrata cells stimulated to encyst by extracts of composted pine bark (CI, DCIP, DUP4), carrageenan (CGN) and gellan gum.
- LA HA gellan gellan CI DCIP DUP4 CGN CGN # gum gum Charge Anionic Anionic Anionic Origin Plant Plant Plant Seaweed Seaweed Bacteria Bacteria mg/mL Percent of cells that encysted 0.195 56 60 55 66 51 32 47 0.0381 77 59 79 65 52 38 66 0.0781 81 59 90 67 65 49 58 0.1563 61 86 71 64 48 82 0.3125 68 90 68 67 55 91 0.625 82 92 81 83 43 91 1.25 81 98 86 92 62 2.5 86 99 58 1 CGN# was modified by the addition of HEPES pH7 (NaOH) at 10 mM prior to autoclaving.
- FIG. 8 The encystment using the three control infusion buffers are shown in FIG. 8 , highlighting the bark infusion preparations result in high efficiency of encystment.
- FIG. 9 shows the proportion of cells that encysted using preparations of carrageenan and gellan gum. Carrageenan and HA-gellan gum buffer solutions demonstrated high encystment efficiency T. rostrata.
- Example 8 Encystment of T. rostrata in Carrageenan Buffer Solutions Result in Durable Cysts
- the theronts produced in carrageenan buffer solutions at 0.025% and 0.125% w/v show the same characteristic bi-lobed macronucleus and a micronucleus as those produced in buffered compost infusion (CI—H) or 62.5 ⁇ M MgSO4 when Giemsa stained (see FIG. 10 ).
- the MPN assay determines the number of viable cells present, which could multiply and establish a trophont culture.
- the culture was monitored by observing and counting cell morphology, as the cells changed from trophonts (day 0) through to cysts during starvation (day 1 to 3) and then theronts after excystment (day 5 to 7).
- the excysted cells were confirmed to be theronts by Giemsa staining and showed the characteristic bi-lobed macronucleus and a micronucleus.
- the theronts size remained stable.
- D. reticulatum lethality experiments were performed using theronts that had excysted from cysts produced in buffered 0.025% w/v carrageenan, and the results are shown in FIG. 12 .
- D. reticulatum slugs were exposed to 1 ⁇ 105 theronts produced in buffered compost infusion (UP-6), 0.025% w/v carrageenan, or 62.5 ⁇ M MgSO4. They were also exposed to 1 ⁇ 105 trophonts in HEPES buffer. The survival of the slugs was monitored over 28 days.
- Example 10 Encystment and Excystment of T. rostrata at Higher Cell Densities
- Carrageenan (Sigma C1013) was dissolved in ultrapure water at room temperature to form a hydrocolloid suspension/solution, and autoclaved at 121° C. for 20 minutes, and then cooled to room temperature. 0.025% w/v carrageenan solution was then added at to T. rostrata cells at 3 ⁇ 105 cells per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 20° C. Control infusion buffer solutions were prepared using compost pine bark (CI) and collected, dried and resuspended composted pine park particles (UP6) buffered with HEPES buffer pH 7 to a final concentration of 10 mM, and then added to T.
- HEPES pH 7 NaOH
- Control infusion buffer solutions were prepared using compost pine bark (CI) and collected, dried and resuspended composted pine park particles (UP6) buffered with HEPES buffer pH 7 to a final concentration of 10 mM, and then added to
- rostrata cells at 3 ⁇ 105 cell per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 20° C. After 26 hours, the infusion buffer solutions were screened for their ability to encyst and excyst T. rostrata at high cell densities (see Table 2).
- Theronts yield when T. rostrata is encysted & excysted at 20° C. at a cell density of 3 ⁇ 10 5 cell per ml in various encystment buffers.
- Culture at 8 days at 20° C. Cell density on day 1 was 3 ⁇ 10 5 trophonts per ml) % of the ciliated cells Infusion Cells % that are Theronts buffer per ml Ciliates theronts per ml CI 2.6 ⁇ 10 5 86 73 1.6 ⁇ 10 5 UP6 3.5 ⁇ 10 5 85 89 2.6 ⁇ 10 5 CGN 2.0 ⁇ 10 5 77 74 1.1 ⁇ 10 5
- Example 11 Identification of Other Polysaccharides that Encyst T. rostrata
- polysaccharides carrageenan and gellan gum
- a range of other polysaccharides were selected and sourced to screen for their ability to encyst T. rostrata , as outlined in Table 3.
- the polysaccharides were dissolved at a known concentration (either 0.125% w/v or 0.25% w/v) in stirred ultrapure water and heated to ensure full dissolution and hydration of the polysaccharide before cooling to room temperature to form an aqueous polysaccharide solution/suspension.
- T. rostrata cells stimulated to encyst by various polysaccharide buffer solutions at 26° C. after 26 hours. Encystment of T. rostrata cells in 10 mM HEPES pH 7 (NaOH) alone was used as a control where 50% are cysts after 26 hours at 26o C.
- the encystment data demonstrates that a range of polysaccharides can encyst T. rostrata at higher percentages compared to the control using HEPES buffer alone as the encystment buffer (i.e. no polysaccharide).
- carrageenan buffer solutions encysted T. rostrata with k-carrageenan (kappa) and I-carrageenan (iota) demonstrating high encystment efficiency (see FIG. 13 ).
- the anionic polysaccharide Xanthan gum encysted T. rostrata with very high efficiency (see FIG. 13 ).
- Example 12 Structural Form of the Polysaccharide May be Important to Encyst T. rostrata
- the polysaccharides were dissolved at 0.125% w/v in stirred heated to 90-100° C. or 50-60° C. ultrapure water to ensure full dissolution and hydration of the polysaccharide before cooling to room temperature or in stirred ultrapure water at room temperature (17-20° C.).
- the polysaccharide solutions/suspension was then added at 2-fold dilutions to T. rostrata at 1-3 ⁇ 104 cells per ml (low cell density).
- the cultures comprising the polysaccharide were then buffered with HEPES pH 7 (NaOH) at 10 mM and incubated at 26° C. for 26 hours. The percent of round/oval cells were counted, and these were determined to be cysts visually. For cysts a defined capsule layer around the protozoa with cells that are slightly compressed within the layer were seen. For many slight cyclopsis (internal rotating movement) was occurring and the cells clustered and adhered together.
- TABLE 4 The percent of T. rostrata cells stimulated to encyst by various polysaccharide buffer solutions at 26° C. after 26 hours. Encystment of T. rostrata cells in 10 mM HEPES pH 7 (NaOH) alone was used as a control where 50% are cysts after 26 hours at 26° C.
- Heating and cooling the HA-gellan likely changes the structural matrix that this hydrocolloid forms.
- the encystment data suggests that the structure matrix of polysaccharides is important to encyst T. rostrata at higher percentages compared to the control using HEPES buffer alone as the encystment buffer (i.e. no polysaccharide).
- HA gellan that has not been heat-cooled encysted T. rostrata with high encystment efficiency see FIG. 14 ).
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dispersion Chemistry (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The present disclosure relates to compositions and methods for inducing encystment of and/or stabilising ciliate cells. In particular, the present disclosure relates to polymers and polymeric solutions, including hydrocolloids, which may be used to induce encystment of trophont ciliate cells to form encysted ciliate cells and/or stabilise encysted cells. The present disclosure also relates to methods of infecting and/or colonising molluscs with the compositions and ciliates described herein.
Description
- This application claims the benefit of Australia Patent Application No. 202190775 filed on Mar. 17, 2021, and PCT/AU2022/050235 filed Mar. 17, 2022, which are hereby incorporated by reference.
- The present disclosure relates to compositions and methods for inducing encystment of and/or stabilising ciliate cells. In particular, the present disclosure relates to polymers and polymeric solutions which may be used to induce encystment of trophont ciliate cells to form encysted ciliate cells and/or stabilise encysted cells. The present disclosure also relates to methods of infecting and/or colonising molluscs with the compositions and ciliates described herein.
- Pests, for example slugs and snails, are a problem in agriculture and horticulture because they damage plants and affect the productivity and quality of crops and plant products. Various strategies have been used to control pest molluscs which include the use of chemical molluscicides (e.g. methiocarb and metaldehyde) which are usually distributed in baits. These chemicals are not just specific for molluscs, and target other animals raising concerns about their toxic effect and environmental contamination.
- Biological agents, such as biological pesticides, have been proposed as an alternative to chemical molluscicides. One example is the slug parasitic ciliate Tetrahymena rostrata. T. rostrata ciliates transition from being feeding ciliated cells (called “trophont” cells) to reproductive or resting cyst cells (called “cyst” or “encysted” cells) via a process called “encystment”. The encysted cells then undergo “excystment” to form juvenile cells (called “theront” cells).
- Various problems arise associated with using ciliate cells as biological pesticides due to their developmental life cycle, including that cells grown in culture media are not robust and/or have limited cell viability so cannot be stored for long periods of time thus are unsuitable for use as pest control agents. There is therefore a need to develop new processes to enhance the storage, stability, methods for application, and/or parasitic activity of ciliate cells for use in pest control, or at least provide the public with a useful alternative.
- The present inventors have identified processes for growing and formulating ciliate cells at various developmental stages for production, storage and delivery as a biological pesticide for the control of pests, such as molluscs. In particular, the present inventors have identified that various polymers improve the storage, stability and viability of ciliate cells. The polymers described herein can induce the encystment of trophont ciliate cells to form one or more encysted ciliate cells. The polymers can be provided as an aqueous polymer solution, which may be used to encyst or stabilise ciliate cells suspended therein or can be a dried polymer (e.g. via dehydration) wherein one or more encysted ciliate cells are interspersed therein. The polymers may be non-ionically crosslinked.
- The encysted ciliate cells remain viable during storage either suspended in the polymeric solution or interspersed within the polymer following dehydration. Alternatively, the polymers described herein can be used to stabilise and store preformed encysted cells. The encysted ciliate cells can be subsequently released from the polymer and undergo excystment into theront ciliate cells, which the inventors have also identified can be highly infective to pests such as molluscs. The present invention therefore provides compositions which can be used to store, stabilise and transport viable encysted ciliate cells, allowing for their use as an effective pest control agent, such as being applied to areas affected or likely to be affected by a pest species.
- In a first aspect, there is provided a composition comprising encysted ciliate cells that are interspersed within a polymer. The polymer may be a non-ionically crosslinked polymer.
- In one embodiment, the polymer comprises a polysaccharide. In one embodiment, the polysaccharide is an anionic polysaccharide. In one embodiment, the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria. In one embodiment, the polysaccharide is derived from algae or bacteria. In one embodiment, the polysaccharide is an algal polysaccharide or a bacterial polysaccharide. In one embodiment, the polysaccharide is an algal polysaccharide. In one embodiment, the polysaccharide is a bacterial polysaccharide. In one embodiment, the polysaccharide is selected from the group consisting of carrageenan, agarose, agar, alginate, xanthan gum and gellan gum or a mixture thereof. In one embodiment, the polysaccharide is carrageenan, xanthan gum or gellan gum, or a mixture thereof. In one embodiment, the polysaccharide is carrageenan. In another embodiment, the polysaccharide is xanthan gum. In another embodiment, the polysaccharide is gellan gum.
- In one embodiment, the polymer is dispersed in an aqueous solution, and the encysted ciliate cells are suspended in the aqueous solution comprising the polymer. Alternatively, in one embodiment, the polymer is a dried polymer. In one embodiment, the aqueous solution comprising the polymer forms a hydrocolloid. In some embodiments, the aqueous solution comprising the polymer forms an anionic hydrocolloid. The ciliate cells may be suspended within the hydrocolloid. In one embodiment, the aqueous solution comprises between about 0.01% w/v to about 5% w/v polymer based on the total volume of the aqueous solution. In one embodiment, the aqueous solution comprises between about 0.01% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
- In one embodiment, the aqueous solution is a buffer solution. In one embodiment, the buffer solution comprises a HEPES buffering agent. In one embodiment, the concentration of the HEPES buffering agent in the buffer solution is between about 1 mM to about 25 mM. In one embodiment, the buffer solution has a pH of between about 6.0 to about 9.0.
- In one embodiment, the encysted ciliate cells interspersed within the polymer remain viable for at least about four weeks.
- In one embodiment, the ciliate cells are a member of the Ciliophora phylum. In one embodiment, the ciliate cells are a member of the Heterotrichea, Karyorelictea, Armophorea, Litostomatea, Colpodea, Nassophorea, Phyllopharyngea, Prostomatea, Plagiopylea, Oligohymenophorea, Protocruziea, Spirotrichea, or Cariotrichea class. In one embodiment, the ciliate cells are a member of the Apostomatia, Astomatia, Hymenostomatia, Peniculia, Peritrichia, or Scuticociliatia order. In one embodiment, the ciliate cells are a member of the Tetrahymenidae, Ophryoglenina, or Peniculina family. In one embodiment, the ciliate cells are a member of the Tetrahymena genus. In one embodiment, the ciliate cells are of the T. rostrata, T. hegewischi, T. hyperangularis, T. malaccensis, T. patula, T. pigmentosa, T. foissneri, T. deweyae T. pyriformis, T. thermophila, T. vorax, T. geleii, T. corlissi, T. empidokyrea or T. limacis species. In one embodiment, the ciliate cells are of the T. rostrata species.
- In a related and second aspect, there is provided a method of inducing the encystment of ciliate cells, the method comprising incubating a population of trophont ciliate cells in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- In a related and third aspect, there is provided a method of stabilising encysted ciliate cells, the method comprising suspending a population of encysted ciliate cells in an aqueous solution comprising a polymer. The embodiments described above for the polymer, aqueous solution and ciliate cells in relation to the composition comprising ciliate cells equally apply to the methods of encystment and stabilising of ciliate cells described herein.
- In some embodiments, the aqueous solution comprising the polymer forms a hydrocolloid. In some embodiments, the aqueous solution comprising the polymer forms an anionic hydrocolloid. In one embodiment, the polymer is not ionically crosslinked during encystment.
- In one embodiment, the trophont ciliate cells are incubated in the aqueous solution at a temperature of between about 10° C. to about 30° C. In one embodiment, the trophont ciliate cells are incubated in the aqueous solution for period of time of between about 12 to about 72 hours. In one embodiment, the encysted ciliate cells are stored in the aqueous solution at a temperature of between about 10° C. to about 30° C.
- In some embodiments, the method further comprises the step of adding magnesium ions to the aqueous solution prior to or during incubation in an amount effective to stimulate encystment of one or more trophont ciliate cells. Alternatively or additionally, the method may further comprise the step of adding magnesium ions to the aqueous solution following incubation in an amount effective to stabilise the one or more encysted ciliate cells. In either embodiment, the magnesium ions may be provided by a suitable magnesium salt, for example magnesium sulfate.
- In some embodiments, the method further comprises dehydrating the aqueous solution to obtain a dried polymer wherein the one or more encysted ciliate cells are interspersed within the polymer.
- In a related and fourth aspect, there is provided an encystment media composition comprising an aqueous solution and a non-ionically crosslinked polymer. The embodiments described above for the polymer and aqueous solution in relation to the compositions comprising ciliate cells and methods of encystment and stabilising of ciliate cells methods equally apply to the encystment media composition described herein.
- In a related and fifth aspect, there is provided an agricultural or horticultural composition comprising the composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above, in combination with one or more agriculturally or horticulturally acceptable carriers.
- In a related and sixth aspect, there is provided a method of infecting or colonising a pest species with a ciliate, the method comprising applying to an area affected or likely to be affected by a pest species a composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above.
- In a related and seventh aspect, there is provided a method of infecting or colonising a pest species with a ciliate, the method comprising applying a composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above to the pest species.
- In a related and eighth aspect, there is provided a method for reducing agricultural crop damage comprising applying to an agricultural crop area affected or likely to be affected by a pest species a pest species a composition as described above or an encysted ciliate cell prepared or stabilised by the method as described above.
- In one embodiment, the method results in the ciliate killing or affecting the fitness of the pest species. In one embodiment, the pest species is an invertebrate. In one embodiment, the pest species is a mollusc. In one embodiment, the mollusc is a Gastropod. In one embodiment, the Gastropod is a snail or slug.
- Any embodiment herein shall be taken to apply mutatis mutandis to any other embodiment unless specifically stated otherwise. For instance, the skilled person would understand that examples and embodiments of polymers, aqueous solutions, additives and ciliate cells described herein in relation to the composition comprising encysted ciliate cells equally apply to the method of inducing encystment and method of stabilising ciliate cells, encystment media compositions, agricultural or horticultural compositions, methods of infecting a pest species and/or methods for reducing agricultural crop damage.
- The present invention is not to be limited in scope by the specific embodiments described herein, which are intended for the purpose of exemplification only. Functionally-equivalent products, compositions and methods are clearly within the scope of the invention, as described herein.
- Throughout this specification, unless specifically stated otherwise or the context requires otherwise, reference to a single step, composition of matter, group of steps or group of compositions of matter shall be taken to encompass one and a plurality (i.e. one or more) of those steps, compositions of matter, groups of steps or group of compositions of matter.
-
FIG. 1 —Ciliate cell developmental stages: Schematic diagram of the main developmental stages of the ciliate T. rostrata depicting 1) trophont ciliate cells, 2) encysted ciliate cells and 3) theront ciliate cells. Trophont ciliate cells undergo “encystment” to form encysted ciliate cells (or “cysts”). Encysted ciliate cells undergo “excystment” to form theront ciliate cells. Theront ciliate cells undergo “maturation” to form trophont ciliate cells. -
FIG. 2 —Carrageenan induces encystment of T. rostrata at 26° C.: Percentage of encysted cells (% round) following incubation of trophonts in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) at 26° C. The corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days incubation. -
FIG. 3 —Carrageenan induces encystment of T. rostrata at 20° C.: Percentage of encysted cells (% round) following incubation of trophonts in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) at 20° C. The corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days incubation. -
FIG. 4 —Encysted ciliate cells suspended in carrageenan remain stable after 4 weeks storage: Encysted ciliate cells in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) were transferred and stored to 20° C. The corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days storage at 20° C. -
FIG. 5 —Magnesium sulfate stabilises encysted ciliate cells in carrageenan: Survival of encysted ciliate cells in 0.25% w/v carrageenan buffer solution (0.25% w/v carrageenan-H; triangle and grey), 0.125% carrageenan buffer solution (0.125% carrageenan-H; square and light grey) and compost infusion (CI—H; circle and black) exposed to 50 mM magnesium sulfate after 24 hours incubation at 26° C. prior to transfer to 20° C. The corresponding dashed lines represent the viability of the encysted ciliate cells after 31 days storage at 20° C. -
FIG. 6 —Morphology of encysted ciliate cells in carrageenan: Micrograph of encysted ciliate cells formed in carrageenan having the distinctive capsules characteristic of typical T. rostrata cysts. -
FIG. 7 —Encysted ciliate cells in carrageenan tolerate dehydration: Micrograph of encysted ciliate cells in carrageenan following dehydration. -
FIG. 8 —Composted pine bark particles induce encystment of T. rostrata: Extracts of composted pine bark (CI, DCIP and DUP4) were added at various concentration to T. rostrata at 1-3×104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours the percent of cells that had encysted was determined. -
FIG. 9 —Carrageenan and gellan gum induce encystment of T. rostrata: Solutions of carrageenan buffered before and after (#) autoclaving and gellan gum (HA and LA) were added at various concentration to T. rostrata at 1-3×104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours the percent of cells that had encysted was determined. -
FIG. 10 —Morphology of encysted ciliate cells in compost infusion, MgSO4 and carrageenan: Giemsa stained theronts produced in buffered CI, MgSO4, 0.025% w/v carrageenan (CGN) and 0.125% w/v carrageenan (CGN) at 26° C./20° C. at a low cell density of 1-3×104 cells per ml. -
FIG. 11 —Carrageenan produces infections theronts: Trophonts cultures were encysted in encystment buffer with CI (circles), 62.5 uM MgSO4 (squares), 0.025% w/v carrageenan (CGN) (diamonds) and 0.125% w/v carrageenan (CGN) (triangles) at 26° C. resulting in cyst suspensions on days 1-3. The cysts were transferred to 20° C. and excystment of theronts was completed by day 7-8 and were then maintained under starvation conditions in the respective encystment buffer at 20° C. The average viable counts per ml are shown with maximum and minimal values of three separate culture. A summary timeline for encystment, excystment and theront persistence is given. -
FIG. 12 —Survival of slugs exposed to theronts produced in carrageenan: Survival of D. reticulatum slugs when challenge with theronts made in carrageenan, UP6 (extract of composted pine bark) and 62.5 uM MgSO4 buffer solutions -
FIG. 13 —Carrageenan and xanthan gum induce encystment of T. rostrata: Extracts of composted pine bark, carrageenan and xanthan gum were added at various concentration to T. rostrata at 1-3×104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours the percent of cells that had encysted was determined. -
FIG. 14 —High acyl gellan gum induce encystment of T. rostrata: Solutions of HA gellan gum, made with a heat (90-100° C. or 50-60° C.)—cooling (to 17-20° C.) step or without (17-20° C.), were added at various concentration to T. rostrata at 1-3×104 cells per ml (low cell density) in buffer to stimulate encystment at 26° C. After 26 hours, the percent of cells that had encysted was determined. - Unless specifically defined otherwise, all technical and scientific terms used herein shall be taken to have the same meaning as commonly understood by one of ordinary skill in the art (e.g., polymer, buffer, pest control, and ciliate physiology).
- As used herein, the term “about”, unless stated to the contrary, refers to +/−10%, more preferably +/−5%, more preferably +/−1%, of the designated value.
- Throughout this specification the word “comprise”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element, integer or step, or group of elements, integers or steps, but not the exclusion of any other element, integer or step, or group of elements, integers or steps.
- The term “consists of”, or variations such as “consisting of”, refers to the inclusion of any stated element, integer or step, or group of elements, integers or steps, that are recited in context with this term, and excludes any other element, integer or step, or group of elements, integers or steps, that are not recited in context with this term.
- As used in this application, the term “or” is intended to mean an inclusive “or” rather than an exclusive “or”. That is, unless specified otherwise, or clear from context, “X employs A or B” is intended to mean any of the natural inclusive permutations. That is, if X employs A; X employs B; or X employs both A and B, then “X employs A or B” is satisfied under any of the foregoing instances. Further, at least one of A and B and/or the like generally means A or B or both A and B. In addition, the articles “a” and “an” as used in this application and the appended claims may generally be construed to mean “one or more” unless specified otherwise or clear from context to be directed to a singular form.
- The term “suspended”, “suspension” or “suspending” in the context of ciliate cells being suspended in an aqueous solution comprising a polymer, refers to a polymer solution that can flow but is sufficient to hold the ciliate cells in suspension. The ciliate cells can migrate throughout the polymer solution while remaining suspended.
- The term “intersperse”, “interspersion” or “interspersed” in the context of ciliate cells being interspersed within a polymer, refers to ciliate cells being at least in part distributed and scattered within the polymer.
- The term “incubate”, “incubating” or “incubated” in the context of ciliate cells being incubated in an aqueous solution, refers to maintaining ciliate cells under controlled conditions favourable for inducing encystment and/or maintaining viability of the ciliate cells.
- The term “biological pesticide” refers to a pest management agent that is based on organisms or natural products that provide pest intervention through a predatory, parasitic or chemical relationship, often having a short term effect on the environment.
- In some embodiments or examples, the methods and compositions of the present invention comprise the incubation/suspension/interspersion of ciliate cells within a polymer, for example an aqueous solution comprising the polymer or a dried polymer.
- The term “ciliates” refers to a group of protozoans characterized by the presence of hair-like organelles called cilia. It is the presence of cilia which distinguishes ciliate cells from other protist cells. The developmental stage cycle of ciliate cells can be separated into three main stages, namely the formation of 1) “trophont” ciliate cells (also known as trophozoites), 2) “encysted” or “cyst” ciliate cells and 3) “theront” ciliate cells. Cells go through several stages of development during autogamy and cyst maturation. The ciliate cells may be ciliate protozoa cells.
- Briefly, the trophont cells are at the growing and feeding stage, encysted cells are the reproductive or resting stage, and theront cells are excysted cells. A simple summary of the life cycle of ciliate cells is provided in
FIG. 1 , where trophont cells undergo a process called “encystment” to form encysted cells. The encysted cells can then undergo a process called “excystment” to form theront cells. The developmental cycle closes where the theront cells mature (i.e. “maturation”) to form trophont cells. The encystment of trophont ciliate cells can be induced by various external stimuli such as starvation and cell aggregation. For example, trophonts respond to encystment stimuli by transforming into small, rapid swimming pre-cystic cells and then round up and secrete large amounts of mucin which condenses and gradually forms a laminar cyst wall which develops into the thick wall of encysted ciliate cells. - The present inventors have identified that, in some embodiments, polymers, such as polysaccharides, can induce encystment of trophont ciliate cells into encysted ciliate cells. The encysted ciliate cells incubated/suspended in the aqueous solution remain stable and viable and do not excyst into theront ciliate cells, even after dehydration to form a dried polymer wherein the encysted ciliate cells are interspersed within the polymer. In some embodiments, theront ciliate cells may be incubated/suspended/interspersed within the aqueous solution. Accordingly, it will be appreciated that a ciliate cell from any developmental stage may be used in the methods and compositions of the present invention.
- In some embodiments, the ciliate cells may be encysted ciliate cells or trophont ciliate cells. In one preferred embodiment, the ciliate cells are trophont ciliate cells. In an alternative embodiment, the ciliate cells are encysted ciliate cells. In some embodiments, the ciliate cells are excysted ciliate cells. In one embodiment, the ciliate cells are theront cells. In some embodiments, the ciliate cells may be a mixture of trophont ciliate cells or encysted ciliate cells. In one embodiment, the trophont ciliate cell may undergo encystment within the aqueous solution to form an encysted ciliate cell. The present inventors have found that, in some embodiments, ciliate cells remained stable and viable for a longer period of time in the presence of polymers described herein.
- The ciliate cells may be any member of the Ciliophora phylum. In one preferred embodiment, the ciliate cells are cells that are capable of encystment. The specific type of ciliate cell that is used may also depend on a number of variables, including but not limited to, the type of polymer and/or aqueous solution, the area to be treated with polymer, the soil type the polymer is being dispersed in, and/or the pest species being targeted for pest control (e.g. the type of pest, such as a Gastropod).
- In some embodiments, the ciliate cell is a member of the Intramacronucleata, Ventrata, Spirotrichia, or Rhabdophora subphylum. In one preferred embodiment, the ciliate cell is a member of the Intramacronucleata subphylum.
- In some embodiments, the ciliate cell is a member of Heterotrichea, Karyorelictea, Armophorea, Litostomatea, Colpodea, Nassophorea, Phyllopharyngea, Prostomatea, Plagiopylea, Oligohymenophorea, Protocruziea, Spirotrichea, or Cariotrichea class. In a preferred embodiment, the ciliate cells are a member of the Oligohymenophorea class.
- In some embodiments, the ciliate cells are a member of the Apostomatia, Astomatia, Hymenostomatia, Peniculia, Peritrichia, or Scuticociliatia order. In a preferred embodiment, the ciliate cells are a member of the Hymenostomatia order.
- In some embodiment, the ciliate cells are a member of the Tetrahymenina, or Ophryoglenia sub order. In one embodiment, the ciliate cells are a member of the Tetrahymenina sub order. In another embodiment, the ciliate cells are a member of the Ophryoglenia sub order.
- In some embodiments, the ciliate cells are a member of the Tetrahymenidae, Ophryoglenina, or Peniculina family.
- In some embodiments, the ciliate cells are a member of the Tetrahymena or Lambornella genus. In one embodiment, the ciliate cells are a member of the Lambornella genus. In a preferred embodiment, the ciliate cells are a member of the Tetrahymena genus.
- In some embodiments, the ciliate cells are of the T. rostrata, T. hegewischi, T. hyperangularis, T. malaccensis, T. patula, T. pigmentosa, T. foissneri, T. deweyae, T. pyriformis, T. thermophila, T. vorax, T. geleii, T. corlissi, T. empidokyrea or T. limacis. In a preferred embodiment, the ciliate cells is of the T. rostrata species. In other embodiments, the ciliate cells are of the Lambornella clarki species.
- In one embodiment, the ciliate cells are cultured from an isolated strain of T. rostrata TRAUS (deposited under PTA-126056 on 13 Aug. 2019 at the American Type Culture Collection).
- It will be appreciated that the embodiments described above and herein in relation to the ciliate cells equally to the ciliate cells of the encystment methods, stabilisation methods, and encystment media composition as described herein.
- The present inventors have identified a composition comprising encysted ciliate cells that are interspersed within a polymer can improve the storage, stability and viability of ciliate cells. In some embodiments, the polymer of the composition may be provided as an aqueous polymer solution or as a dried polymer. The polymer may be a hydrocolloid as described herein. The polymer and aqueous solution comprising a polymer are described herein.
- The polymer is not lethal to ciliate cells, and allows sufficient diffusion of oxygen to the ciliate cells incubated/suspended therein to maintain cell viability.
- In one embodiment, the polymer is a hydrophilic polymer. In some embodiments, the polymer may be selected hydrophilic acrylics, peptides, dendrimers, star-polymers, aliphatic polymers, natural polymers, polysaccharides, synthetic polymers, anionic polymers, cationic polymers, neutral polymers, and synthetic polymers, and mixtures or co-polymers thereof. In one embodiment, the polymer is an anionic polymer.
- The polymer may have a high molecular weight (Mw). In some embodiments, the polymer has an average molecular weight (MW) in the range of between about 100 to about 1,000 kDa. In some embodiments, the polymer has an average molecular weight (MW) of at least about 100, 200, 300, 400, 500, 600, 700, 800 900 or 1,000 kDa. In other embodiments, the polymer has an average molecular weight (MW) of less than about 1,000, 900, 800, 700, 600, 500, 400, 300, 200 or 100 kDa. Combinations of these molecular weights to form various ranges are also possible, for example the polymer has an average molecular weight (MW) of between about 200 kDa to about 800 kDa. It will be appreciated that the molecular weight of the polymer may vary depending on the type used to prepare the aqueous solution (e.g. hydrocolloid). For example, different grades of carrageenan can be used.
- In one embodiment, the polymer comprises a polysaccharide (i.e. a carbohydrate polymer). A polysaccharide is a polymeric carbohydrate comprising two or more monosaccharide units bound together by glycosidic linkages. Polysaccharides are widespread in nature and can be found in animals, plants, and bacteria, and can also be synthetically manufactured. In some embodiments, the polysaccharide may be a naturally occurring polysaccharide (e.g. derived from bacteria or algae such as xanthan gum, gellan gum or carrageenan) or a synthetic polysaccharide (e.g. CMC), or a mixture thereof.
- According to at least some embodiments or examples described herein, the present inventors have surprisingly identified that polysaccharides can induce encystment of trophont ciliate cells to form encysted ciliate cells, which remain encysted and viable during storage. Without wishing to be bound by theory, it is believed that the presence of hydroxyl (—OH) groups along with the presence of various hydrophilic groups (e.g. —NH2, —COOH, —OH, —CONH2, —CONH—, and —SO3H) within polysaccharides, such as sulphate groups on carrageenan and carboxyl groups on the gellan gum and xanthan gum, can increase the affinity for binding to water molecules of the aqueous solution and capture of water to form a hydrocolloid, and in turn effectively dehydrates the trophont cells suspended within the polysaccharide solution, thus inducing encystment. Alternatively or additionally, the complex structure and hydrocolloid formation of various polysaccharides when dissolved in water may cause mechanical stress inducing encystment due to crowding the ciliate cells. Depending on the nature of the polysaccharide and/or process conditions used to prepare the aqueous hydrocolloid (e.g. heat treatment and cooling), the internal structure of the hydrocolloid may vary from randomly arranged polysaccharide subunits such as linear or coiled domains to a more ordered structure such as double helices or matrices. These double helices or matrices may further aggregate into a more complex hydrocolloid structure. By manipulating the internal structure of the hydrocolloid (e.g. via heat treatment and cooling of the polysaccharide aqueous solution prior to incubation), encystment efficiency may be improved. Alternatively or additionally, the hydrocolloid molecules may interact with one or more ligands on the surface of the ciliate cells to stimulate an encystment response, including for example interaction with one or more surface-exposed glycoproteins.
- In one embodiment, the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria. In one embodiment, the polysaccharide is an algal polysaccharide or a bacterial polysaccharide.
- In one embodiment, the plant polysaccharide (e.g. derived from plants) is selected from the group consisting of cellulose, starch, guar gum, pectin, locust bean gum, gum arabic, tragacanth and karaya, or a mixture thereof.
- In one embodiment, the algal polysaccharide (e.g. derived from algae) is selected from the group consisting of carrageenan, agarose, agar and alginate, or a mixture thereof. In one embodiment, the polysaccharide is carrageenan.
- In one embodiment, the animal derived polysaccharide is chitosan (e.g. from crustacean shells), chitin or gelatin, or a mixture thereof. In one embodiment, the fungal polysaccharide is galactomannan.
- In one embodiment, the bacterial polysaccharide may be an extracellular polysaccharide. The extracellular polysaccharide may be selected from the group consisting of xanthan gum, gellan gum (including derivatives such as sphingans, welan, rhamsan and diutan), bacterial alginate, glucans (including alpha-glucans such as dextran, mutan, alternan and reuteran, and beta-glucans, such as cellulose and curdlan), hyaluronan, succinoglycan, levan, GalactoPol and FucoPol.
- It will be appreciated that the polysaccharides may be obtained by any suitable method. Some non-limiting examples include polysaccharides obtained from a commercial supplier, or polysaccharides extracted from soil particles (including for example composted or non-composted particles, such as pine bark, peat or sugarcane bagasse and other composted or non-composted plant substrates). For example and in some embodiments, bacterial polysaccharides as described herein may be derived from composted pine bark particles. In some embodiments, bacterial polysaccharides derived from the composted pine bark particles may be harvested from the composted pine bark (e.g. isolated from the composted pine bark), and subcultured separately and added to the aqueous solution. Alternatively, the composted pine bark particles may be included as an additive which is suspended in the aqueous solution, wherein the bacterial polysaccharide (or other metabolite) is derived therefrom. The aqueous solution described herein (including in relation to the compositions, encystment media and methods of inducing encystment) may further comprise composted pine bark particles. The composted pine bark particles are described herein, including under the heading “Additives”.
- The term “composted” refers to particles, such as pine park particles, that have been obtained through a composting process, that is have undergone microbial decomposition. By way of example only, composted pine bark particles may be obtained by adding urea (and optionally some trace elements) to saturated pine bark particles. It will be appreciated that the pine bark is the major carbon source and urea is the source of nitrogen, which together triggers the bacterial decomposition of the pine bark particles to obtain the “composted” pine bark particles. Alternatively, the “composted” pine bark particles may be obtained from a suitable potting mix. The term “potting mix” refers to a growing mix often used in gardens and nurseries, which comprise composted pine bark particles and other ingredients such as sand, added nutrients and other additives such as vermiculite. An example of a potting mix is Australian Growing Solutions. The potting mix may be filtered to obtain the composted pine bark particles. The pine bark particles may comprise Pinus radiata pine particles. In some embodiments, adding composted pine bark particles to the aqueous solution introduces the bacterial polysaccharides into the aqueous solution.
- In other embodiments, the bacterial polysaccharides as described herein may be derived from non-composted particles. For example, non-composted particles such as pine bark particles or sugarcane bagasse particles, may be subjected to conditions effective to encourage microbial growth on the particles, e.g. the particles undergo a microbial fermentation or culturing under conditions effective to encourage microbial growth on the particle surface (e.g. maceration). Alternatively, non-composted particles may be fermented with a defined culture of one or more bacteria to provide a non-composted particle preparation that provides on or more bacterial polysaccharides that can induce encystment. In this embodiment, it would be appreciated that growing bacterial polysaccharides on a plant material requires a nitrogen source (e.g. urea) and optionally a buffer such as a phosphate buffer, followed by removal the larger particles to obtain the bacterial polysaccharide. For example, xanthan gum may be produced by culturing Xanthomonas campestris on non-composted particles such as sugarcane bagasse, followed by removal of the large particles to obtain xanthan gum, which can be precipitated to obtain small particles comprising the xanthan gum, which can be dried and then rehydrated for later use in encystment. In one embodiment, the bacterial polysaccharide is isolated from composted pine bark or fermented sugarcane bagasse.
- In one embodiment, the polysaccharide may be a synthetic polysaccharide, including synthetic versions of one or more of the polysaccharides described herein. Examples of suitable synthetic polysaccharides include carboxymethyl cellulose (CMC). In one embodiment, the polysaccharide is an anionic polysaccharide. The term “anionic” in the context of a polysaccharide refers to a polysaccharide comprising one or more anionic groups (e.g. sulfate; SO32- or carboxylate; COO—). The anionic nature of the polysaccharide may be controlled by the environment, for example by controlling the pH of the aqueous solution described herein (e.g. suspending the polysaccharide in an aqueous buffer solution (e.g. HEPES buffer pH 7). According to some embodiments or examples described herein, the present inventors have surprisingly identified that anionic polysaccharides can induce encystment of trophont ciliate cells to form encysted ciliate cells which remain encysted and viable during storage. Without wishing to be bound by theory, it is believed that the polysaccharides anionic groups may interact with one or more ligands on the surface of T. rostrata trophont ciliate cells, including for example interaction with one or more surface-exposed glycoproteins, which may help stimulate encystment, for example either by aggregating the cells and/or stimulating capsule formation. For example, the sulfate (SO32-) groups on carrageenan, and carboxylate (COO—) groups on gellan gum have a strong negative charge and affinity to polycation macromolecule and/or amphoteric proteins on the surface of ciliate cells. The resulting interaction may be sensed by the cell and trigger encystment.
- In some embodiments, the polysaccharide may be selected from the group consisting of carrageenan, agarose, agar, alginate, alginic acid, carboxymethylcellulose, pectin, pectic acid, hyaluronic acid, polyglucuronic acid, cellulose, gellan gum, xanthan gum, starch, chitosan, and chitin, or mixtures or co-polymers thereof. In one embodiment, the polymer comprises a polysaccharide selected from the group consisting of carrageenan, agarose, gellan gum, xanthan gum and agar, or a mixture thereof. In one embodiment, the polymer comprises a polysaccharide selected from the group consisting of carrageenan, gellan gum and xanthan gum, or a mixture thereof.
- It will be appreciated that the polymer may comprise any one or more of the above mentioned polymers (e.g. polysaccharides), including synthetic versions, mixtures or copolymers thereof.
- In one embodiment, the polymer is carrageenan. Carrageenan is a sulfated polysaccharide, namely a sulfated galactan that is extracted from seaweed. Carrageenan comprises an anionic linear polymers comprising 1,3α-1,4β-galactans having one (κ-) two (τ-) or three (λ-) sulfates per disaccharide unit.
- The present inventors have identified that, in some embodiments, carrageenan can induce encystment of trophont ciliate cells to form encysted ciliate cells which remain encysted and viable during storage. Alternatively, carrageenan can be used to suspend and store preformed encysted ciliate cells. The encysted ciliate cells can excyst to form theront cells once released from the carrageenan and can infect pests such as molluscs.
- In some embodiments, the carrageenan comprises a mixture of κ-carrageenan, τ-carrageenan, and λ-carrageenan. The carrageenan may comprise predominantly of κ-carrageenan (e.g. one sulfate per disaccharide unit). In one embodiment, the polymer is carrageenan purchased from Sigma Aldrich, catalogue number C1013 (CAS Number 9000-07-1). The carrageenan may comprise a small amount of potassium cations, for example less than about 15%, 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001%, or 0.0001% w/w potassium cations.
- The aqueous solution comprising carrageenan can form a hydrocolloid. Without wishing to be bound by theory, it is believed that solubilised carrageenan chains change conformation to from being random coils to a more ordered helical structure, which can then aggregate via weak intermolecular interactions, namely hydrogen bonding, between the carrageenan helices to form the hydrocolloid. The carrageenan may also comprise a small fraction of potassium (K+) cations, the presence of which can stabilize the junction zones between two carrageenan helices by binding to the negatively charged sulfate groups without hindering the hydrogen bonding of the two helices. Importantly, the stabilisation of junction zones between carrageenan helices by monovalent potassium cations does not result in ionic crosslinking thus retaining the hydrocolloids water-soluble properties.
- It will be appreciated that carrageenan has a sulfate content (SO3-). In some embodiments, the polymer has a sulfate content of between about 1% to about 50% w/w sulfate based on the total mass of the polymer. In some embodiments, the polymer has a sulfate content of at least about 1, 2, 5, 10, 15, 20, 25, 30, 40 or 50% w/w sulfate based on the total weight of the polymer. In some embodiments, the polymer has a sulfate content of less than about 50, 40, 30, 25, 20, 15, 10, 5, 2 or 1% w/w sulfate based on the total weight of the polymer. Combinations of any two of these upper or lower values to form a range is also possible, for example between about 5% to about 40% w/w, or between about 10% to about 30% w/w sulfate based on the total weight of the polymer.
- In another embodiment, the polysaccharide is gellan gum. Gellan gum is a bacterial polysaccharide and, like carrageenan, is a linear polymer which can act as a hydrocolloid. Gellan gum comprises tetrasaccharide repeats, 1,4-α-L-rhamnose, 1,3-β-D-glucose, 1,4-β-D-glucose, 1,4-β-D-glucuronic acid. Gellan gum comprises two acyl substituents, acetate and glycerate, which occur on the same glucose subunit. Depending on the number of acyl substituents, gellan gum can exist in either high acyl (HA), native, or low acyl (LA) forms. In one embodiment, the polysaccharide is a high acyl (HA) gellan gum (Kelcogel® LT100 HA gellan gum). In a related embodiment, the gellan gum has an acyl content (e.g. the number of acyl groups attached to the polysaccharide) of at least 25%, 30%, 35%, 40%, 45% or 50% w/w based on the total weight of the gellan gum. According to some embodiments or examples described herein, a gellan gum hydrocolloid stimulates encystment of T. rostrata, with HA gellan gum capable of producing durable cysts. In some embodiments, gellan gum that has not been heat-treated may induce encystment with high efficiency. Without wishing to be bound by theory, in relation to gellan gum it is believed the gellan gum polymers within the hydrocolloid interact in an irregular matrix structure resulting in a higher viscosity compared to gellan gum which has been heat treated and cooled which results in a softer, lower viscosity hydrocolloid. Nonetheless, both heat-treated and non-heat treated gellan gum was found to induce encystment.
- In another embodiment, the polysaccharide is xanthan gum. Xanthan gum is a hetero-polysaccharide produced by the fermentation of the bacterial microbe Xanthomonas campestris. Its main chain is made up of glucose units. The beta-D-glucoses are linked (1->4) to form the backbone similar to cellulose. At every second glucose residue is an added trisaccharide side chain consisting of alpha-D-mannose, beta-D-glucuronic acid, and a beta-D-mannose terminal unit. Thus, the overall repeating structure is a pentasaccharide. The mannose residue closer to the backbone often has an acetyl group at its C-6 position, the more distant mannose residue often has a pyruvate group between its C-4 and C-6 atom. In general, about one branch in two has a pyruvate group, but the ratio of pyruvate to acetate varies depending on the substrain of Xanthomonas campestris used and the conditions of fermentation. The overall repeating structure is a pentasaccharide. The glucuronic and pyruvic acid groups give xanthan gum a highly negative charge.
- In one preferred embodiment, the polymer is not ionically crosslinked. As used herein, the term “crosslink, “crosslinked” or “crosslinking” refers to the formation of interactions within or between polymers which result in the formation of a three-dimensional matrix. An ionically cross linked polymer is linked together by ionic interactions (i.e. an electrostatic attraction between oppositely charged ions). For example, ionic-cross linking may be a charge interaction between the polymer and an oppositely charged molecule as the linker, such as may be a cation or anion, as described in Parhi et al. (2017). In relation to this embodiment, it will be understood that there are no ionic cross-linking interactions which result in the formation of a three-dimensional polymer matrix, for example a hydrogel. The term “hydrogel” refers to a substance formed when a hydrogel-forming polymer (e.g. natural or synthetic polymer) is cross-linked (e.g. via ionic crosslinking) to create a three-dimensional “solid” matrix structure which entraps water molecules to form a gel. Consequently, where the polymer is part of an aqueous solution (e.g. suspended or dissolved in an aqueous buffer solution), it will be understood that the absence of any ionic crosslinking means the polymer remains suspended and dispersed within the aqueous solution and does not form a three-dimensional polymer matrix, such as a hydrogel. In one embodiment, the composition is not a hydrogel. In one embodiment, the composition is not an alginate hydrogel.
- The lack of ionic crosslinking does not preclude the presence of weaker interactions between the polymer and water molecules, for example other types of physical cross-linking such as hydrogen bonding which, according to some embodiments or examples described, can facilitate the formation of a hydrocolloid. Examples of non-ionic physical cross-linking includes molecular entanglement of the polymer, hydrogen bonding and hydrophobic interaction.
- In a related embodiment, the composition does not comprise an effective amount of an ionic cross-linker, for example a multivalent metal cation or multivalent anion, in an amount effective to ionically crosslink the polymer to form a hydrogel (e.g. capable of crosslinking the polymer to form a hydrogel as defined above).
- It will be appreciated that the embodiments described above and herein in relation to the polymer apply equally to the polymers of the encystment methods, stabilisation methods, and encystment media composition as described herein.
- The polymer may be dispersed in an aqueous solution. The encysted ciliate cells may be interspersed/suspended in the aqueous solution comprising the polymer.
- The polymer may be dispersed in an aqueous solution. The aqueous solution comprising the polymer may also be called an aqueous polymer solution. In one embodiment, the aqueous solution comprising the polymer forms a hydrocolloid. The ciliate cells may be suspended within the hydrocolloid. The hydrocolloid may be an anionic hydrocolloid (e.g. derived from an anionic polymer). A “hydrocolloid” can be defined as a water-soluble hydrophilic polymeric that interacts with an aqueous medium (e.g. water) to form a colloid system either as a gel or a sol of solubilised hydrophilic polymer particles. The colloid particles are hydrophilic polymers (e.g. polysaccharides) dispersed in water resulting in a dispersion, and in some cases a viscous dispersion and/or gel. In the case of polysaccharides, the presence of hydroxyl (—OH) groups can increase the affinity for binding to water molecules of the aqueous solution and/or to each other, for example via weak non-ionic interactions (e.g. hydrogen bonding), resulting in a dispersion (i.e. an intermediate between a true solution and a suspension) and thus exhibits the properties of a colloid. In contrast, a hydrogel is three-dimensional “solid” matrix structure formed by a cross-linked hydrophilic polymer, the result of which is insoluble in water. The insoluble cross-linked hydrophilic polymer entraps water molecules (as opposed to being solubilised therein) within the cross-linked matrix structure to form a continuous gel network and is distinct from a hydrocolloid. In one embodiment, the composition is not a hydrogel. In one embodiment, the aqueous solution does not comprise a hydrogel. In one embodiment, the aqueous solution does not comprise an alginate hydrogel.
- The aqueous solution may be water or may be a buffered solution. As used herein, the term “buffer solution” refers to an aqueous solution consisting of a mixture of a weak acid and its conjugate base, or vice versa. The pH of the buffer solution changes very little when a small amount of strong acid or base is added to it. Buffer solutions are used as a means of keeping pH at a nearly constant value. The buffer solution may also be referred to as an aqueous buffer solution.
- The buffer solution may be a HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), a phosphate buffer solution, or a Tris (tris(hydroxymethyl)aminomethane) buffer solution. In one embodiment, the buffer solution is a HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer solution.
- In some embodiment, the concentration of HEPES in the HEPES buffer solution is at least about 1, 2, 5, 7, 10, 12, 15, 20 or 25 mM. In some embodiments, the concentration of HEPES in the HEPES buffer solution is less than about 25, 20, 15, 12, 10, 7, 5, 2 or 1 mM. Combinations of these concentrations are also possible, for example between about 1 mM to about 25 mM, between about 5 mM to about 25 mM, between about 8 mM to 15 mM, for example about 10 mM.
- In some embodiments, the buffer solution has a pH of at least about 6, 6.2, 6.4, 6.6, 6.8, 7, 7.2, 7.4, 7.6, 7.8, 8, 8.2, 8.4, 8.6, 8.8 or 9. In some embodiments, the buffer solution has a pH of less than about 9, 8.8, 8.6, 8.4, 8.2, 8, 7.8, 7.6, 7.4, 7.2, 7, 6.8, 6.4, 6.2, or 6. Combinations of these pH values are also possible, for example between about 6.8 to about 8.2. In one embodiment, the buffer solution has a pH of about 7. The pH of the buffer solution may be adjusted using sodium hydroxide.
- In some embodiments, the concentration of the polymer in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of the polymer in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%. 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 10%, 15%, or 20% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of the polymer in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%. 3.5%, 3%, 2.5%, 2%, 1.5%, 1.4%, 1.3%, 1.2%, 1.1%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the polymer in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, between about 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- The concentration of the polymer in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution. In some embodiments, the concentration of polymer in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5. In some embodiments, the concentration of polymer in the aqueous solution (in mg/ml) may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the polymer in the aqueous solution is between about 0.002 mg/mL to about 2.5 mg/mL.
- In some embodiments, the concentration of the polymer in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of the polymer in the aqueous solution is less than about 5%, 1%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the polymer in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.01% w/v to about 0.3% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of the polymer in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution. It will be appreciated that the above % w/v concentrations apply to any polymer described herein, including those listed above under the heading “Polymer”.
- In one embodiment, the polymer is a polysaccharide. In some embodiments, the concentration of polysaccharide in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of polysaccharide in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15%, 0.2%, 0.25%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%. 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 10%, 15%, or 20% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of polysaccharide in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%. 3.5%, 3%, 2.5%, 2%, 1.5%, 1.4%, 1.3%, 1.2%, 1.1%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of polysaccharide in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- In some embodiments, the concentration of polysaccharide in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of polysaccharide in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of polysaccharide in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.01% w/v to about 0.3% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of polysaccharide in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution.
- The concentration of polysaccharide in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution. In some embodiments, the concentration of polysaccharide in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5. In some embodiments, the concentration of polysaccharide in the aqueous solution (in mg/ml) may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the polysaccharide in the aqueous solution is between about 0.002 mg/mL to about 2.5 mg/mL.
- In one embodiment, the polymer is carrageenan. In some embodiments, the concentration of carrageenan in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of carrageenan in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.5%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%. 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 10%, 15%, or 20% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of carrageenan in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%. 3.5%, 3%, 2.5%, 2%, 1.5%, 1.4%, 1.3%, 1.2%, 1.1%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of carrageenan in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- In some embodiments, the concentration of carrageenan in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of carrageenan in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of carrageenan in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.025% w/v to about 0.25% w/v, or between about 0.1% w/v to about 0.3% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of carrageenan in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution. According to at least some embodiments or examples described herein, it has been surprisingly identified that an aqueous solution/hydrocolloid comprising between about 0.025% w/v to about 0.25% w/v carrageenan stimulates efficient encystment of T. rostrata, and theronts can be effectively excysted therefrom and infect slugs resulting in decreased grazing and significant mortality.
- The concentration of carrageenan in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution. In some embodiments, the concentration of carrageenan in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5. In some embodiments, the concentration of carrageenan in the aqueous solution (in mg/ml) may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of the carrageenan in the aqueous solution is between about 0.002 mg/mL to about 2.5 mg/mL.
- In one embodiment, the polymer is gellan gum. In some embodiments, the concentration of gellan gum in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of gellan gum in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.5%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%. 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 10%, 15%, or 20% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of gellan gum in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%. 3.5%, 3%, 2.5%, 2%, 1.5%, 1.4%, 1.3%, 1.2%, 1.1%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of gellan gum in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- In some embodiments, the concentration of gellan gum in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of gellan gum in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of gellan gum in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.025% w/v to about 0.25% w/v, or between about 0.1% w/v to about 0.3% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of gellan gum in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution.
- The concentration of gellan gum in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution. In some embodiments, the concentration of gellan gum in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5. In some embodiments, the concentration of gellan gum in the aqueous solution (in mg/ml) may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of gellan gum in the aqueous solution is between about 0.1 mg/mL to about 2.5 mg/mL.
- In one embodiment, the polymer is xanthan gum. In some embodiments, the concentration of xanthan gum in the aqueous solution is between about 0.01% w/v to about 20% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of xanthan gum in the aqueous solution is at least about 0.01%, 0.015%, 0.02%, 0.025%, 0.5%, 0.1%, 0.15%, 0.2%, 0.3%, 0.4% 0.5%, 0.6% 0.7%, 0.8%. 0.9%, 1%, 1.1%, 1.2%, 1.3%, 1.4%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 10%, 15%, or 20% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of xanthan gum in the aqueous solution is less than about 20%, 15%, 10%, 5%, 4.5%, 4%. 3.5%, 3%, 2.5%, 2%, 1.5%, 1.4%, 1.3%, 1.2%, 1.1%, 1%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of xanthan gum in the aqueous solution is between about 0.01% w/v to about 15% w/v, between about 0.01% w/v to about 10% w/v, between about 0.01% w/v to about 5% w/v, or between about 0.01% w/v to about 1% w/v based on the total volume of the aqueous solution.
- In some embodiments, the concentration of xanthan gum in the aqueous solution is least about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, 0.5%, 1% or 5% w/v based on the total volume of the aqueous solution. In other embodiments, the concentration of xanthan gum in the aqueous solution is less than about 5%, 1%, 0.5%, 0.5%, 0.45%, 0.4%, 0.35%, 0.3%, 0.25%, 0.2%, 0.15%, 0.1%, 0.05%, 0.025%, 0.02%, 0.015%, or 0.01% w/v based on the total volume of the aqueous solution. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of xanthan gum in the aqueous solution is between about 0.01% w/v to about 0.5% w/v, between about 0.025% w/v to about 0.25% w/v, or between about 0.1% w/v to about 0.3% w/v based on the total volume of the aqueous solution. In some embodiments, the concentration of xanthan gum in the aqueous solution is about 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.1%, 0.15% 0.2%, 0.25%, 0.3%, 0.35%, 0.4%, 0.45%, or 0.5% w/v based on the total volume of the aqueous solution.
- The concentration of xanthan gum in the aqueous solution may also be provided in mg/mL based on the total volume of the aqueous solution. In some embodiments, the concentration of xanthan gum in the aqueous solution (in mg/mL) is at least about 0.001, 0.002, 0.005, 0.01, 0.02, 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.5, 4, 4.5 or 5. In some embodiments, the concentration of xanthan gum in the aqueous solution (in mg/ml) may be less than about 5, 4.5, 4, 3.5, 3, 2.75, 2.5, 2.25, 2, 1.75, 1.5, 1.25, 1, 0.75, 0.5, 0.25, 0.2, 0.175, 0.15, 0.125, 0.1, 0.05, 0.02, 0.01, 0.005, 0.002, 0.001. Combinations of any two of these upper or lower values to form a range are also possible, for example the concentration of xanthan gum in the aqueous solution is between about 0.1 mg/mL to about 2.5 mg/mL.
- The aqueous solution comprising the polymer may have a viscosity. The viscosity of the aqueous solution when the polymer is dispersed therein may be higher (e.g. “thicker”) than the native aqueous solution (e.g. no polymer dispersed therein). In some embodiments, the viscosity of the aqueous solution comprising the polymer may be between about 5 to about 1,000 mPa·s when measured using a rotating cylinder method.
- In some embodiments, the density of the ciliate cells in the aqueous solution is between about 1×102 cells/mL to about 1×1010 cells/mL. The density of the ciliate cells in the aqueous solution may be at least about 1×102 cells/mL, 1×103 cells/mL, 1×104 cells/mL, 1×105 cells/mL, 1×106 cells/mL, 1×107 cells/mL, 1×108 cells/mL, 1×109 cells/mL, or 1×1010 cells/mL. The density of the ciliate cells in the aqueous solution may be less than about 1×1010 cells/mL, 1×109 cells/mL, 1×108 cells/mL, 1×107 cells/mL, 1×106 cells/mL, 1×105 cells/mL, 1×104 cells/mL, 1×103 cells/mL, or 1×102 cells/mL. Combinations of any two of these upper or lower values to form a range are also possible, for example between about 1×103 cells/mL to about 1×106 cells/mL, between about 1×103 cells/mL to about 1×105 cells/mL, or between about 1×104 cells/mL to about 1×105 cells/mL.
- In some embodiments, the aqueous solution comprises at least about 0.5, 1, 2, 5, 10, 15, 20, 25, 30, 35 or 40% w/v ciliate cells. In some embodiments, the aqueous solution comprises less than about 40, 35, 30, 25, 20, 15, 10, 5, 2, 1 or 0.5% w/v ciliate cells. Combinations of these % w/v values are also possible, for example the aqueous solution comprises between about 0.5% w/v to about 40% w/v ciliate cells.
- In some embodiments, the vol:vol ratio of the ciliate cells to the aqueous solution is between about 1:10 to about 10:1. In some embodiments, the vol:vol ratio of the ciliate cells to the aqueous solution is at least about 1:10, 1:8, 1:4, 1:2, 1:1, 2:1, 4:1, 6:1, 8:1, or 10:1. In some embodiments, the vol:vol ratio of the ciliate cells to the aqueous solution is less than about 10:1, 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:6, 1:8, or 1:10. Combinations of any two of these upper or lower values to form a range are also possible.
- It will be appreciated that the embodiments described above and herein in relation to the aqueous solution apply equally to the aqueous solution of the encystment methods, stabilisation methods, and encystment media composition as described herein.
- The composition may further comprise additional additives, including those described under the heading “Additives” in relation to the method of inducing encystment of ciliate cells. Other examples of additives include preservatives such as parabens, benzoates, sorbic acid, citrates or parabens, humectants such as glycerol or propylene glycol, antioxidants such as butylhydroxytoluene or butylhydroxyanisole, tocopherol, ascorbic acid, flavourings or other formulation auxiliaries. These may be dissolved/suspended in the aqueous solution with the polymer and ciliate cells, or mixed as separate components with the polymer encapsulating the ciliate cells.
- In one embodiment, the composition further comprises an attractant or feeding stimulant. As used herein, the term “attractant” refers to an agent which assists in attracting one or more pest species to consume the polymer. As used herein, the term “feeding stimulant” refers to an agent that encourages one or more pest species to remain consuming the polymer for a period of time to allow for the release of ciliate cells suspended or interspersed therein and the pest species to be exposed to the ciliate cells. However, it will be appreciated that the polymers can be consumed by a pest species without the use of attractants and/or feeding stimulants. The attractant may include a pheromone or a nutrient source. In some embodiments, the attractant may be selected from one or more of a starch, carbohydrate, protein, amino acid, plant extracts (e.g. any one of essential oils, saps, resins, chlorophyll and other crude extracts of a plant that a pest species (e.g. slug or snail) may detect as a food source) or a pheromone.
- In one embodiment, the composition further comprises a nutrient source. The nutrient source may be a molasses or a sugar. In some embodiments, the nutrient source may be selected from the group consisting of starch, sugar, semolina, couscous or combination thereof. The nutrient source may also be a carbohydrate or a plant product.
- In one embodiment, the composition further comprises a feeding stimulant. In some embodiments, the feeding stimulant may be selected from one or more of a starch, carbohydrate, protein, amino acid, plant extracts (e.g. any one of essential oils, saps, resins, chlorophyll and other crude extracts of a plant that a pest species (e.g. slug or snail) may detect as a food source).
- In some embodiments, the composition may comprise a single species of ciliate, multiple species of ciliate, or one or more species of ciliates with other organisms, such as pathogenic bacteria, fungal spores, or pathogenic nematodes. Accordingly, in some embodiments, the composition may further comprise one or more other additional components such as one or more of a bait, pesticide, biocontrol agent, or other organisms such as pathogenic bacteria, fungal spores or pathogenic nematodes. In another embodiment, the composition may further comprise one or more metallic salts, for example metallic phosphates and metallic sulfates. In some embodiments, the composition may further comprise iron(III) phosphate (FePO4), iron (II) phosphate (Fe3(PO4)2) and copper (II) sulfate (CuSO4).
- In one embodiment, the composition further comprises pathogenic bacteria or fungal spores. The pathogenic bacteria or fungal spores may be suspended within the polymer with the ciliate cells, or may be inside the ciliate cells prior to suspension/interspersion within the polymer. Without wishing to be bound by theory, it is believed that as some bacteria and fungi are pathogenic to pest species, such as slugs and snails, the presence of both ciliate cells and bacteria or fungal spores may result in a higher killing effect. For example, ciliate cells that have ingested bacteria and/or fungi may be released from the polymer and subsequently enter or be ingested by a pest species (e.g. a slug). Once inside the pest species, the ciliate cells may release the bacteria and/or fungi which also has an adverse effect on the pest species, thus resulting in a higher killing effect.
- It will be appreciated that the embodiments described above and herein in relation to the additives apply equally to the additives of the encystment methods, stabilisation methods, and encystment media composition as described herein.
- The present inventors have also identified an encystment media composition which can be used to induce encystment of trophont ciliate cells. The encystment media composition comprises an aqueous solution and a polymer as described herein. In one embodiment, the encystment media composition comprises an aqueous solution and a non-ionically crosslinked polymer as described herein.
- In one embodiment, the aqueous solution comprising the polymer forms a hydrocolloid. In one embodiment, the aqueous solution comprising the polymer forms an anionic hydrocolloid. In one embodiment, the polymer comprises a polysaccharide. In one embodiment, the polysaccharide is an anionic polysaccharide. In one embodiment, the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria. In one embodiment, the polysaccharide is derived from algae. In one embodiment, the algal polysaccharide is selected from the group consisting of carrageenan, agarose, agar and alginate, or a mixture thereof. In one embodiment, the polysaccharide is carrageenan.
- In one embodiment, aqueous solution comprises between about 0.1% w/v to about 5% w/v polymer based on the total volume of the aqueous solution. In one embodiment, the aqueous solution comprises between about 0.1% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
- In one embodiment, the aqueous solution is a buffer solution. In one embodiment, the buffer solution comprises a HEPES buffering agent. In one embodiment, the concentration of the HEPES buffering agent in the buffer solution is between about 1 mM to about 25 mM, or between about 5 mM to about 25 mM. In one embodiment, the buffer solution has a pH of between about 6.0 to about 9.0.
- In one embodiment, the aqueous solution comprises magnesium ions in an amount effective to stimulate encystment of one or more trophont ciliate cells. In this embodiment, it will be appreciated that concentration of the magnesium ions in the aqueous solution is in a non-crosslinking amount, i.e. the magnesium ions are not present in an amount effective to ionically cross-link the polymer (e.g. carrageenan, xanthan gum and/or gellan gum). In some embodiments, the concentration of the magnesium ions in the aqueous solution is between about 15 μM to about 500 μM. In some embodiments, the concentration of the magnesium ions in the aqueous solution is at least about 15, 20, 30, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500 or 1000 μM. In other embodiments, the concentration of the magnesium ions in the aqueous solution is less than about 1000, 500, 450, 400, 350, 300, 250, 200, 100, 50, 30, 20, or 15 μM. Combinations of these concentration values to form various ranges are also possible, for example the concentration of the magnesium ions in the aqueous solution is between about 15 μM to about 1000 μM, between about 20 μM to about 300 μM, between about 30 μM to about 200 μM, or between about 50 μM to about 150 μM. In one embodiment, the concentration of magnesium ions in the aqueous solution is between about 60 μM to about 65 μM, for example about 62.5 μM. In one embodiment, the aqueous solution comprises magnesium sulfate (MgSO4) or magnesium carbonate (MgCO3). In one preferred embodiment, the aqueous solution comprises magnesium sulfate (MgSO4). It will be appreciated that when the magnesium sulfate or magnesium carbonate is dissolved in the aqueous solution, magnesium ions (Mg2+) are present.
- In one embodiment, there is provided a use of an encystment media composition as described herein, for inducing encystment of ciliate cells. In another embodiment, there is provided a method of inducing encystment of ciliate cells, the method comprising incubating a population of trophont ciliate cells in an encystment media composition as described herein at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- In addition to the above embodiments, it will be appreciated that the embodiments described above and herein for the polymer, polysaccharide, hydrocolloid, additives and aqueous solution in relation to the composition comprising encysted ciliate cells equally apply to the polymer, polysaccharide, hydrocolloid, additives and aqueous solution of the encystment media composition described herein.
- The present inventors have identified a method of inducing encystment of trophont ciliate cells into encysted ciliate cells using an aqueous solution comprising a polymer, which may be buffered (e.g. with HEPES) to form a buffered aqueous polymer solution. The aqueous solution comprises a polymer as described herein. The aqueous solution comprising the polymer may also be called an aqueous polymer solution. By incubating trophont ciliate cells in the aqueous solution, one or more trophont ciliate cells undergo encystment to form encysted ciliate cells.
- In one aspect or embodiment, there is provided a method of inducing the encystment of ciliate cells, the method comprising incubating a population of trophont ciliate cells in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- The aqueous solution may be an encystment media composition as described herein. In one embodiment, the aqueous solution comprising the polymer forms a hydrocolloid as described herein. In one embodiment, the polymer is not ionically crosslinked as described herein. In one embodiment, the polymer is not ionically crosslinked during encystment of the trophont ciliate cells.
- In one embodiment, the polymer comprises a polysaccharide. In one embodiment, the polysaccharide is an anionic polysaccharide. In one embodiment, the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria. In one embodiment, the polysaccharide is derived from algae or bacteria. In one embodiment, the polysaccharide is selected from the group consisting of carrageenan, xanthan gum, gellan gum, agarose, agar and alginate, or a mixture thereof. In one embodiment, the polysaccharide is carrageenan, xanthan gum or gellan gum.
- In one embodiment, aqueous solution comprises between about 0.1% w/v to about 5% w/v polymer based on the total volume of the aqueous solution. In one embodiment, the aqueous solution comprises between about 0.1% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
- In one embodiment, the aqueous solution is a buffer solution. In one embodiment, the buffer solution comprises a HEPES buffering agent. In one embodiment, the concentration of the HEPES buffering agent in the buffer solution is between about 5 mM to about 25 mM. In one embodiment, the buffer solution has a pH of between about 6.0 to about 9.0.
- In one embodiment, the method does not comprise adding an effective amount of an ionic cross-linker to the aqueous solution, for example a multivalent metal cation or multivalent anion, in an amount effective to ionically crosslink the polymer to form a hydrogel (e.g. capable of crosslinking the polymer to form a hydrogel as defined above).
- In one embodiment, the aqueous solution comprising the polymer is heat-treated prior to incubation with the trophont ciliate cells. In some embodiments, the aqueous solution is heated to a temperature (in ° C.) of at least about 30, 40, 50, 60, 60, 70, 80, 90, 100, 110, 120 or 130 prior to incubation with the trophont ciliate cells. In some embodiments, the aqueous solution is heated to a temperature (in ° C.) of less than about 130, 120, 110, 100, 90, 80, 70, 60, 50, 40 or 30 prior to incubation with the trophont ciliate cells. The heating temperature may be in a range provided by any two of these upper and/or lower values, for example between about 90° C. to about 130° C. The heat treatment may be performed by any suitable method, for example heating the aqueous solution on a hotplate or in an autoclave. In one embodiment, the aqueous solution is heat-treated for a period of time (in minutes) or at least 1, 2, 5, 10, 15, 20, 25, 30 or 60 prior to incubation with the trophont ciliate cells. The heat treatment period may be a range provided by any two of these upper and/or lower values, for example between about 5 minutes to about 20 minutes. Following heating, the aqueous solution may be cooled to room temperature prior to incubation with the trophont ciliate cells. In an alternative embodiment, the aqueous solution comprising the polymer is not heat-treated prior to incubation with the trophont ciliate cells. According to some embodiments or examples described herein, the presence or absence of a heat treatment step prior to incubation may improve encystment efficiency due to altering the internal hydrocolloid structure. Nonetheless, the compositions of the present invention induced encystment of trophont ciliate cells irrespective of whether the aqueous solution was heat treated prior to incubation, highlighting the versatility of the encystment composition described herein. In one embodiment, the method comprises including
- The embodiments described above and herein in for the ciliate cells, polymer, polysaccharide, hydrocolloid, aqueous solution and additives in relation to the composition comprising encysted ciliate cells and encystment media equally apply to the ciliate cells, polymer, polysaccharide, hydrocolloid, aqueous solution and additives of the method of inducing encystment of ciliate cells, where applicable.
- Further additional embodiments specific to the method of inducing encystment are described below.
- In some embodiments, the trophont ciliate cells are young trophont ciliate cultures, for example have undergone less than 10, 9, 8, 7, 6, 5, 4, 3, 2 or 1 subcultures. The number of subcultures give an indication of the number of cell generations that have occurred since cells last went through autogamy. Trophont ciliate cultures that have undergone less than 10 subcultures are considered to contain “young” trophont cells.
- In some embodiments, the vol:vol ratio of the population of ciliate cells to the aqueous solution is between about 1:10 to about 10:1. In some embodiments, the vol:vol ratio of the population of ciliate cells to the aqueous solution is at least about 1:10, 1:8, 1:4, 1:2, 1:1, 2:1, 4:1, 6:1, 8:1, or 10:1. In some embodiments, the vol:vol ratio of the population of ciliate cells to the aqueous solution is less than about 10:1, 8:1, 6:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:6, 1:8, or 1:10. Combinations of any two of these upper or lower values to form a range are also possible.
- The population of trophont ciliate cells are incubated in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
- In some embodiments, the trophont ciliate cells may be incubated in the aqueous solution at a temperature effective to induce encystment to form encysted ciliate cells. The temperature may be between 10° C. to about 40° C. The temperature may be at least about 10, 15, 20, 25, 30, 35 or 40° C. The temperature may be less than about 40, 35, 30, 25, 20, 15 or 10° C. Combinations of any two of these upper or lower values to form a range is possible, for example between about 20° C. to about 30° C.
- In some embodiments, the trophont ciliate cells may be incubated in the aqueous solution at a temperature of at least about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C. The temperature may be less than about 30, 29, 28, 27, 26, 25, 24, 23, 22, 21 or 20° C. Combinations of any two of these upper or lower values to form a range is possible, for example between about 20° C. to about 28° C. In some embodiments, the trophont ciliate cells may be incubated in the aqueous solution at a temperature of about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C.
- In some embodiments, the trophont ciliate cells may be incubated in the aqueous solution for a period of time effective to induce encystment to form encysted ciliate cells. The period of time may be between about 0.5 hours to about 96 hours. The period of time may be at least about 12, 24, 36, 48, 60, 72, 84, or 96 hours. The period of time may be less than about 96, 84, 72, 60, 48, 36, 24 or 12 hours. Combinations of any two of these upper or lower values to form a range is possible, for example between about 12 hours to about 72 hours.
- In some embodiments, the trophont ciliate cells may be incubated in the aqueous solution at a temperature and for a period of time effective to induce encystment to form encysted ciliate cells (i.e. an encystment temperature) and then subsequently incubated at a temperature effective to store the encysted ciliate cells (i.e. a storage temperature). It will be appreciated that the encystment and storage temperature may be the same. For example, the ciliate cells may be incubated at i) a first temperature to induce encystment to form encysted ciliate cells and then ii) transferred to a second temperature to store the encysted ciliate cells.
- The encystment temperature i) may be at least about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C. The encystment temperature may be less than about 30, 29, 28, 27, 26, 25, 24, 23, 22, 21 or 20° C. Combinations of any two of these upper or lower values to form a range is possible, for example between about 10° C. to about 30° C., e.g. about 26° C. The storage temperature ii) may be at least about 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30° C. The storage temperature may be less than about 30, 29, 28, 27, 26, 25, 24, 23, 22, 21, 20, 19, 18, 17, 16, or 15° C. Combinations of any two of these upper or lower values to form a range is possible, for example between about 10° C. to about 30° C., or between about 15° C. to about 25° C., e.g. about 20° C.
- The encystment temperature i) may be maintained for a period of time of between about 0.5 hours to about 96 hours. The encystment temperature may be maintained for at least about 12, 24, 36, 48, 60, 72, 84, or 96 hours. The encystment temperature may be maintained for less than about 96, 84, 72, 60, 48, 36, 24 or 12 hours. Combinations of any two of these upper or lower values to form a range is possible, for example between about 12 hours to about 72 hours. The storage temperature ii) may be maintained for a period of time of at least 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 12 weeks, 15 weeks, or 20 weeks.
- The method may further comprise the step of dehydrating the aqueous solution to obtain a dried polymer wherein the one or more encysted ciliate cells are interspersed within the polymer. The dehydration step essentially evaporates the aqueous solution leaving a dried polymer. It will be appreciated that the polymer can be rehydrated upon contact with a suitable aqueous environment, such as water (e.g. rain or a sprinkler following application to an environment) or an aqueous solution as described herein. The aqueous solution may be dried using any conventional means, such as room temperature airflow, mild heat and/or vacuum. The ciliate cells interspersed within the dried polymer remain viable even after dehydration. Encystment of trophonts to ciliate cells may occur during dehydration.
- The aqueous solution may be dehydrated from a humidity under ambient conditions (e.g. an ambient humidity at 20° C. and atmospheric pressure) to a reduced humidity. For example, dehydrating the aqueous solution will result in a relative humidity of less than 100%. In some embodiments, the aqueous soil solution comprising the incubated trophont ciliate cells and suspended soil particles is dehydrated to a relative humidity of less than about 100%, 95%, 90%, 85%, 80%, 75%, 70%, 65%, 60%, 55%, 50%, 45%, or 40%, for example less than about 80%, 75%, or 70%. Combinations of these relative humidities are also possible, for example about 40% to about 75% relative to the ambient humidity. The dehydrated environment may be obtained by any suitable means, including for example using humidity chambers. The humidity levels may be measured by any routine means including a humidity monitor or hygrometer, such as a gravimetric hygrometer. In some embodiments, the aqueous solution is dehydrated for at least about 0.5, 1, 2, 3, 4, 5, 8, 10, 12, 15, 18, 20, 24 or 30 days. In some embodiments, the aqueous solution is dehydrated at a temperature of between about 20° C. to about 30° C., for example about 20° C.
- In some embodiments, the hydrocolloid comprising the ciliate cells may be dried (e.g. dehydrated) to form a dried polymer/hydrocolloid comprising the ciliate cells.
- In some embodiments, prior to incubating in the aqueous polymer solutions, the trophont cells were obtained via culturing T. rostrata in PPYE media (0.5% (w/v) proteose peptone (Oxoid LP0085), 0.5% (w/v) yeast extract (Oxoid LP0021), and 0.125% (w/v) glucose) or PP media (1% w/v Proteose Peptone (Oxoid LP0085) and 0.125% w/v glucose). In one embodiment, the trophont cells are then subcultured in PP media. Using trophont cells cultured in PPYE and sub cultured in PP media may provide further advantages such as increased cyst resilience following encystment.
- In some embodiments, the encysted ciliate cells are subsequently transferred to fresh nutrient medium where they undergo excystment to form theront ciliate cells. Alternatively, the encysted ciliate cells may be stabilised and stored at a suitable temperature and for a period of time as described herein, for example at 20° C. or by dehydration.
- One or more additives may be added to the aqueous solution either prior to or during incubation (e.g. prior to or during) encystment or after incubation (e.g. after encystment) of the ciliate cells.
- In one embodiment, magnesium ions may be added to the aqueous solution prior to or during incubation in an amount effective to stimulate encystment of one or more trophont ciliate cells. In this embodiment, it will be appreciated that concentration of the magnesium ions added to the aqueous solution prior to or during incubation is in a non-crosslinking amount, i.e. the magnesium ions are not present in an amount effective to ionically cross-link the polymer (e.g. carrageenan, xanthan gum and/or gellan gum) in which the trophont ciliate cells are interspersed therein.
- In some embodiments, the concentration of the magnesium ions in the aqueous solution prior to or during incubation is provided in an amount effective to stimulate encystment of the one or more trophont ciliate cells, for example between is about 15 μM to about 500 μM. In some embodiments, the concentration of the magnesium ions in the aqueous solution prior to or during incubation is at least about 15, 20, 30, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500 or 1000 μM. In other embodiments, the concentration of the magnesium ions in the aqueous solution prior to or during incubation is less than about 1000, 500, 450, 400, 350, 300, 250, 200, 100, 50, 30, 20, or 15 μM. Combinations of these concentration values to form various ranges are also possible, for example the concentration of the magnesium ions in the aqueous solution prior to or during incubation is between about 15 μM to about 1000 μM, between about 20 μM to about 300 μM, between about 30 μM to about 200 μM, or between about 50 μM to about 150 μM. In one embodiment, the concentration of magnesium ions in the aqueous solution prior to or during incubation is between about 60 μM to about 65 μM, for example about 62.5 μM. The magnesium ions (e.g. provided by magnesium sulfate) may be added to the aqueous solution at any point prior to or during incubation to stimulate encystment of one or more trophont ciliate cells.
- Alternatively or additionally, the method may further comprise the step of adding magnesium ions to the aqueous solution following incubation (e.g. following encystment) in an amount effective to stabilise the one or more encysted ciliate cells. According to some embodiments or examples described herein, the present inventors have found that adding magnesium ions to the buffer solutions comprising encysted ciliate cells prior to storing stabilised the one or more encysted cells for a prolonged period of time.
- In some embodiments, the concentration of magnesium ions added to the aqueous solution following incubation is in an amount effective to stabilise encysted ciliate cells, for example between about 25 mM to about 100 mM. In some embodiments, the concentration of magnesium ions added to the aqueous solution following incubation is at least about 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 90 or 100 mM. In other embodiments, the concentration of magnesium ions added to the aqueous solution following incubation is less than about 100, 90, 80, 75, 70, 65, 60, 55, 50, 40, 35, 30 or 25 mM. Combinations of these concentration values to form various ranges are also possible, for example the concentration of magnesium ions added to the aqueous solution following incubation is between about 25 mM to about 75 mM, for example about 50 mM. In one embodiment, the ciliate cells are incubated with the aqueous solution for at least about 6, 12, 18 or 24 hours prior to the addition of magnesium ions. In one embodiment, the method further comprises the step of adding magnesium ions to the aqueous solution following encystment to stabilise the one or more encysted ciliate cells. In one embodiment, the magnesium ions are added to the aqueous solution after incubation but prior to storing the encysted ciliate cells. In one embodiment, the magnesium ions are added to the aqueous solution after incubation but prior to transferring the aqueous solution from the encystment temperature to the storage temperature. According to some embodiments or examples, the addition of magnesium ions may stabilise encysted cells at lower polymer concentrations.
- The magnesium ions described herein may be provided by a suitable magnesium salt, for example magnesium sulfate (MgSO4) or magnesium carbonate (MgCO3). In one embodiment, the magnesium ions are provided by magnesium sulfate. It will be appreciated that when the magnesium sulfate or magnesium carbonate is dissolved in the aqueous solution, magnesium ions (Mg2+) are present.
- The embodiments described above and herein in relation to the magnesium ions as an additive in relation to the method of inducting encystment equally apply to magnesium ions present as an additive in the compositions described herein.
- In some embodiments, one or more bacterial metabolites, including for example one or more bacterial polysaccharides as described herein, may be added to the aqueous solution. The bacterial metabolites may be derived from composted pine bark particles.
- The composted pine bark particles may have an average particle size of between about 1 μm to about 200 μm. The composted pine bark particles may have an average particle size of at least about 1, 5, 10, 15, 20, 25, 30, 40, 50, 60, 80, 100, or 120 μm. The composted pine bark particles may have an average particle size of less than about 120, 100, 80, 60, 50, 40, 30, 25, 20, 15, 10, 5 or 1 μm. Combinations of average particle sizes are also possible, for example the composted pine bark particles may have an average particles size of between about 5 μm to about 100 μm, or between about 5 μm to about 60 μm. The composted pine bark particles may have an average particle size of less than about 60 μm. In one embodiment, the composted pine bark particles may have an average particle size of less than about 30 μm. As used herein, the term “average particle size” refers to a mean average particle size as determined by sieve analysis.
- In some embodiments, the aqueous solution comprises between about 0.01% w/v to about 10% w/v composted pine bark particles based on the total volume of the aqueous solution. In some embodiments, the aqueous solution comprises at least about 0.001, 0.01, 0.02, 0.05, 0.08, 0.1, 0.2, 0.5, 1, 2, 5, or 10% w/v composted pine bark particles based on the total volume of the aqueous solution. In some embodiments, the aqueous solution comprises less than 10, 5, 2, 1, 0.5, 0.2, 0.1, 0.08, 0.05, 0.02, 0.01 or 0.001% w/v composted pine bark particles based on the total volume of the aqueous solution. Combinations of these ranges are also possible.
- Alternatively or additionally, the aqueous solution may comprise other particles, such as algal cells, starch (e.g. corn starch), grains (e.g. rice), activated charcoal, magnesium silicate, polystyrene and dextrans (e.g. sulphopropyl and quaternary ammonia ethyl substituted dextrans) or bacterial cells, including in the % w/v amounts recited above for the composted pine bark particles.
- The aqueous solution and compositions described herein may comprise any one or more additives as described above and herein in relation to the method of encysting ciliate cells.
- The polymer solutions described herein can also stabilised ciliate cells.
- In one aspect or embodiment, there is provided a method of stabilising encysted ciliate cells, the method comprising suspending a population of encysted ciliate cells in an aqueous solution comprising a polymer as described herein.
- The encysted ciliate cells may be obtained by methods described herein, or one or more alternative encystment methods. For example, the encysted ciliate cells may be obtained by incubating a population of trophont ciliate cells in a buffer solution comprising magnesium ions, or by incubating a population of trophont ciliate cells in an aqueous solution comprising suspended soil particles (i.e. an aqueous soil solution), wherein the trophont ciliate cells undergo encystment to form one or more encysted ciliate cells. Alternatively, the encysted ciliate cells are obtained by incubating a population of trophont ciliate cells in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells, as described herein.
- In another aspect or embodiment, there is provided a method of stabilising excysted ciliate cells (e.g. theronts), the method comprising suspending a population of excysted ciliate cells in an aqueous solution comprising a polymer as described herein.
- It will be appreciated that the embodiments provided above for the polymer, ciliate cells, aqueous solution and additives in relation to the composition, encystment media and method of inducing encystment also equally apply to the polymer, ciliate cells, aqueous solution and additives to the method of stabilising encysted ciliate cells, where applicable.
- The polymers, aqueous solutions and/or hydrocolloids comprising the ciliate cells are stable and the ciliate cells remained viable during storage. In one embodiment, the ciliate cells within the polymer (either as an aqueous solution, hydrocolloid or dried polymer) remained as encysted ciliate cells during storage. For example, the present inventors discovered that, in some embodiments, trophont ciliate cells that were incubated within an aqueous polymer solution underwent encystment to form encysted ciliate cells, and remained as encysted ciliate cells during storage. Additionally, it was also identified that if pre-formed encysted cells were suspended or interspersed within the polymer as described herein, they also remained as encysted ciliate cells during storage. This demonstrates that ciliate cells can be stored and remain stable when suspended in polymers of the present disclosure.
- In some embodiments, nearly all of the encysted ciliate cells within the polymer remained as encysted ciliate cells and viable for at least about 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks, 9 weeks, 10 weeks, 12 weeks, 15 weeks, 20 weeks, 6 months, 12 months, 18 months or 24 months, highlighting the effect suspension/interspersion within the polymer (e.g. carrageenan) has on ciliate cell stability. In some embodiments, the polymer comprising encysted ciliate cells is stored in a sealed container.
- In one embodiment, the ciliate cells suspended or interspersed within the polymer can be stored under ambient conditions (e.g. in the dark, room temperature). For example, the storage temperature may be between about 1° C. to about 30° C. In some embodiments, the storage temperature may be at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, or 30° C. In other embodiments, the storage temperature may be less than about 30, 28, 26, 24, 22, 20, 18, 16, 14, 12, 10, 9, 8, 7, 6, 5, 4, 3, or 2° C. Combinations of these storage temperatures to form various ranges are also possible, for example, between about 3° C. to about 25° C., or between about 4° C. to about 28° C.
- For example, the present inventors have identified that, in some embodiments, the encysted ciliate cells remained encysted and viable after 8 weeks storage at 20° C. These encysted cells remained viable and following release from the polymer, the encysted cells were able to excyst into theront cells and establish new populations in culture, highlighting the improved storage properties of the polymers of the present invention.
- In another embodiment, the ciliate cells suspended or interspersed within the polymer can be stored in the dark. In some embodiments, the ciliate cells suspended or interspersed within the polymer can be stored with minimal to no additional moisture.
- In some embodiments, the suspended or interspersed ciliate cells can subsequently be released from the polymer into the external environment. For example, the polymer can be suspended/soaked in water which softening the polymer structure allowing for the encysted or encapsulated cells to be released to the external environment.
- In some embodiments, the encysted cells within the polymer are able to undergo excystment to form theront ciliate cells upon release from the polymer. For example, when the polymer comprising the encysted ciliate cells is suspended in fresh media (e.g. sodium citrate buffer or PPYE medium), the encysted ciliate cells are gradually released which then undergo excystment to form theront ciliate cells. The theront ciliate cells can then mature into a healthy new trophont cell cultures.
- Methods and Compositions for Infecting or Colonising a Pest Species with a Ciliate
- Theront cells are the infective form of T. rostrata which were more effective at killing or reducing the fitness of slugs faster than trophont ciliate cells. In some embodiments, the compositions of the present invention can be used to transport and deliver viable and stable encysted ciliate cells to a pest species and/or to an area affected or likely to be affected by a pest species (e.g. slugs or snails), where once the cells are released from within the polymer, they can undergo excystment to form the infective theront ciliate cells which are released into the environment and infect the pest species.
- In other embodiments, the compositions of present invention can be used to transport and deliver viable and stable excysted ciliate cells (e.g. theronts) to a pest species and/or to an area affected or likely to be affected by a pest species (e.g. slugs or snails). According to some embodiments or examples described herein, it has been identified that the compositions described herein can also stabilise theronts which remain viable and infective for a sufficient period of time, which can then be directly applied to pest species as described herein.
- Therefore, in some embodiments, the compositions and ciliate cells as described herein can be dispersed in the environment for infection or colonisation of pests. In one embodiment, the aqueous polymer solutions or polymers suspending ciliate cells as described herein can be dispersed in the environment for infection or colonisation of pests.
- In a related aspect or embodiment, there is provided a method of infecting or colonising a pest species with a ciliate, the method comprising applying to an area affected or likely to be affected by a pest species a composition described herein or an encysted ciliate cell prepared or stabilised by the methods described herein, or a composition as described herein. In a related aspect or embodiment, there is provided a method of infecting or colonising a pest species with a ciliate, the method comprising applying a composition as described herein or an encysted ciliate cell prepared or stabilised by the method as herein to the pest species.
- As used herein, the term “colonisation” or variants thereof refers to the entry of the protist to an external facing tissue or orifice of the pest such as the sub-mantle tissue lining or gut tissue following ingestion of the polymer or ciliate cells released therefrom. The pest species may consume the polymer and release the encapsulated or suspended ciliate cells.
- In some embodiments, the compositions or ciliate cells can be applied to the pest species (e.g. applied directly to the pest species). Such direct application may include spraying the composition or ciliate cells onto the pest species.
- In other embodiments, the compositions or ciliate cells can be applied to an agricultural, water (i.e. aquaculture) environment and/or horticultural environment. In one embodiment, the compositions or ciliate cells may be applied to an area of soil affected by a pest (such as a slug or a snail). For example, in relation to the aqueous polymer solution or polymer comprising the ciliate cells may dissolve/disintegrate in the moist soil environment and release the ciliate cells into the soil. The encysted ciliate cells released may subsequently undergo excystment within the soil into theront ciliate cells which are infective and can infect various pest species living in, on or around the soil area. If the cells released from the polymer are trophont ciliate cells, then once released, the trophont ciliate cells may encyst in the soil environment to form encysted ciliate cells, which can then subsequently excyst to form the infective theront ciliate cells, as per the life cycle in
FIG. 1 or can invade the pest animal tissue directly. The released ciliate cells may also be ingested by the pest, and undergo transformation within the pest to form theront ciliate cells. In yet another embodiment, if the released ciliate cells are theront ciliate cells, these may go on to infect the pest species. - In other embodiments, the compositions or ciliate cells could be applied to an area and subsequently wetted (e.g. by the rain, sprinkler, inundation, or drip irrigation etc.) wherein the water environment promotes the release of the ciliate cells. For example, a dried polymer (e.g. carrageenan) may dissolve in the moist environment and release the ciliate cells, which can go on to form theront ciliate cells, and subsequently infect pest species. In some embodiments, the compositions or ciliate cells are applied directly to the pest species (e.g. by spraying onto the pest species). It will be appreciated that such direct application may occur simultaneously with the application of the composition or ciliate cells to an area affected or likely to be affected by a pest species as described herein. For example, by directly applying the compositions or ciliate cells to the pest species, the infected pest species may then spread the theronts to niches where other pests take refuge thus promoting colonising and infection.
- Other areas that may be affected by pests that the compositions and ciliate cells of the present invention can be applied to include farms, gardens, crops, nurseries, pastures, fields, greenhouses, shadehouses, hydroponic nurseries.
- In one embodiment, the area or environment the compositions or ciliate cells are applied to is an agricultural crop. In one aspect or embodiment, there is provided a method for reducing agricultural crop damage comprising applying to an agricultural crop area affected or likely to be affected by a pest species a pest species a composition described herein or an encysted ciliate cell prepared or stabilised by the methods described herein, or a composition as described herein.
- In another aspect or embodiment, there is provided an agricultural or horticultural composition comprising the composition described herein or an encysted ciliate cell prepared or stabilised by the methods described herein, in combination with one or more agriculturally or horticulturally acceptable carriers.
- In another embodiment, the compositions or ciliate cells may be added to a container with holes to allow access for pest species, for example commercial traps (refuges) currently on the market for pest control, such as slug and snail traps. Without wishing to be bound by theory, placing the compositions or ciliate cells in such traps may expose the pests long enough for them to get infected with the ciliate cells which then kills them, or even if the pests manage to leave the trap, the infected pest would disperse the ciliates as they migrate around the adjacent area, thus spreading the ciliate infection to other pests in the area. The trap can then be refilled with more of the compositions or ciliate cells as the pest species consumes them. Other advantages may be provided by such using traps to deliver the compositions or ciliate cells to pest species, such as portability to different garden areas as damage to plants is observed indicating the presence of pests requiring control. It will be appreciated that other delivery methods are also envisaged and the above examples are not to be considered limiting.
- In some embodiments, the compositions or ciliate cells may comprise or be further mixed with one or more acceptable carriers. The acceptable carrier may be an agriculturally or horticulturally acceptable carrier. As used herein, an “acceptable carrier” and/or an “agriculturally acceptable carrier” and/or a “horticulturally acceptable carrier” is any carrier on which can facilitate the transport of the compositions or ciliate cells to an area affected or likely to be affected by a pest species (such as an invertebrate), and which is otherwise suitable for agricultural or horticultural use. Any such suitable acceptable carrier can be used, including but not limited to seeds, seed coats, granular carriers, liquid slurry carriers, and liquid suspension carriers.
- Suitable agriculturally or horticulturally acceptable carriers include fillers, solvents, excipients, surfactants, suspending agents, spreaders/stickers (adhesives), antifoaming agents, dispersants, wetting agents, drift reducing agents, auxiliaries, adjuvants or a mixture thereof. For example, the agriculturally or horticulturally acceptable carrier may be selected from the group consisting of a filler stimulant, an anti-caking agent, a wetting agent, an emulsifier, and an antioxidant, for example said composition comprises at least one of each of a filler stimulant, an anti-caking agent, a wetting agent, an emulsifier, and an antioxidant.
- In one embodiment solid carriers include but are not limited to mineral earths such as silicic acids, silica gels, silicates, talc, kaolin, attapulgus clay, limestone, lime, chalk, bole, loess, clay, bentonite, dolomite, diatomaceous earth, aluminas calcium sulfate, magnesium sulfate, magnesium oxide, peat, humates, ground plastics, fertilizers such as ammonium sulfate, ammonium phosphate, ammonium nitrate, and ureas, and vegetable products such as grain meals, bark meal, wood meal, and nutshell meal, cellulosic powders, seaweed powders, peat, talc, carbohydrates such as mono-saccharides and di-saccharides, starch extracted from corn or potato or tapioca, chemically or physically altered corn starch and the like. As solid carriers for the compositions, cells and strains of the present invention, the following are suitable as carriers: crushed or fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite; synthetic granules of inorganic or organic meals; granules of organic material such as sawdust, coconut shells, corn cobs, corn husks or tobacco stalks; kieselguhr, tricalcium phosphate, powdered cork, or absorbent carbon black; water soluble polymers, resins, waxes; or solid fertilizers. Such solid compositions may, if desired, contain one or more compatible wetting, dispersing, emulsifying or colouring agents which, when solid, may also serve as a diluent.
- The acceptable carrier preferably has a sufficient shelf life, and preferably assists in the dispersion of the compositions, ciliate cells and/or isolated strains to an area affected or likely to be affected by a pest species (such as an invertebrate).
- The pest species can be an invertebrate or a vertebrate. In one embodiment, the vertebrate is a lower vertebrate.
- In one embodiment, the pest species is an invertebrate. The invertebrate may be a mollusc or arthropod, such as a dipteran (e.g. a mosquito). In another embodiment, the pest species is a vertebrate, for example a fish species. In a preferred embodiment, the invertebrate is a mollusc, for example a Gastropod.
- The Gastropod may be a snail or a slug. The slugs and snails to be controlled in include all land-dwelling slugs and snails, for example those which occur as polyphagus pests in agricultural and horticultural crops. Agriculturally and horticulturally problematic slug and snail types are, for example, slugs such as the invasive Anion ater group such as A ater, A rufus, and A vulgaris). Other non-limiting examples of slugs to be controlled include Ambigolimax valentianus, Deroceras invadens, Limacus flavus, Deroceras reticulatum (i.e. grey field slugs).
- All media and solutions were prepared fresh using laboratory grade water and sterilised by autoclaving at 121° Celsius for 20 minutes unless otherwise noted. PPYE media consisted of 0.5% (w/v) proteose peptone (Oxoid LP0085), 0.5% (w/v) yeast extract (Oxoid LP0021), and 0.125% (w/v) glucose. PP medium was PPYE without yeast extract (0.5% w/v Proteose Peptone (Oxoid LP0085) and 0.125% w/v glucose).
- Isolation of T. rostrata TRAUS
- Strain TRAUS was isolated from an egg laid by a F1 laboratory-reared D. reticulatum whose parents were collected from Melbourne, Australia. The egg was surface sterilised in 0.01% v/v hypochlorite for 5 min then washed several times in sterile distilled water to remove the hypochlorite. The egg was aseptically opened using a needle to release the ciliates into water and then immediately transferred to 10 ml of SPP media in a 25 cm2 tissue culture flask with a vented lid (IWAKI).
- To prepare the 0.25% w/v carrageenan buffer solution, 1.5 g carrageenan (Sigma C1013, CAS Number: 9000-07-1) was mixed with 600 mL of water either at 17-20° C. or 90-100° C. for 15 minutes, or autoclaved at 121° C. for 10 minutes, and then allowed to cooled before addition of 10
mM HEPES pH 7 NaOH buffer. - Preparation of 0.125% Carrageenan Buffer Solution (0.125% w/v Carrageenan-H)
- To prepare the 0.125% w/v carrageenan buffer solution, 0.75 g carrageenan (Sigma C1013, CAS Number: 9000-07-1) was mixed with 600 mL of water either at 17-20° C. or 90-100° C. for 15 minutes, or autoclaved at 121° C. for 10 minutes, and then allowed to cooled before addition of 10
mM HEPES pH 7 NaOH buffer - A composted pine bark infusion buffer (CI—H) was prepared, according to a modified protocol by Segade et al. (2016) by mixing 50 g of medium grade composted pine bark (Pinus radiata; Australian Growing Solutions, Tyabb, Victoria, Australia) in Milli Q ultrapure water. The suspension was maintained in agitation for 15 min at room temperature (20° C.) and then large particles were removed by sieving and/or centrifugation. The decanted suspension was sterilised by autoclaving and
HEPES buffer pH 7 was added to a final concentration of 10 mM. - UP6 and UP4 filtered composted pine bark infusion buffers were prepared by washing the fine surface layer particles out from approximately 500 g of the medium grade composted pine bark, in two batches in a 400 micron sieve (hop spider), with reverse osmosis water. The flow through was then passed through a 50 micron Nitex mesh netting cloth (Australian Entomological Supplies) and the collected filtrate was sterilised by autoclaving, then stored at room temperature.
- Harvesting Dried Particles from CI (DCIP), UP4 (DUP4) and UP6 (DUPE)
- Particles from the infusions were harvested by centrifugation at 800 g for 10 min. The particles were then air dried, and then rehydrated to the desired concentration.
- Magnesium sulfate (MgSO4) was dissolved in ultrapure water at a concentration of 62.5 μM and subsequently autoclaved at 121° C. for 20 minutes.
- T. rostrata trophonts were obtained using an isolated strain of T. rostrata TRAUS (deposited under PTA-126056 on 13 Aug. 2019 at the American Type Culture Collection) and were cultivated at 20° C. in PPYE and subcultured in PP. The density of the culture was assessed by a direct cell counting using a haemocytometer indicating the culture was 4.6×104 cell/ml.
- Trophonts grown in PP media were harvested (800×
g 10 min), washed in 2 volumes of 10mM HEPES pH 7 NaOH (HEPES) and resuspended to a volume equivalent to 5×104 original trophonts per ml in either 1) 0.25% carrageenan-H; 2) 0.125% carrageenan-H; or 3) CI—H, and subsequently transferred to tissue culture plates and incubated under various conditions to evaluate the response of trophonts to incubation in the solutions at different temperatures. - Trophonts are tear-drop shaped (rostrate) whereas they change to a rounded form during encystment into encysted ciliate cells. The rounding of the trophonts was the indication that the conditions may stimulate cyst formation. Rounded cells were examined microscopically for characteristic cyst capsules. The viability of the cyst-like cells was assessed by restoring the cells to conditions permissive for growth and measuring the viability as the ability to multiply using the Most Probable Number Method (MPN) over 31 days. T=0 (days) from the commencement of the PP trophont culture. For the viability counts, trophonts were determined as viable through their movement and were directly counted. All other viability counts on the cultures were done by determining MPN on 3 individual cultures and the 95% confidence limits are shown. The percent round cells counts on the incubated cultures were determined from their individual cultures with the maximum and minimum values.
- Laboratory-reared D. reticulatum were maintained as previously described by Billman-Jacobe et al. (2020). Young slugs, ˜0.8 cm long, were selected for all experiments. Each slug was housed in a 25 ml tube containing 3 g of moist potting soil (Plugger 111-Seedraising Mix, Australian Growing Solutions). The tubes were placed in a humidified box and kept in a controlled environment at 17° C. with a 12-hour photoperiod. There were 20 slugs per treatment. The grazing activity and mortality of slugs was assessed daily or weekly, depending on the experiment. Each slug was provided Chinese cabbage for food and the cabbage was replaced as required.
- For experiments, 20 replicates of individually-housed D. reticulatum slugs were exposed to 105 or zero trophonts or theronts. The theronts and trophonts were concentrated by centrifugation at 800 g for 10 min for the challenge. Trophonts used for challenge experiments were derived from cysts and cultured in PPYE for 4 days to stimulate excystment and conversion to trophonts. Trophonts were washed free of media using 10
mM HEPES pH 7 NaOH and stored at 20° C. for 1 day at a density of 3×104 cells/ml (a density at which the trophonts do not encyst at 20° C.). - The response of the trophonts incubated in the autoclaved carrageenan buffer solutions at 26° C. is shown in
FIG. 2 . The efficiency of encystment in 0.125% carrageenan-H and 0.25% carrageenan-H was equivalent to the CI—H encystment. After 31 days, some of the encysted cells excysted into theront cells, however at a lesser rate carrageenan-H compared to CI—H. The cysts formed in carrageenan have distinctive capsules which are characteristic of typical T. rostrata cysts (seeFIG. 6 ). - The response of the trophonts incubated in the autoclaved carrageenan buffer solutions at 20° C. is shown in
FIG. 3 . Encystment was tested carried out at 20° C. In CI—H there is a flux between encysted-excysted-re-encysted cells resulting in low overall cyst yield and a diversity in the cell population. This is seen in wide margins of error in cell counts. The number of cells that encysted in 0.25% carrageenan-H was greater than in 0.125% carrageenan-H or for the CI—H. - The response of the trophonts incubated in the autoclaved carrageenan buffer solutions at 26° C. followed by transfer to 20° C. is shown in
FIG. 4 . Cysts formed in CI—H at 26° C. excyst when they are transferred to 20° C. Cysts made in 0.25% carrageenan-H remained encysted at the lower temperature. This finding demonstrates that stable cysts can be made in a single step and may offer a simpler process than the two-step process with encystment followed by stabilisation with other additives (such as MgSO4, see below). - The effect of adding magnesium ions to the buffer solutions comprising encysted ciliate cells was evaluated and shown in
FIG. 5 . This treatment was tested by adding MgSO4 after 24 hours incubation at 26° C. but prior to transfer to 20° C. The MgSO4 prevented excystment of cells in CI—H and both carrageenan-H solutions, and did not affect viability of any of the cells in any treatment. The Addition of metal can be used to produce stable cysts with different concentrations of polymer. - The trophonts were suspended in 0.25% or 0.125% carrageenan-H and CI—H and were placed in humidity chambers at 20° C. suspended in humidity chambers above different saturated salts, sodium chloride or sodium bromide, which would equalise at relative humidity 75.7% or 59.1%, respectively. They were allowed to dehydrate at 20° C. The cell morphology in the dried carrageenan was assessed microscopically after 18 days and 31 days. All cells were round and cyst-like and were trapped in the dried film (
FIG. 7 ). - The above examples show that T. rostrata TRAUS is capable of converting from trophonts to cysts in carrageenan solutions. Stable encystment in carrageenan is very efficient at both 20° C. and 26° C. and the cysts remained viable and stable.
- Carrageenan (Sigma C1013), LA-gellan gum (Kelcogel® F LA-gellan gum) and HA-gellan gum (Kelcogel® LT100 HA-gellan) were each dissolved separately in ultrapure water at room temperature to form a hydrocolloid suspension/solution. The carrageenan (CGN) was autoclaved at 121° C. for 20 minutes, and then cooled to room temperature. The gellan were not heat treated. The suspensions/solutions were then added at various concentrations to T. rostrata cells at 1-3×104 cell per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 26° C.
- The encystment in carrageenan and gellan gum buffer solutions were compared to three control infusion buffer solutions prepared using compost pine bark (CI) and collected, dried and resuspended composted pine park particles (CDIP and DUP4) buffered with
HEPES buffer pH 7 to a final concentration of 10 mM, and were then added at various concentrations to T. rostrata cells at 1-3×104 cell per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 26° C. - After 26 hours, the infusion buffer solutions were screened for their ability to encyst T. rostrata. Table 1 shows the proportion of T. rostrata cells that encysted using either the control pine bark infusion buffer solutions or the carrageenan/gellan gum buffer solution.
-
TABLE 1 The percent of T. rostrata cells stimulated to encyst by extracts of composted pine bark (CI, DCIP, DUP4), carrageenan (CGN) and gellan gum. LA HA gellan gellan CI DCIP DUP4 CGN CGN # gum gum Charge Anionic Anionic Anionic Anionic Origin Plant Plant Plant Seaweed Seaweed Bacteria Bacteria mg/mL Percent of cells that encysted 0.195 56 60 55 66 51 32 47 0.0381 77 59 79 65 52 38 66 0.0781 81 59 90 67 65 49 58 0.1563 61 86 71 64 48 82 0.3125 68 90 68 67 55 91 0.625 82 92 81 83 43 91 1.25 81 98 86 92 62 2.5 86 99 58 1CGN# was modified by the addition of HEPES pH7 (NaOH) at 10 mM prior to autoclaving. - The encystment using the three control infusion buffers are shown in
FIG. 8 , highlighting the bark infusion preparations result in high efficiency of encystment.FIG. 9 shows the proportion of cells that encysted using preparations of carrageenan and gellan gum. Carrageenan and HA-gellan gum buffer solutions demonstrated high encystment efficiency T. rostrata. - As carrageenan stimulates high efficiency of encystment of T. rostrata, the durability of the resulting cysts and infectivity of the excysted theronts was determined. The resulting cysts are durable and tolerated conditions like dehydration and certain salt concentrations. Carrageenan encysts T. rostrata when used in a buffer solution at 0.025% to 0.25% w/v. At the lower carrageenan concentration, 2 days is required for peak encystment, unlike 1 day at the higher carrageenan concentrations. Excystment of the theronts occurs at 20° C. when carrageenan is used in a buffer solution at 0.025% to 0.125% w/v. A higher concentration of carrageenan (0.25% w/v) resulted in a lower rate of excystment.
- The theronts produced in carrageenan buffer solutions at 0.025% and 0.125% w/v show the same characteristic bi-lobed macronucleus and a micronucleus as those produced in buffered compost infusion (CI—H) or 62.5 μM MgSO4 when Giemsa stained (see
FIG. 10 ). - Populations of theronts in the encystment buffer solutions at 20° C. were monitored for up to 120 days by determining viable counts, using Most Probable Number (MPN) assays (see
FIG. 11 ). The MPN assay determines the number of viable cells present, which could multiply and establish a trophont culture. The culture was monitored by observing and counting cell morphology, as the cells changed from trophonts (day 0) through to cysts during starvation (day 1 to 3) and then theronts after excystment (day 5 to 7). The excysted cells were confirmed to be theronts by Giemsa staining and showed the characteristic bi-lobed macronucleus and a micronucleus. - Theronts produced and then stored at 20° C. in either buffered 0.025% w/v carrageenan persist for 2 months in a similar way to those in buffered CI (see
FIG. 10 ). The theronts size remained stable. Theronts produced and then stored at 20° C. in either buffered 0.125% w/v carrageenan or 62.5 μM MgSO4 also persist for 2 months. - D. reticulatum lethality experiments were performed using theronts that had excysted from cysts produced in buffered 0.025% w/v carrageenan, and the results are shown in
FIG. 12 . D. reticulatum slugs were exposed to 1×105 theronts produced in buffered compost infusion (UP-6), 0.025% w/v carrageenan, or 62.5 μM MgSO4. They were also exposed to 1×105 trophonts in HEPES buffer. The survival of the slugs was monitored over 28 days. - The impact of the theronts made in compost infusion buffer (UP6) and carrageenan, on mortality and grazing was apparent after 7 days of exposure. And by 2 weeks 95% of the slugs exposed to theronts produced in compost infusion buffer (UP6) and carrageenan were affected and 16 or 15/20 of the slugs, respectively, were dead. In contrast, when slugs were exposed to theronts produced in 62.5 μM MgSO4 or trophonts more than ½ the slugs were alive at 28 days post exposure.
- Carrageenan (Sigma C1013) was dissolved in ultrapure water at room temperature to form a hydrocolloid suspension/solution, and autoclaved at 121° C. for 20 minutes, and then cooled to room temperature. 0.025% w/v carrageenan solution was then added at to T. rostrata cells at 3×105 cells per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 20° C. Control infusion buffer solutions were prepared using compost pine bark (CI) and collected, dried and resuspended composted pine park particles (UP6) buffered with
HEPES buffer pH 7 to a final concentration of 10 mM, and then added to T. rostrata cells at 3×105 cell per ml and the culture was buffered with HEPES pH 7 (NaOH) at 10 mM to stimulate encystment at 20° C. After 26 hours, the infusion buffer solutions were screened for their ability to encyst and excyst T. rostrata at high cell densities (see Table 2). -
TABLE 2 Theronts yield when T. rostrata is encysted & excysted at 20° C. at a cell density of 3 × 105 cell per ml in various encystment buffers. Culture at 8 days at 20° C. (Cell density on day 1 was3 × 105 trophonts per ml) % of the ciliated cells Infusion Cells % that are Theronts buffer per ml Ciliates theronts per ml CI 2.6 × 105 86 73 1.6 × 105 UP6 3.5 × 105 85 89 2.6 × 105 CGN 2.0 × 105 77 74 1.1 × 105 - In addition to the polysaccharides carrageenan and gellan gum, a range of other polysaccharides were selected and sourced to screen for their ability to encyst T. rostrata, as outlined in Table 3. The polysaccharides were dissolved at a known concentration (either 0.125% w/v or 0.25% w/v) in stirred ultrapure water and heated to ensure full dissolution and hydration of the polysaccharide before cooling to room temperature to form an aqueous polysaccharide solution/suspension.
- The cooled polysaccharide solutions/suspension was then added at 2-fold dilutions to T. rostrata at 1-3×104 cells per ml (low cell density). The cultures comprising the polysaccharide were then buffered with HEPES pH 7 (NaOH) at 10 mM and incubated at 26° C. for 26 hours. The percent of round/oval cells were counted, and these were determined to be cysts visually. For cysts a defined capsule layer around the protozoa with cells that are slightly compressed within the layer were seen. Many cells displayed cyclopsis (internal rotating movement) was occurring and the cells clustered and adhered together. To evaluate encystment efficiency, the encystment of T. rostrata cells in 10 mM HEPES pH 7 (NaOH) alone was used as a control, where 50% are cysts after 26 hours at 26° C. The type of polysaccharide and encystment results are shown in Table 3:
-
TABLE 3 The percent of T. rostrata cells stimulated to encyst by various polysaccharide buffer solutions at 26° C. after 26 hours. Encystment of T. rostrata cells in 10 mM HEPES pH 7 (NaOH) alone was used as a control where 50% are cysts after 26 hours at 26º C. Polysaccharide Dextran Fucoi- Na- sulphate k-CGN I-CGN λ-CGN dian alginate Xanthan Xanthan 40 kDa CMC (Sigma k-CGN (Sigma I-CGN (Sigma (Sigma (Sigma (MFD (MFD (Sigma Guar (Sigma C1013) (MFD) C1138) (MFD) 22049) F8315) A2033) viscosity) thickener) 42867) (MFD) 419338) Charge Anionic Anionic Anionic Anionic Anionic Anionic Anionic Anionic Anionic Anionic Neutral Anionic Origin Seaweed Seaweed Seaweed Seaweed Seaweed Seaweed Seaweed Bacteria Bacteria Bacteria Plant Synthetic Heat treatment 90- 90- 90- 90- 90- 90- 60°C 90- 90- 17- 17- 17- 100° C. 100° C. 100° C. 100° C. 100° C. 100° C. 100° C. 100° C. 21° C. 21° C. 21° C. mg/mL Percent of cells that encysted 0.00488 39 0.00977 63 0.01953 69 51 52 58 0.03906 77 80 64 60 53 0.07813 84 52 84 83 87 56 49 0.15625 95 53 88 62 36 55 98 81 63* 46 75* 0.3125 93 79 95 51 68 51 40 98 99 76* 53 74* 0.625 97 96 100 70 73 33 67* 100 99 nd* 58 71* 1.25 98 98 97 79* 84 75 66* nd* 64 2.5 *Indicates presence of cell lysis. - The encystment data demonstrates that a range of polysaccharides can encyst T. rostrata at higher percentages compared to the control using HEPES buffer alone as the encystment buffer (i.e. no polysaccharide). Consistent with the earlier examples, carrageenan buffer solutions encysted T. rostrata, with k-carrageenan (kappa) and I-carrageenan (iota) demonstrating high encystment efficiency (see
FIG. 13 ). The anionic polysaccharide Xanthan gum encysted T. rostrata with very high efficiency (seeFIG. 13 ). - The effect of heat treatment during hydrocolloid formation on T. rostrata encystment was investigated, as outlined in Table 4
- The polysaccharides were dissolved at 0.125% w/v in stirred heated to 90-100° C. or 50-60° C. ultrapure water to ensure full dissolution and hydration of the polysaccharide before cooling to room temperature or in stirred ultrapure water at room temperature (17-20° C.). The polysaccharide solutions/suspension was then added at 2-fold dilutions to T. rostrata at 1-3×104 cells per ml (low cell density). The cultures comprising the polysaccharide were then buffered with HEPES pH 7 (NaOH) at 10 mM and incubated at 26° C. for 26 hours. The percent of round/oval cells were counted, and these were determined to be cysts visually. For cysts a defined capsule layer around the protozoa with cells that are slightly compressed within the layer were seen. For many slight cyclopsis (internal rotating movement) was occurring and the cells clustered and adhered together.
- To evaluate encystment efficiency, the encystment of T. rostrata cells in 10 mM HEPES pH 7 (NaOH) alone was used as a control, where 50% are cysts after 26 hours at 26° C. The type of polysaccharide and encystment results are shown in Table 4:
-
TABLE 4 The percent of T. rostrata cells stimulated to encyst by various polysaccharide buffer solutions at 26° C. after 26 hours. Encystment of T. rostrata cells in 10 mM HEPES pH 7 (NaOH) alone was used as a control where 50% are cysts after 26 hours at 26° C. Polysaccharide k-CGN HA-gellan HA-gellan HA-gellan (90-100° C.) (90-100° C.) (50-60° C.) (17-20° C.) Charge Anionic Anionic Anionic Anionic Origin Seaweed Bacteria Bacteria Bacteria mg/mL Percent of cells that encysted 0.01953 62 0.03906 81 54 0.07813 71 63 0.15625 96 54 48 91 0.3125 88 49 58 96 0.625 91 67 62 96 1.25 99 - Heating and cooling the HA-gellan likely changes the structural matrix that this hydrocolloid forms. The encystment data suggests that the structure matrix of polysaccharides is important to encyst T. rostrata at higher percentages compared to the control using HEPES buffer alone as the encystment buffer (i.e. no polysaccharide). HA gellan that has not been heat-cooled encysted T. rostrata with high encystment efficiency (see
FIG. 14 ). - It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive.
- All publications discussed and/or referenced herein are incorporated herein in their entirety.
- Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is solely for the purpose of providing a context for the present invention. It is not to be taken as an admission that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention as it existed before the priority date of each claim of this application.
- The present application claims priority from AU2021900775 filed on 17 Mar. 2021, the entire contents of which are incorporated herein by reference.
-
- Billman-Jacobe et al. (2020), Biocontrol Sci. Technol 30: 920-928
- Parhi et al. (2017) Adv Pharm Bull 7:515-530
- Segade et al. (2016) Parasitol Res 115:771-777
Claims (76)
1. A composition comprising encysted ciliate cells that are interspersed within a non-ionically crosslinked polymer.
2. The composition of claim 1 , wherein the polymer comprises a polysaccharide.
3. The composition of claim 2 , wherein the polysaccharide is an anionic polysaccharide.
4. The composition of claim 2 or claim 3 , wherein the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria.
5. The composition of any one of claims 2 to 4 , wherein the polysaccharide is an algal polysaccharide or a bacterial polysaccharide.
6. The composition of claim 5 , wherein the polysaccharide is selected from the group consisting of carrageenan, agarose, agar, alginate, xanthan gum and gellan gum, or a mixture thereof.
7. The composition of any one of claims 1 to 6 , wherein the polysaccharide is carrageenan, xanthan gum or gellan gum, or a mixture thereof.
8. The composition of any one of claims 1 to 7 , wherein the polymer is dispersed in an aqueous solution, and the encysted ciliate cells are suspended in the aqueous solution comprising the polymer.
9. The composition of claim 8 , wherein the aqueous solution comprising the polymer forms a hydrocolloid.
10. The composition of any one of claims 1 to 9 , wherein the aqueous solution comprises between about 0.01% w/v to about 5% w/v polymer based on the total volume of the aqueous solution.
11. The composition of any one of claims 1 to 10 , wherein the aqueous solution comprises between about 0.01% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
12. The composition of any one of claims 1 to 11 , wherein the aqueous solution is a buffer solution.
13. The composition of claim 12 , wherein the buffer solution comprises a HEPES buffering agent.
14. The composition of claim 13 , wherein the concentration of the HEPES buffering agent in the buffer solution is between about 5 mM to about 25 mM.
15. The composition of any one of claims 12 to 14 , wherein the buffer solution has a pH of between about 6.0 to about 9.0.
16. The composition of any one of claims 1 to 15 , wherein the encysted ciliate cells interspersed within the polymer remain viable for at least about four weeks.
17. The composition of any one of claims 1 to 16 , wherein the ciliate cells are a member of the Ciliophora phylum.
18. The composition of any one of claims 1 to 17 , wherein the ciliate cells are a member of the Heterotrichea, Karyorelictea, Armophorea, Litostomatea, Colpodea, Nassophorea, Phyllopharyngea, Prostomatea, Plagiopylea, Oligohymenophorea, Protocruziea, Spirotrichea, or Cariotrichea class.
19. The composition of any one of claims 1 to 18 , wherein the ciliate cells are a member of the Apostomatia, Astomatia, Hymenostomatia, Peniculia, Peritrichia, or Scuticociliatia order.
20. The composition of any one of claims 1 to 19 , wherein the ciliate cells are a member of the Tetrahymenidae, Ophryoglenina, or Peniculina family.
21. The composition of any one of claims 1 to 20 , wherein the ciliate cells are a member of the Tetrahymena genus.
22. The composition of any one of claims 1 to 21 , wherein the ciliate cells are of the T. rostrata, T. hegewischi, T. hyperangularis, T. malaccensis, T. patula, T. pigmentosa, T. foissneri, T. deweyae, T. pyriformis, T. thermophila, T. vorax, T. geleii, T. corlissi, T. empidokyrea or T. limacis species.
23. The composition of any one of claims 1 to 22 , wherein the ciliate cells are of the T. rostrata species.
24. A method of inducing the encystment of ciliate cells, the method comprising incubating a population of trophont ciliate cells in an aqueous solution comprising a polymer at a temperature and for a period of time effective to induce the encystment of the trophont ciliate cells to form one or more encysted ciliate cells.
25. A method of stabilising encysted ciliate cells, the method comprising suspending a population of encysted ciliate cells in an aqueous solution comprising a polymer.
26. The method of claim 24 or claim 25 , wherein the aqueous solution comprising the polymer forms a hydrocolloid.
27. The method of any one of claim 25 to claim 26 , wherein the polymer is not ionically crosslinked during encystment.
28. The method of any one of claims 24 to 27 , wherein the polymer comprises a polysaccharide.
29. The method of claim 28 , wherein the polysaccharide is an anionic polysaccharide.
30. The method of claim 28 or claim 29 , wherein the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria.
31. The method of any one of claims 28 to 30 , wherein the polysaccharide is derived from algae or bacteria.
32. The method of claim 31 , wherein the polysaccharide is selected from the group consisting of carrageenan, agarose, agar, alginate, xanthan gum and gellan gum, or a mixture thereof.
33. The method of any one of claims 24 to 32 , wherein the polysaccharide is carrageenan, xanthan gum or gellan gum, or a mixture thereof.
34. The method of any one of claims 24 to 33 , wherein the aqueous solution comprises between about 0.01% w/v to about 5% w/v polymer based on the total volume of the aqueous solution.
35. The method of any one of claims 24 to 34 , wherein the aqueous solution comprises between about 0.01% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
36. The method of claim 24 or any one of claims 25 to 35 , wherein the trophont ciliate cells are incubated in the aqueous solution at a temperature of between about 10° C. to about 30° C.
37. The method of claim 24 , or any one of claims 25 to 36 , wherein the trophont ciliate cells are incubated in the aqueous solution for period of time of between about 12 to about 72 hours.
38. The method of any one of claims 24 to 37 , wherein the aqueous solution is a buffer solution.
39. The method of claim 38 , wherein the buffer solution comprises a HEPES buffering agent.
40. The method of claim 39 , wherein the concentration of the HEPES buffering agent in the buffer solution is between about 1 mM to about 25 mM.
41. The method of any one of claims 38 to 40 , wherein the buffer solution has a pH of between about 6.0 to about 9.0.
42. The method of any one of claims 24 to 41 , further comprising the step of adding magnesium ions to the aqueous solution prior to or during incubation in an amount effective to stimulate encystment of one or more trophont ciliate cells.
43. The method of any one of claims 24 to 42 , further comprising the step of adding magnesium ions to the aqueous solution following incubation in an amount effective to stabilise the one or more encysted ciliate cells.
44. The method of claim 43 , wherein the magnesium ions are provided by magnesium sulfate.
45. The method of any one of claims 24 to 34 , wherein the encysted ciliate cells are stored in the aqueous solution at a temperature of between about 10° C. to about 30° C.
46. The method of any one of claims 24 to 45 , further comprising dehydrating the aqueous solution to obtain a dried polymer wherein the one or more encysted ciliate cells are interspersed within the polymer.
47. The method of any one of claims 24 to 46 , wherein the ciliate cells are a member of the Ciliophora phylum.
48. The method of any one of claims 24 to 47 , wherein the ciliate cells are a member of the Heterotrichea, Karyorelictea, Armophorea, Litostomatea, Colpodea, Nassophorea, Phyllopharyngea, Prostomatea, Plagiopylea, Oligohymenophorea, Protocruziea, Spirotrichea, or Cariotrichea class.
49. The method of any one of claims 24 to 48 , wherein the ciliate cells are a member of the Apostomatia, Astomatia, Hymenostomatia, Peniculia, Peritrichia, or Scuticociliatia order.
50. The method of any one of claims 24 to 49 , wherein the ciliate cells are a member of the Tetrahymenidae, Ophryoglenina, or Peniculina family.
51. The method of any one of claims 24 to 50 , wherein the ciliate cells are a member of the Tetrahymena genus.
52. The method of any one of claims 24 to 51 , wherein the ciliate cells are of the T. rostrata, T. hegewischi, T. hyperangularis, T. malaccensis, T. patula, T. pigmentosa, T. foissneri, T. deweyae, T. pyriformis, T. thermophila, T. vorax, T. geleii, T. corlissi, T. empidokyrea or T. limacis species.
53. The method of any one of claims 24 to 52 , wherein the ciliate cells are of the T. rostrata species.
54. An encystment media composition comprising an aqueous solution and a non-ionically crosslinked polymer.
55. The composition of claim 54 , wherein the aqueous solution comprising the polymer forms a hydrocolloid.
56. The composition of claim 54 or claim 55 , wherein the polymer comprises a polysaccharide.
57. The composition of claim 56 , wherein the polysaccharide is an anionic polysaccharide.
58. The composition of claim 56 or claim 57 , wherein the polysaccharide is derived from one or more of algae, plants, animals, fungi, or bacteria.
59. The composition of any one of claims 56 to 58 , wherein the polysaccharide is derived from algae.
60. The composition of claim 59 , wherein the algal polysaccharide is selected from the group consisting of carrageenan, agarose, agar and alginate, or a mixture or copolymer thereof.
61. The composition of any one of claims 54 to 60 , wherein the polysaccharide is carrageenan.
62. The composition of any one of claims 54 to 61 , wherein the aqueous solution comprises between about 0.1% w/v to about 5% w/v polymer based on the total volume of the aqueous solution.
63. The composition of any one of claims 54 to 62 , wherein the aqueous solution comprises between about 0.1% w/v to about 1% w/v polymer based on the total volume of the aqueous solution.
64. The composition of any one of claims 54 to 63 , wherein the aqueous solution is a buffer solution.
65. The composition of claim 64 , wherein the buffer solution comprises a HEPES buffering agent.
66. The composition of claim 65 , wherein the concentration of the HEPES buffering agent in the buffer solution is between about 1 mM to about 25 mM.
67. The composition of any one of claims 64 to 66 , wherein the buffer solution has a pH of between about 6.0 to about 9.0.
68. An agricultural or horticultural composition comprising the composition of any one of claims 1 to 23 or an encysted ciliate cell prepared or stabilised by the method according to any one of claims 24 to 53 , in combination with one or more agriculturally or horticulturally acceptable carriers.
69. A method of infecting or colonising a pest species with a ciliate, the method comprising applying to an area affected or likely to be affected by a pest species a composition of any one of claim 1 to 23 or 68 or an encysted ciliate cell prepared or stabilised by the method according to any one of claims 24 to 53 .
70. A method of infecting or colonising a pest species with a ciliate, the method comprising applying a composition of any one of claim 1 to 23 or 68 or an encysted ciliate cell prepared or stabilised by the method according to any one of claims 24 to 53 to the pest species
71. A method for reducing agricultural crop damage comprising applying to an agricultural crop area affected or likely to be affected by a pest species a pest species a composition of any one of claim 1 to 23 or 68 or an encysted ciliate cell prepared or stabilised by the method according to any one of claims 24 to 53 .
72. The method of any one of claims 69 to 71 , which results in the ciliate killing or affecting the fitness of the pest species.
73. The method of any one of claims 69 to 72 , wherein the pest species is an invertebrate.
74. The method of claim 73 , wherein the pest species is a mollusc.
75. The method of claim 74 , wherein the mollusc is a Gastropod.
76. The method of claim 75 , wherein the Gastropod is a snail or slug.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021900775A AU2021900775A0 (en) | 2021-03-17 | Encystment and stabilisation of ciliate protoza cells | |
AU2021900775 | 2021-03-17 | ||
PCT/AU2022/050235 WO2022192956A1 (en) | 2021-03-17 | 2022-03-17 | Encystment and stabilisation of ciliate protozoa cells |
Publications (1)
Publication Number | Publication Date |
---|---|
US20240150747A1 true US20240150747A1 (en) | 2024-05-09 |
Family
ID=83321837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/281,486 Pending US20240150747A1 (en) | 2021-03-17 | 2021-03-17 | Encystment and stabiilisation of ciliate protozoa cells |
Country Status (2)
Country | Link |
---|---|
US (1) | US20240150747A1 (en) |
WO (1) | WO2022192956A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8326633D0 (en) * | 1983-08-04 | 1983-11-09 | Unilever Plc | Compositions |
US9603368B2 (en) * | 2012-09-17 | 2017-03-28 | University Of Connecticut | Microbial carriers for targeted delivery of agricultural payloads |
WO2021046618A1 (en) * | 2019-09-13 | 2021-03-18 | The University Of Melbourne | Hydrogel compositions comprising protist cells |
-
2021
- 2021-03-17 US US18/281,486 patent/US20240150747A1/en active Pending
-
2022
- 2022-03-17 WO PCT/AU2022/050235 patent/WO2022192956A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022192956A1 (en) | 2022-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tittabutr et al. | Growth, survival and field performance of bradyrhizobial liquid inoculant formulations with polymeric additives | |
Castelar et al. | Ulva lactuca and U. flexuosa (Chlorophyta, Ulvophyceae) cultivation in Brazilian tropical waters: recruitment, growth, and ulvan yield | |
CN109679884B (en) | Efficient corn growth-promoting bacterium capable of reducing application of nitrogen and phosphorus fertilizers and application thereof | |
WO2010115335A1 (en) | Paecilomyces cicadae biological microbial agent, preparation method therefor and use thereof in controlling plant nematodes | |
CN105505836A (en) | Bacillus subtilis and methods for preparing and using bacillus subtilis microbial agent for controlling potato scab | |
CN105859381A (en) | Compound microbial-fermented organic fertilizer and preparation method therefor | |
WO2017107872A1 (en) | Microbial attractant, and use | |
CN107779408A (en) | A kind of beauveria bassiana and its microbial bacterial agent for being used to prevent and treat chafer | |
CN102657155B (en) | Nematicide granules with sawdust as carrier and preparation method thereof | |
CN102657235B (en) | Nematicidal composition containing verticillium chlamydosporium and Paecilomyces lilacinus and preparation method thereof | |
CN102907458B (en) | Biological mosquitocide and preparation method thereof | |
US20240150747A1 (en) | Encystment and stabiilisation of ciliate protozoa cells | |
CN103981108A (en) | Beauveria bassiana for preventing radysia odoriphaga and application thereof | |
US20220340863A1 (en) | Hydrogel compositions comprising protist cells | |
CN110100843A (en) | The method that worm bait is lured using fruit fermenting and preparing biological | |
CN105746520B (en) | Application of the nanometer chitin in terms of tobacco production and quality is improved | |
KR20070024792A (en) | Encapsulation of agro-probiotics for promoting viable cell activity | |
CN110616165B (en) | Bacillus cereus MA23, microbial inoculum, preparation method and application | |
CN102599196A (en) | Tall fescue growth adjusting method of employing bacillus thuringiensis fermentation broth | |
Hay et al. | Use of novel film forming starch complexes to directly and indirectly reduce insect damage to plants | |
CN105859382A (en) | Novel microbial organic fertilizer for preventing and treating perennial root dwarf disease of Saccharum officinarum and preparation method therefor | |
CN112189673B (en) | Application of combination of serratia marcescens and streptomyces citri aurantii CGMCC4.6285 in preparation of biological pesticide | |
CN103392743B (en) | Bactericidal composition containing bacillus and echinomycin and preparation method thereof and application | |
BR102016000130A2 (en) | BIOINOCULANT CONTAINING BACILLUS MEGATERIUM IN POLYMERIC COMPOUND | |
JPS5823365B2 (en) | Saikin Seisatsu Yuzai Oyobi Sono Seizou Hohou |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION UNDERGOING PREEXAM PROCESSING |